


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:51:36Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12404894" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12404894</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>ijmm</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Med</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Med</journal-id><journal-id journal-id-type="pmc-domain-id">1936</journal-id><journal-id journal-id-type="pmc-domain">ijmm</journal-id><journal-id journal-id-type="publisher-id">IJMM</journal-id><journal-title-group><journal-title>International Journal of Molecular Medicine</journal-title></journal-title-group><issn pub-type="ppub">1107-3756</issn><issn pub-type="epub">1791-244X</issn><publisher><publisher-name>Spandidos Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12404894</article-id><article-id pub-id-type="pmcid-ver">PMC12404894.1</article-id><article-id pub-id-type="pmcaid">12404894</article-id><article-id pub-id-type="pmcaiid">12404894</article-id><article-id pub-id-type="pmid">40849821</article-id><article-id pub-id-type="doi">10.3892/ijmm.2025.5614</article-id><article-id pub-id-type="publisher-id">ijmm-56-05-05614</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Pathogen virulence genes: Advances, challenges and future directions in infectious disease research (Review)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Chen</surname><given-names initials="Y">Yun</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref><xref rid="c1-ijmm-56-05-05614" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="X">Xiaolong</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref><xref rid="af2-ijmm-56-05-05614" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="C">Chengcheng</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="J">Jianxiang</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref><xref rid="af2-ijmm-56-05-05614" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhang</surname><given-names initials="L">Lingyu</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref><xref rid="af3-ijmm-56-05-05614" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Qiu</surname><given-names initials="P">Peng</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zheng</surname><given-names initials="D">Danling</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="W">Wang</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="S">Shuyao</given-names></name><xref rid="af1-ijmm-56-05-05614" ref-type="aff">1</xref><xref rid="af2-ijmm-56-05-05614" ref-type="aff">2</xref><xref rid="af3-ijmm-56-05-05614" ref-type="aff">3</xref><xref rid="c1-ijmm-56-05-05614" ref-type="corresp"/></contrib></contrib-group><aff id="af1-ijmm-56-05-05614">
<label>1</label>Department of Pharmacy, Guangzhou Red Cross Hospital (Guangzhou Red Cross Hospital of Jinan University), Guangzhou, Guangdong 510220, P.R. China</aff><aff id="af2-ijmm-56-05-05614">
<label>2</label>College of Pharmacy, Jinan University, Guangzhou, Guangdong 511436, P.R. China</aff><aff id="af3-ijmm-56-05-05614">
<label>3</label>Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong 515041, P.R. China</aff><author-notes><corresp id="c1-ijmm-56-05-05614">Correspondence to: Professor Shuyao Zhang or Dr Yun Chen, Department of Pharmacy, Guangzhou Red Cross Hospital (Guangzhou Red Cross Hospital of Jinan University), 396 Tongfu Zhong Road, Guangzhou, Guangdong 510220, P.R. China, E-mail: <email>shuyao0754@qq.com</email>, E-mail: <email>gd_chenyun@163.com</email></corresp></author-notes><pub-date pub-type="collection"><month>11</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>22</day><month>8</month><year>2025</year></pub-date><volume>56</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">495445</issue-id><elocation-id>173</elocation-id><history><date date-type="received"><day>16</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>27</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright: &#169; 2025 Chen et al.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="ijmm-56-05-05614.pdf"/><abstract><p>Pathogens, including bacteria, viruses and fungi, employ virulence genes to invade their hosts, circumvent immunity and induce diseases. The present review examines the categorization and regulatory mechanisms of virulence genes and their co-evolution with antimicrobial resistance. The present review focused on the fimbrial adhesion H adhesion gene of <italic toggle="yes">Escherichia coli</italic>, the spike protein gene of severe acute respiratory syndrome coronavirus 2 and the enhanced filamentous growth protein 1 (EFG1) morphological transition gene of <italic toggle="yes">Candida albicans</italic>, as well as their roles in host adhesion, immune evasion and tissue damage. Application of technologies, including multi-omics integration, artificial intelligence and CRISPR-based genome editing, is discussed in the context of precision diagnostics, targeted therapy and vaccine development. By elucidating pathogen adaptation dynamics and host-pathogen interactions, the present review offers a basis for reducing the global burden of drug-resistant infections through improved surveillance and personalized interventions.</p></abstract><kwd-group><title>Key words</title><kwd>pathogen</kwd><kwd>virulence gene</kwd><kwd>antimicrobial resistance</kwd><kwd>multi-omics</kwd></kwd-group><funding-group><award-group><funding-source>2024 Guangdong Provincial Basic and Applied Basic Research Fund Natural Science Foundation Project-General project</funding-source><award-id>2024A1515010633</award-id></award-group><award-group><funding-source>2022 Special Fund for Hospital Pharmaceutical Research of Guangdong Province Hospital Association</funding-source><award-id>YXKY202204</award-id></award-group><award-group><funding-source>2023 Guangdong Provincial Hospital Pharmacist Youth Trust Research Fund</funding-source><award-id>2023QNTJ14</award-id></award-group><award-group><funding-source>2024 Guangdong Provincial Hospital Pharmaceutical Research Foundation</funding-source><award-id>2024A05</award-id></award-group><award-group><funding-source>2025 Guangzhou Health Science and Technology General Guidance Project</funding-source><award-id>20251A010011</award-id></award-group><funding-statement>The present study was supported by the 2024 Guangdong Provincial Basic and Applied Basic Research Fund Natural Science Foundation Project-General project (grant no. 2024A1515010633), the 2022 Special Fund for Hospital Pharmaceutical Research of Guangdong Province Hospital Association (grant no. YXKY202204), the 2023 Guangdong Provincial Hospital Pharmacist Youth Trust Research Fund (Qingyue Pharmacy Fund; grant no. 2023QNTJ14), the 2024 Guangdong Provincial Hospital Pharmaceutical Research Foundation (grant no. 2024A05) and the 2025 Guangzhou Health Science and Technology General Guidance Project (grant no. 20251A010011).</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><label>1.</label><title>Introduction</title><p>Pathogens, including bacteria, viruses, fungi and parasites, are the primary causes of infectious disease in humans, animals and plants, posing a significant burden on global health and the environment. According to the World Health Organization, infectious diseases account for millions of deaths annually, leading to substantial economic losses due to increased healthcare costs, decreased labor productivity, and declines in agricultural and livestock production (<xref rid="b1-ijmm-56-05-05614" ref-type="bibr">1</xref>,<xref rid="b2-ijmm-56-05-05614" ref-type="bibr">2</xref>).</p><p>Virulence genes are key to the pathogenicity of pathogens and encode products that facilitate host infection, colonization, tissue invasion, immune evasion and disease symptomatology (<xref rid="b3-ijmm-56-05-05614" ref-type="bibr">3</xref>,<xref rid="b4-ijmm-56-05-05614" ref-type="bibr">4</xref>). Virulence genes dynamically co-evolve with antibiotic resistance genes in mobile genetic elements such as plasmids and transposons (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>-<xref rid="b13-ijmm-56-05-05614" ref-type="bibr">13</xref>). This phenomenon was first identified in extended-spectrum &#946;-lactamase (<italic toggle="yes">ESBL</italic>)-producing <italic toggle="yes">Escherichia coli</italic> strains, where adhesin (<italic toggle="yes">fimH</italic>) and &#946;-lactamase <italic toggle="yes">(blaCTX-M</italic>) co-localize on incompatibility group F (<italic toggle="yes">IncF</italic>) plasmids (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>). This is in contrast to earlier models that viewed virulence and resistance as independent genetic traits (<xref rid="b6-ijmm-56-05-05614" ref-type="bibr">6</xref>,<xref rid="b14-ijmm-56-05-05614" ref-type="bibr">14</xref>). In-depth exploration of virulence genes can accurately elucidate pathogenic mechanisms and provide key insights for the development of prevention and control strategies against infectious disease. Furthermore, such research aids the development of innovative diagnostic techniques, targeted therapeutic drugs and efficient vaccines, thereby promoting the advancement of precision medicine (<xref rid="b4-ijmm-56-05-05614" ref-type="bibr">4</xref>,<xref rid="b15-ijmm-56-05-05614" ref-type="bibr">15</xref>,<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>).</p><p>The pathogens discussed in the present review (such as <italic toggle="yes">E. coli</italic>, <italic toggle="yes">S. aureus</italic>, <italic toggle="yes">C. albicans</italic> and SARS-CoV-2) were selected based on three criteria: global disease burden, clinical relevance to antimicrobial resistance and utility as model organisms in virulence research (<xref rid="b2-ijmm-56-05-05614" ref-type="bibr">2</xref>,<xref rid="b17-ijmm-56-05-05614" ref-type="bibr">17</xref>). For example, <italic toggle="yes">E. coli</italic> is among the top causes of bacterial infection worldwide, with numerous annual cases of urinary tract infection and diarrheal diseases, whereas <italic toggle="yes">ESBL</italic>-producing strains exemplify the co-evolution of virulence and resistance genes on mobile genetic elements (<xref rid="b1-ijmm-56-05-05614" ref-type="bibr">1</xref>,<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>). <italic toggle="yes">C. albicans</italic>, responsible for a large number of invasive fungal infections annually, serves as a model for studying fungal adaptability in immunocompromised hosts, such as biofilm-mediated resistance in catheter-associated infection (<xref rid="b18-ijmm-56-05-05614" ref-type="bibr">18</xref>). Emerging viruses such as SARS-CoV-2 have been prioritized because of their pandemic impact, with a large number of confirmed cases globally, highlighting the urgency of understanding virulence gene plasticity (such as <italic toggle="yes">S</italic> protein mutations driving immune evasion in &#959; variants) (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>). These criteria ensure a balanced representation of pathogens with notable public health implications and provide mechanistic insight into the virulence-antimicrobial resistance interplay.</p><p>The present review focuses on research progress in the field of pathogen virulence genes and practical applications. By integrating research findings on various pathogens, the characteristics, detection methods, and associations with drug resistance of different virulence genes can offer a reference for related research. This can also contribute to improving the clinical diagnosis and treatment of pathogenic infections and the prevention and control of drug resistance.</p></sec><sec sec-type="other"><label>2.</label><title>Mechanisms of pathogen virulence genes</title><sec><title>Mechanisms of virulence genes in pathogens</title><p>The virulence genes of pathogens regulate infection processes through specific molecular mechanisms, exhibiting differences in the genetic basis, infection strategy, and environmental responses of bacteria, viruses and fungi. As detailed in <xref rid="tI-ijmm-56-05-05614" ref-type="table">Table I</xref>, virulence factors are functionally categorized into four classes based on their mechanisms: i) Toxin genes that disrupt host cell integrity; ii) Adhesin genes mediating pathogen attachment; iii) Invasion genes enabling barrier penetration; and iv) Immune evasion genes subverting host defenses, with representative examples across bacterial, viral and fungal pathogens. These genes collectively form a sophisticated pathogenic network.</p></sec><sec><title>Bacteria: Mobile genetic element-driven invasive and adaptive networks</title><p>Bacterial virulence genes often cluster within pathogenicity islands (such as the locus of enterocyte effacement island in <italic toggle="yes">E. coli</italic>) or mobile genetic elements, such as plasmids and transposons (<xref rid="b17-ijmm-56-05-05614" ref-type="bibr">17</xref>,<xref rid="b20-ijmm-56-05-05614" ref-type="bibr">20</xref>). CRISPR-CRISPR associated protein (Cas) systems, traditionally known for their role in bacterial immunity against bacteriophages, have been shown to regulate the expression of virulence genes (<xref rid="b21-ijmm-56-05-05614" ref-type="bibr">21</xref>). In <italic toggle="yes">Salmonella</italic>, Cas12a, a component of the CRISPR-Cas system, exhibits non-specific RNase activity when activated under host immune or antibiotic pressure (<xref rid="b20-ijmm-56-05-05614" ref-type="bibr">20</xref>,<xref rid="b22-ijmm-56-05-05614" ref-type="bibr">22</xref>). This activity leads to global transcriptional suppression and induces a dormant state in the bacterial population (<xref rid="b22-ijmm-56-05-05614" ref-type="bibr">22</xref>). This physiological shift decreases overall invasiveness [including expression of virulence factors such as those encoded by <italic toggle="yes">Salmonella</italic> pathogenicity island 1 (<italic toggle="yes">SPI-1</italic>)] and promotes bacterial persistence, representing a mechanism distinct from its canonical phage defense function and contributing to chronic infection dynamics (<xref rid="b20-ijmm-56-05-05614" ref-type="bibr">20</xref>,<xref rid="b22-ijmm-56-05-05614" ref-type="bibr">22</xref>).</p><p>During adhesion and colonization, the <italic toggle="yes">fimH</italic> gene of <italic toggle="yes">E. coli</italic> encodes the tip protein of type 1 pili that specifically binds to mannose receptors on urinary epithelial cells and serves as a key pathogenic factor in urinary tract infections (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>,<xref rid="b23-ijmm-56-05-05614" ref-type="bibr">23</xref>). By contrast, the fibronectin-binding protein A (<italic toggle="yes">fnbA)</italic> gene of <italic toggle="yes">Staphylococcus aureus</italic> encodes fibronectin-binding proteins that mediate adhesion and colonization of damaged tissue surfaces (<xref rid="b24-ijmm-56-05-05614" ref-type="bibr">24</xref>,<xref rid="b25-ijmm-56-05-05614" ref-type="bibr">25</xref>). For invasion and immune evasion, enteropathogenic <italic toggle="yes">E. coli</italic> (EPEC) injects the effector protein translocated intimin receptor (Tir) into host cells via the type III secretion system [<italic toggle="yes">T3SS</italic>; enteropathogenic secretion genes <italic toggle="yes">(esc)</italic> gene cluster], inducing actin rearrangement to form 'pedestal' structures that disrupt the intestinal barrier (<xref rid="b26-ijmm-56-05-05614" ref-type="bibr">26</xref>,<xref rid="b27-ijmm-56-05-05614" ref-type="bibr">27</xref>). <italic toggle="yes">Streptococcus pneumoniae</italic> relies on the <italic toggle="yes">capsular polysaccharide synthesis (cps)</italic> gene cluster to synthesize capsular polysaccharides and evade complement-mediated phagocytosis by the host (<xref rid="b28-ijmm-56-05-05614" ref-type="bibr">28</xref>,<xref rid="b29-ijmm-56-05-05614" ref-type="bibr">29</xref>). In response to environmental stress within the host, the dormancy survival regulator <italic toggle="yes">(dosR)</italic> regulatory system of <italic toggle="yes">Mycobacterium tuberculosis</italic> is activated in the hypoxic microenvironment of macrophages, entering a dormant state by epigenetically silencing virulence genes (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>). The polyketide synthase (<italic toggle="yes">pks)</italic> gene encodes polyketide synthase to synthesize wax D, which enhances resistance to lysosomal degradation (<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>,<xref rid="b32-ijmm-56-05-05614" ref-type="bibr">32</xref>). The capacity of these mobile genetic elements to carry multiple genes of these mobile genetic elements often leads to the colocalization of bacterial virulence and resistance genes, such as <italic toggle="yes">fimH</italic> and <italic toggle="yes">blaCTX-M</italic> co-carried on <italic toggle="yes">IncF</italic> plasmids in ESBL-producing <italic toggle="yes">E. coli</italic>, forming 'pathogenic-resistant' co-evolutionary modules (<xref rid="b7-ijmm-56-05-05614" ref-type="bibr">7</xref>).</p><p>The interaction between bacterial virulence genes and host immunity is a dynamic process that drives pathogen adaptation. For example, <italic toggle="yes">M. tuberculosis</italic> uses the <italic toggle="yes">dosR</italic> regulon, a hypoxia-responsive genetic network, to enter metabolic dormancy within macrophages, thereby evading immune system clearance. This regulon includes genes, such as <italic toggle="yes">Rv3133c</italic>, which are key for maintaining bacterial persistence in granulomas. However, host-derived IFN-&#947; disrupts <italic toggle="yes">dosR</italic>-mediated dormancy by suppressing its transcriptional activity, leading to bacterial reactivation and the release of virulence factors such as early secreted antigenic target 6 kDa, which triggers granuloma rupture and systemic dissemination (<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>). Similarly, in ESBL-producing <italic toggle="yes">E. coli</italic>, selective pressure from antibiotic use promotes co-localization of virulence genes (such as <italic toggle="yes">fimH</italic>, encoding type 1 fimbriae) and resistance genes (such as <italic toggle="yes">blaCTX-M</italic>) on conjugative plasmids (<xref rid="b7-ijmm-56-05-05614" ref-type="bibr">7</xref>). Clinical data have revealed that <italic toggle="yes">fimH</italic> is more prevalent in ESBL-producing strains compared with non-ESBL-producing strains, with co-localized plasmids exhibiting markedly enhanced HGT efficiency (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>). This highlights how host-imposed antibiotic pressure directly facilitates the spread of hypervirulent resistant clones in the gastrointestinal tract. Additionally, <italic toggle="yes">S. aureus</italic> dynamically modulates biofilm formation via the intracellular adhesion locus ABCD (<italic toggle="yes">icaABCD</italic>) operon under neutrophil attack. Exposure to neutrophil-derived reactive oxygen species (ROS) upregulates ica expression, leading to biofilm structures that substantially decrease phagocytic clearance and are associated with increased bacterial persistence in chronic infection (<xref rid="b35-ijmm-56-05-05614" ref-type="bibr">35</xref>,<xref rid="b36-ijmm-56-05-05614" ref-type="bibr">36</xref>). These findings illustrate how bacterial pathogens exploit host immune cues to recalibrate their virulence strategies.</p></sec><sec><title>Viruses: Host-dependent invasion and antigenic variation strategies</title><p>Viral virulence genes directly determine infection tropism and immune escape efficiency, with functions that are dependent on host cell receptors and signaling pathways (<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein binds to lung cells via its receptor-binding domain (RBD). The N501Y mutation of the &#959; variant emerged under antibody pressure, driven by template switching during replication, a mechanism uncovered through single-genome sequencing (<xref rid="b39-ijmm-56-05-05614" ref-type="bibr">39</xref>). This finding contrasts with earlier hypotheses that viral mutations are randomly distributed (<xref rid="b40-ijmm-56-05-05614" ref-type="bibr">40</xref>). The human immunodeficiency virus <italic toggle="yes">(HIV) envelope (env) gene</italic> encodes glycoprotein (gp)120, which binds to CD4<sup>+</sup> T cell receptors to mediate viral membrane fusion with host cell membranes (<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>-<xref rid="b45-ijmm-56-05-05614" ref-type="bibr">45</xref>). To escape host immunity, the hemagglutinin (<italic toggle="yes">HA</italic>) gene of influenza viruses undergoes antigenic drift (such as point mutations in the HA1 domain of H3N2), altering the antibody recognition sites (<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b46-ijmm-56-05-05614" ref-type="bibr">46</xref>). The Hepatitis B virus X protein (HBx) protein of the hepatitis B virus interferes with host DNA repair and apoptosis signals by inhibiting the p53 pathway (<xref rid="b45-ijmm-56-05-05614" ref-type="bibr">45</xref>,<xref rid="b47-ijmm-56-05-05614" ref-type="bibr">47</xref>). In terms of gene expression regulation, adenovirus early region 1A activates host cell cyclins to create conditions for viral DNA replication (<xref rid="b48-ijmm-56-05-05614" ref-type="bibr">48</xref>,<xref rid="b49-ijmm-56-05-05614" ref-type="bibr">49</xref>). The quasispecies diversity of viruses (such as the high mutation rate of HIV) leads to the dynamic evolution of virulence phenotypes, making monotherapy prone to inducing drug-resistant mutations (<xref rid="b50-ijmm-56-05-05614" ref-type="bibr">50</xref>,<xref rid="b51-ijmm-56-05-05614" ref-type="bibr">51</xref>).</p><p>Viral evolution is associated with host immune surveillance. The SARS-CoV-2 S protein RBD undergoes mutations (such as &#959; N501Y) under neutralizing antibody pressure, enhancing angiotensin-converting enzyme (ACE)2 affinity while evading antibody recognition (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>). HIV-1 exhibits a similar plasticity. Hypermutation of the <italic toggle="yes">env</italic> gene in regions targeted by CD8<sup>+</sup> T cells drives immune escape, with notably higher mutation rates in patients with robust cytotoxic T lymphocyte response (<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>). Additionally, prolonged type I IFN exposure results in the selection of influenza A virus mutants [such as polymerase basic 2 (<italic toggle="yes">PB2</italic>) E627K] that evade IFN-mediated restriction, enhancing their replication in human cells (<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>). These examples highlight the evolutionary race between viral adaptation and host immunity.</p></sec><sec><title>Fungi: Dual virulence networks of morphological transition and microenvironmental response</title><p>Fungal virulence gene expression is regulated by the host microenvironment (temperature, pH and nutrients), facilitating invasion and colonization through morphological plasticity and metabolic adaptation (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>). In <italic toggle="yes">Candida albicans</italic>, enhanced filamentous growth protein 1 (EFG1) triggers yeast-to-hyphal growth at body temperature (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>). Recent studies have shown that low pH in macrophage phagosomes activates histone deacetylase 1 (Hda1), an enzyme that modifies the EFG1 promoter via histone H3 lysine 9 acetylation marks, linking environmental cues to virulence (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>). <italic toggle="yes">This mechanism has not been identified in previous transcriptional profiling studies</italic> (<xref rid="b56-ijmm-56-05-05614" ref-type="bibr">56</xref>,<xref rid="b57-ijmm-56-05-05614" ref-type="bibr">57</xref>). Hyphal wall protein 1 <italic toggle="yes">(HWP1</italic>) expresses hyphal wall proteins that mediate host cell adhesion and tissue penetration (<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>,<xref rid="b57-ijmm-56-05-05614" ref-type="bibr">57</xref>). The capsule induction gene 1 (<italic toggle="yes">Cig1</italic>) gene of <italic toggle="yes">Cryptococcus neoformans</italic> regulates capsular polysaccharide synthesis, notably increasing capsule thickness in macrophages (<xref rid="b58-ijmm-56-05-05614" ref-type="bibr">58</xref>,<xref rid="b59-ijmm-56-05-05614" ref-type="bibr">59</xref>). During immune evasion and damage, the rodlet protein A (<italic toggle="yes">RodA</italic>) hydrophobic protein of <italic toggle="yes">Aspergillus fumigatus</italic> mediates adhesion of conidia to the respiratory epithelium (<xref rid="b60-ijmm-56-05-05614" ref-type="bibr">60</xref>,<xref rid="b61-ijmm-56-05-05614" ref-type="bibr">61</xref>). The stress seventy subfamily A member 1 (<italic toggle="yes">ssa1)</italic> gene of <italic toggle="yes">Candida auris</italic> regulates heat shock protein (HSP) expression to enhance survival in hospital environments while carrying the azole resistance gene ergosterol biosynthesis gene 11 (<italic toggle="yes">ERG11</italic>) (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). Additionally, the biofilm and cell wall regulator 1 (<italic toggle="yes">Bcr1</italic>) gene of <italic toggle="yes">C. albicans</italic> regulates biofilm matrix synthesis, substantially decreasing antifungal drug penetration efficiency and leading to refractory catheter-associated infections (<xref rid="b63-ijmm-56-05-05614" ref-type="bibr">63</xref>-<xref rid="b66-ijmm-56-05-05614" ref-type="bibr">66</xref>).</p><p>Fungal pathogens exhibit adaptability to the host immune microenvironment. <italic toggle="yes">C. albicans</italic> transitions from yeast to hyphae in response to macrophage-derived reactive oxygen species (ROS), a process governed by the transcription factor EFG1. Hyphal morphogenesis enables tissue penetration and is coupled with the secretion of aspartyl proteases (<italic toggle="yes">Sap2-6</italic>), which degrade host antimicrobial peptides such as defensins and markedly decrease phagocytic killing (<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>,<xref rid="b67-ijmm-56-05-05614" ref-type="bibr">67</xref>). In immunocompromised hosts, <italic toggle="yes">C. albicans</italic> exploits IL-17A deficiency to colonize mucosal surfaces, with IL-17A-knockout mice showing a substantially higher fungal burden compared with wild-type controls (<xref rid="b68-ijmm-56-05-05614" ref-type="bibr">68</xref>). <italic toggle="yes">A. fumigatus</italic> adapts to hypoxic lung environments by upregulating iron acquisition genes siderophore biosynthesis enzyme A (<italic toggle="yes">SidA</italic>) and the allergenic protease aspf1 (Asp f1). Hypoxia-inducible factor 1&#945; signaling in host epithelial cells exacerbates fungal virulence by promoting <italic toggle="yes">SidA</italic>-mediated iron scavenging, and enhancing fungal survival and tissue invasion (<xref rid="b69-ijmm-56-05-05614" ref-type="bibr">69</xref>-<xref rid="b71-ijmm-56-05-05614" ref-type="bibr">71</xref>). These mechanisms highlight the bidirectional interaction between fungal virulence and the host immune defense.</p></sec><sec><title>Comparative mechanisms of virulence across pathogen types</title><p>Although bacteria, viruses and fungi employ distinct virulence strategies, shared themes emerge in their adaptations to the host environment. Bacterial pathogens (such as <italic toggle="yes">E. coli</italic> and <italic toggle="yes">S. aureus</italic>) often use secretion systems (such as <italic toggle="yes">T3SS</italic>) to directly inject effector proteins into host cells, thereby disrupting cellular processes (<xref rid="b36-ijmm-56-05-05614" ref-type="bibr">36</xref>,<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>). By contrast, viral pathogens (such as SARS-CoV-2 and HIV) rely on the host machinery for replication, with virulence genes (such as S protein and <italic toggle="yes">env</italic>) mediating entry and immune evasion through rapid mutations (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b39-ijmm-56-05-05614" ref-type="bibr">39</xref>). Fungal pathogens (such as <italic toggle="yes">C. albicans</italic> and <italic toggle="yes">A. fumigatus</italic>) exhibit morphological plasticity (such as the yeast-to-hyphal transition) and secrete hydrolases to penetrate host barriers (<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>,<xref rid="b73-ijmm-56-05-05614" ref-type="bibr">73</xref>). A unifying feature of all pathogens is the dynamic regulation of virulence genes in response to host immune pressure, such as biofilm formation in bacteria and antigenic drift in viruses (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b29-ijmm-56-05-05614" ref-type="bibr">29</xref>) (<xref rid="tII-ijmm-56-05-05614" ref-type="table">Table II</xref>).</p></sec><sec><title>Comparative mechanisms of immune-driven virulence evolution</title><p>Host immune pressure exerts selective forces on pathogen evolution, driving adaptations that balance pathogen survival and virulence. <italic toggle="yes">C. auris</italic> exemplifies this dynamic through its unique stress response strategy (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>,<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>). When challenged by neutrophil-derived ROS, <italic toggle="yes">C. auris</italic> activates the <italic toggle="yes">HSP90</italic>-calcineurin axis, a highly conserved pathway (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). <italic toggle="yes">HSP90</italic>, a molecular chaperone, stabilizes calcineurin under oxidative stress, enabling the fungus to maintain hyphal morphogenesis and escape phagolysosomal degradation (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>,<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>). Pharmacological inhibition of <italic toggle="yes">HSP90</italic> with geldanamycin disrupts this axis, restoring fluconazole susceptibility in resistant clinical isolates (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). This contrasts with <italic toggle="yes">C. albicans</italic>, which predominantly relies on the <italic toggle="yes">EFG1</italic>-mediated pathway for hyphal transition under similar conditions (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>). Notably, <italic toggle="yes">C. auris</italic> exhibits higher <italic toggle="yes">HSP90</italic> expression in host niches than <italic toggle="yes">C. albicans</italic>, a trait amplified in multidrug-resistant strains (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>,<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>). Transcriptomic profiling has revealed that <italic toggle="yes">C. auris</italic> integrates <italic toggle="yes">HSP90</italic> activity with up-regulation of the efflux pump gene Candida drug resistance 1 (<italic toggle="yes">CDR1</italic>), thereby establishing a dual defense against immune clearance and antifungal drugs (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). Such adaptations explain its dominance in immunocompromised hosts, where simultaneous immune evasion and drug resistance confer survival advantages.</p><p>These evolutionary adaptations mirror the strategies observed in <italic toggle="yes">A. fumigatus</italic>, where hypoxia-induced <italic toggle="yes">HSP90</italic> upregulation enhances iron acquisition and tissue invasion (<xref rid="b73-ijmm-56-05-05614" ref-type="bibr">73</xref>). <italic toggle="yes">C. auris</italic> uniquely co-opts this pathway to bridge environmental persistence and clinical virulence. For example, <italic toggle="yes">HSP90</italic>-dependent calcineurin signaling not only promotes hyphal growth but also activates biofilm-associated adhesins agglutinin-like sequence 3 (<italic toggle="yes">ALS3</italic>), facilitating the colonization of medical devices (<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>). This multifunctional exploitation of stress-response pathways highlights the ability to thrive under diverse selective pressures, from hospital disinfection protocols to host immune responses.</p></sec><sec><title>Evolutionary dynamics of virulence genes</title><sec><title>Horizontal gene transfer (HGT) and virulence dissemination</title><p>Bacterial virulence evolution is shaped by HGT, a process driven by mobile genetic elements such as plasmids, transposons and pathogenicity islands, which enable the rapid dissemination of virulence factors and typically couple virulence with antibiotic resistance (<xref rid="b7-ijmm-56-05-05614" ref-type="bibr">7</xref>,<xref rid="b10-ijmm-56-05-05614" ref-type="bibr">10</xref>). In <italic toggle="yes">E. coli</italic>, the <italic toggle="yes">IncF</italic> plasmid exemplifies this phenomenon by co-localizing the fimH adhesin gene (key for urinary tract infection) and the blaCTX-M &#946;-lactamase gene, resulting in ESBL-producing strains with higher fimH prevalence, with notably enhanced transfer efficiency (<xref rid="b8-ijmm-56-05-05614" ref-type="bibr">8</xref>,<xref rid="b9-ijmm-56-05-05614" ref-type="bibr">9</xref>). The transposon 554 (Tn554) transposon in <italic toggle="yes">S. aureus</italic> carries both the erythromycin resistance methylase (erm) resistance gene and the exfoliative toxin B (etb) toxin gene to drive multidrug-resistant, hypervirulent clones, such as USA300, which exhibit markedly higher transfer efficiency and mortality rates in severe infection (<xref rid="b75-ijmm-56-05-05614" ref-type="bibr">75</xref>). CRISPR-Cas systems, which are typically linked to phage defense, participate in the evolution of virulence. Under immune pressure, <italic toggle="yes">Salmonella</italic> Cas12a cleaves transcripts of the SPI-1 virulence island (<xref rid="b21-ijmm-56-05-05614" ref-type="bibr">21</xref>). This downregulates invasion genes to balance the severity of infection with host survival and promotes chronicity of the disease.</p></sec><sec><title>Immune pressure-driven genetic adaptation</title><p>Host immune responses impose selective pressure on viral virulence determinants, driving adaptive genetic diversification and structural evolution (<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>). Viruses such as influenza A and SARS-CoV-2 exhibit accelerated antigenic evolution through continuous genomic alterations (<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>). Seasonal H3N2 strains accumulate mutations in the HA gp (such as the E190G substitution) that compromise the antibody neutralization capacity and diminish vaccine effectiveness (<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b46-ijmm-56-05-05614" ref-type="bibr">46</xref>). Concurrently, the SARS-CoV-2 &#959; variant exhibits key amino acid substitutions in the RBD of the S protein, notably the N501Y mutation, resulting in enhanced ACE2 receptor binding affinity alongside immune evasion from neutralizing antibodies (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>). Bacteria such as <italic toggle="yes">S. pneumoniae</italic> modify <italic toggle="yes">cps</italic> genes to alter the capsular polysaccharide structure, notably decrease complement deposition and evade vaccine-induced immune responses (<xref rid="b75-ijmm-56-05-05614" ref-type="bibr">75</xref>). <italic toggle="yes">Shigella</italic> uses <italic toggle="yes">T3SS</italic> to inject invasion plasmid antigen B (<italic toggle="yes">ipaB</italic>), a protein that mimics host apoptotic signals, to suppress inflammatory IL-1&#946; secretion (<xref rid="b76-ijmm-56-05-05614" ref-type="bibr">76</xref>). Fungi such as <italic toggle="yes">C. albicans</italic> use epigenetic reprogramming, in which the Hda1 enzyme modifies the EFG1 promoter to activate hyphal transition, enabling hyphae to secrete <italic toggle="yes">Sap2-6</italic> proteases that degrade host defensins and decrease the phagocytic killing efficiency (<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>).</p></sec><sec><title>Morphological and metabolic evolution in fungal pathogens</title><p>Fungal virulence genes have evolved to optimize adaptation to host microenvironments through morphological plasticity and metabolic reprogramming. <italic toggle="yes">C. albicans</italic> undergoes yeast-to-hyphal transition at 37&#176;C, driven by EFG1-mediated activation of <italic toggle="yes">HWP1</italic> and other hyphal genes, which enhances tissue invasion and biofilm formation via <italic toggle="yes">Bcr1</italic>-regulated exopolysaccharides that decrease drug penetration (<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>). <italic toggle="yes">C. auris</italic> links virulence and drug resistance through genetic colocalization of <italic toggle="yes">ssa1</italic> (encoding a heat shock protein, HSP70) and <italic toggle="yes">ERG11</italic> (encoding lanosterol 14&#945;-demethylase, a target of azole antifungals), allowing survival in hospital environments with high heat stability and decreased fluconazole binding due to ERG11 mutations (<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>,<xref rid="b77-ijmm-56-05-05614" ref-type="bibr">77</xref>,<xref rid="b78-ijmm-56-05-05614" ref-type="bibr">78</xref>). In hypoxic host niches, <italic toggle="yes">A. fumigatus</italic> upregulates <italic toggle="yes">SidA</italic> for iron acquisition via siderophores, a process enhanced by host HIF-1&#945; signaling. <italic toggle="yes">RodA</italic> hydrophobins on conidia shield antigens to decrease dendritic cell activation (<xref rid="b57-ijmm-56-05-05614" ref-type="bibr">57</xref>,<xref rid="b73-ijmm-56-05-05614" ref-type="bibr">73</xref>).</p></sec><sec><title>Cross-kingdom convergence in virulence evolution</title><p>Pathogens across kingdoms exhibit convergent evolutionary strategies to overcome host defenses, as evidenced by their genetic plasticity, immune evasion and microenvironmental adaptations. Bacteria, viruses and fungi prioritize immune evasion: Bacteria form biofilms (such as <italic toggle="yes">Pseudomonas aeruginosa</italic> Pellicle polysaccharide synthesis locus), viruses mutate surface proteins (such as SARS-CoV-2 <italic toggle="yes">S</italic>) and fungi remodel cell walls (such as <italic toggle="yes">Cryptococcus</italic> capsules) (<xref rid="b79-ijmm-56-05-05614" ref-type="bibr">79</xref>). Microenvironmental adaptation is equally universal among pathogens. <italic toggle="yes">M. tuberculosis</italic> activates the <italic toggle="yes">dosR</italic> regulon to establish dormancy within hypoxic granulomas, <italic toggle="yes">A. fumigatus</italic> up-regulates the siderophore synthase gene <italic toggle="yes">SidA</italic> for iron acquisition in oxygen-poor pulmonary niches, and <italic toggle="yes">influenza A virus</italic> acquires the PB2-E627K mutation to optimize polymerase function at mammalian body temperature (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>,<xref rid="b70-ijmm-56-05-05614" ref-type="bibr">70</xref>). These convergent strategies reflect a shared evolutionary imperative to balance survival, replication and transmission within the constraints of the host immunity and physiology. Based on their functions and mechanisms of action, virulence genes can be classified into categories (<xref rid="f1-ijmm-56-05-05614" ref-type="fig">Fig. 1</xref>).</p></sec><sec><title>Research challenges and unresolved questions</title><p>Despite these significant advances, several critical gaps remain in the understanding of the biology underlying virulence genes.</p></sec><sec><title>Unclear molecular mechanisms of cross-species virulence gene HGT</title><p>HGT of virulence genes is documented in bacteria (such as <italic toggle="yes">E. coli</italic> plasmids carrying <italic toggle="yes">fimH-blaCTX-M</italic>) (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>), but interkingdom HGT between fungi and bacteria remains mechanistically elusive. For <italic toggle="yes">Cryptococcus neoformans</italic>, the Capsule-Associated Protein (<italic toggle="yes">CAP</italic>) cluster encoding its polysaccharide capsule (a key virulence factor) shows phylogenetic clustering with glycosyltransferase genes from soil <italic toggle="yes">Streptomyces Spp</italic> supported by transposase-flanked insertion signatures in the fungal genome (<xref rid="b80-ijmm-56-05-05614" ref-type="bibr">80</xref>). Functional assays have further demonstrated that heterologous expression of <italic toggle="yes">S. coelicolor</italic> glycosyltransferase gene <italic toggle="yes">(Sc_GT</italic>) complements capsule defects in <italic toggle="yes">C. neoformans CAP64</italic> mutants, restoring macrophage survival and virulence in murine models (<xref rid="b80-ijmm-56-05-05614" ref-type="bibr">80</xref>-<xref rid="b82-ijmm-56-05-05614" ref-type="bibr">82</xref>). These findings align with broader patterns of fungal-bacterial HGT in soil ecosystems, where predation (such as fungal trapping of bacteria) and plasmid-mediated transfer facilitate genetic exchange (<xref rid="b81-ijmm-56-05-05614" ref-type="bibr">81</xref>). However, eukaryotic barriers, such as nuclear envelope sequestration and intron-exon splicing incompatibilities, may limit such transfer, explaining why a small proportion of fungal virulence genes show interkingdom origins (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b79-ijmm-56-05-05614" ref-type="bibr">79</xref>). Recent studies have highlighted the potential role of ecological associations in facilitating HGT (<xref rid="b79-ijmm-56-05-05614" ref-type="bibr">79</xref>,<xref rid="b80-ijmm-56-05-05614" ref-type="bibr">80</xref>,<xref rid="b82-ijmm-56-05-05614" ref-type="bibr">82</xref>). For example, soil environments, where fungi and bacteria coexist, may promote genetic exchange through shared niches or phagotrophic interaction. However, experimental validation of such transfers is challenging due to the complexity of replicating natural soil microbiomes <italic toggle="yes">in vitro</italic> and the scarcity of definitive genetic markers for recent cross-kingdom HGT events (<xref rid="b79-ijmm-56-05-05614" ref-type="bibr">79</xref>,<xref rid="b81-ijmm-56-05-05614" ref-type="bibr">81</xref>). Phylogenetic analyses of <italic toggle="yes">C. neoformans</italic> capsule genes (such as <italic toggle="yes">CAP59</italic> and <italic toggle="yes">CAP60</italic>) have revealed limited similarity to bacterial homologs, suggesting either ancient transfer events or alternative evolutionary pathways (<xref rid="b80-ijmm-56-05-05614" ref-type="bibr">80</xref>,<xref rid="b81-ijmm-56-05-05614" ref-type="bibr">81</xref>). Additionally, the lack of conserved synteny or horizontal transfer signatures (such as atypical GC content) further complicates the identification of bacterial donors (<xref rid="b79-ijmm-56-05-05614" ref-type="bibr">79</xref>).</p><p>Another key gap is the paucity of mechanistic insight into how bacterial genetic material integrates into fungal genomes. While HGT in prokaryotes commonly occurs via plasmids, phages or transposons, analogous mechanisms in fungi are less characterized (<xref rid="b10-ijmm-56-05-05614" ref-type="bibr">10</xref>). For example, transposon-mediated gene transfer has been observed in <italic toggle="yes">Cryptococcus</italic> during infection, but its role in acquiring bacterial-derived virulence genes remains speculative (<xref rid="b82-ijmm-56-05-05614" ref-type="bibr">82</xref>). Furthermore, the functional expression of horizontally transferred genes in fungi requires compatibility with eukaryotic transcriptional and translational machinery, which may limit successful transfer (<xref rid="b83-ijmm-56-05-05614" ref-type="bibr">83</xref>).</p><p>To address these gaps, recent studies have leveraged comparative genomics and experimental evolution (<xref rid="b82-ijmm-56-05-05614" ref-type="bibr">82</xref>,<xref rid="b83-ijmm-56-05-05614" ref-type="bibr">83</xref>). For example, genome-wide surveys of fungal pathogens such as <italic toggle="yes">Colletotrichum</italic> have identified bacterial-derived genes involved in carbohydrate metabolism and cell wall degradation, suggesting HGT contributes to niche adaptation (<xref rid="b81-ijmm-56-05-05614" ref-type="bibr">81</xref>,<xref rid="b84-ijmm-56-05-05614" ref-type="bibr">84</xref>). Similarly, experimental co-culture systems have demonstrated interspecific chromosome transfer in fungi, although these events primarily involve fungal-fungal interactions (<xref rid="b83-ijmm-56-05-05614" ref-type="bibr">83</xref>,<xref rid="b84-ijmm-56-05-05614" ref-type="bibr">84</xref>).</p></sec><sec><title>Spatiotemporal heterogeneity in host microenvironment-driven virulence gene regulation</title><p>Models of virulence gene regulation typically overlook spatiotemporal variations in host tissue (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>). For example, <italic toggle="yes">M. tuberculosis</italic> in hypoxic granuloma activates the <italic toggle="yes">dosR</italic> regulon. However, the differential impact of macrophage polarization (M1/M2 phenotypes) on <italic toggle="yes">dosR</italic> expression across infection foci remains unclear (<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>). <italic toggle="yes">dosR</italic> regulon is key for <italic toggle="yes">M. tuberculosis</italic> to adapt to the hypoxic environment within granuloma. It allows the bacterium to enter a dormant state, thereby evading host immune surveillance and increasing its chances of survival (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>,<xref rid="b85-ijmm-56-05-05614" ref-type="bibr">85</xref>,<xref rid="b86-ijmm-56-05-05614" ref-type="bibr">86</xref>). This highlights the complexity of host-pathogen interactions and the need for more precise models that account for microenvironmental heterogeneity (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>,<xref rid="b86-ijmm-56-05-05614" ref-type="bibr">86</xref>).</p><p>Recent studies have investigated the dynamics of macrophage polarization and its effect on <italic toggle="yes">dosR</italic> expression (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>,<xref rid="b87-ijmm-56-05-05614" ref-type="bibr">87</xref>). For example, in the early stages of infection, macrophages are predominantly of the M1 phenotype, which is characterized by the production of pro-inflammatory cytokines such as TNF-&#945; and IFN-&#947;. These cytokines may suppress <italic toggle="yes">dosR</italic> expression, enabling <italic toggle="yes">M. tuberculosis</italic> to maintain higher metabolic activity and virulence, facilitating its rapid dissemination within the host (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>). As the infection progresses and the inflammatory response persists, some macrophages transition to the M2 phenotype, which is associated with anti-inflammatory cytokines such as IL-10. This shift may create a more favorable environment for <italic toggle="yes">M. tuberculosis</italic> to activate its <italic toggle="yes">dosR</italic> regulon (<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>,<xref rid="b87-ijmm-56-05-05614" ref-type="bibr">87</xref>). The activation of <italic toggle="yes">dosR</italic> allows the bacterium to enter a dormant state, enhancing its resistance to host immune attacks and improving its chances of long-term persistence within the host (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>).</p><p>In addition to macrophage polarization, other microenvironmental factors also serve a role in the regulation of <italic toggle="yes">dosR</italic> expression. For example, the availability of nutrients and the presence of other immune cells influence the metabolic state of <italic toggle="yes">M. tuberculosis</italic> (<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>). These findings underscore the need for a more nuanced understanding of how host microenvironments dynamically interact with bacterial virulence genes. Such insights may facilitate development of novel therapeutic strategies that target these regulatory mechanisms, potentially improving the efficacy of treatment for tuberculosis and other chronic infectious diseases.</p></sec><sec><title>Lack of understanding of cross-kingdom regulation of virulence genes by commensal microbiota</title><p>To the best of our knowledge, the influence of commensal microbiota on the expression of virulence genes remains unclear. For example, short-chain fatty acids (SCFAs) produced by gut bacteria may modulate <italic toggle="yes">E. coli fimH</italic> expression. However, direct experimental evidence linking microbiota metabolites to virulence activation is lacking (<xref rid="b88-ijmm-56-05-05614" ref-type="bibr">88</xref>). Recent studies have shown that SCFAs, primarily acetate, propionate and butyrate, serve a significant role in regulating the growth and virulence of enteric pathogens such as <italic toggle="yes">E. coli</italic> (<xref rid="b89-ijmm-56-05-05614" ref-type="bibr">89</xref>-<xref rid="b91-ijmm-56-05-05614" ref-type="bibr">91</xref>). In the ileum, where SCFA concentrations are relatively low, SCFAs enhance the growth and motility of pathosymbiont <italic toggle="yes">E. coli</italic>. However, in the colon, where SCFA concentrations are higher, SCFAs inhibit the growth of <italic toggle="yes">E. coli</italic> and downregulate the expression levels of virulence genes such as <italic toggle="yes">fimH</italic>, flagellin C gene (<italic toggle="yes">fliC</italic>), high-temperature requirement A gene (<italic toggle="yes">htrA</italic>), hemoglobin uptake receptor A gene (<italic toggle="yes">chuA)</italic> and <italic toggle="yes">pks</italic>. This downregulation is associated with decreased bacterial motility, infectivity and type 1 fimbria-mediated agglutination. SCFAs also inhibit the activation of NF-&#954;B and the production of IL-8 by epithelial cells, suggesting a role in modulating host inflammatory responses (<xref rid="b90-ijmm-56-05-05614" ref-type="bibr">90</xref>).</p><p>SCFAs differentially regulate virulence genes in <italic toggle="yes">E. coli</italic> depending on their concentration and the pH of the environment. In a study evaluating the effect of SCFAs on virulence gene expression, colonic SCFAs downregulated the expression of virulence genes in a concentration-dependent manner (<xref rid="b89-ijmm-56-05-05614" ref-type="bibr">89</xref>,<xref rid="b90-ijmm-56-05-05614" ref-type="bibr">90</xref>). Specifically, genes involved in adhesion (<italic toggle="yes">fimH</italic>), motility (<italic toggle="yes">fliC</italic>), invasion (invasion plasmid antigen H) and biofilm formation (Biofilm stimulating substance S, <italic toggle="yes">BssS</italic>) were downregulated in the presence of higher concentrations of SCFAs. Conversely, ileal SCFAs upregulated these genes. This suggests that the chemical microenvironment of the gut, including SCFA levels and pH, serves a key role in determining the virulence potential of <italic toggle="yes">E. coli</italic> (<xref rid="b88-ijmm-56-05-05614" ref-type="bibr">88</xref>).</p><p>In addition to SCFAs, other metabolites produced by commensal microbiota may influence the expression of virulence genes. For example, quorum-sensing molecules such as acyl-homoserine lactones (AHLs) have been detected in the gut microbiota and regulate the expression of virulence genes in pathogens such as <italic toggle="yes">P. aeruginosa</italic> and <italic toggle="yes">Salmonella</italic> (<xref rid="b91-ijmm-56-05-05614" ref-type="bibr">91</xref>,<xref rid="b92-ijmm-56-05-05614" ref-type="bibr">92</xref>). Although the production of AHLs by commensal bacteria is not fully understood, the presence of (Luminescence Regulator homologs in numerous gut bacteria suggests that they can respond to AHLs produced by other members of the microbiota (<xref rid="b92-ijmm-56-05-05614" ref-type="bibr">92</xref>). This cross-kingdom signaling may provide a mechanism for pathogens to sense and adapt to the presence of commensal bacteria, thereby modulating their virulence gene expression. Overall, while there is growing evidence that commensal microbiota and their metabolites modulate the virulence of pathogens, the exact mechanisms and the full extent of these interactions remain to be elucidated (<xref rid="b92-ijmm-56-05-05614" ref-type="bibr">92</xref>). Further research is needed to understand the complex regulatory networks involved in cross-kingdom regulation of virulence genes, which may provide novel therapeutic strategies to prevent and treat infections (<xref rid="b92-ijmm-56-05-05614" ref-type="bibr">92</xref>).</p></sec></sec></sec><sec sec-type="other"><label>3.</label><title>Virulence genes in different pathogens</title><sec><title>Typical cases of bacterial pathogens</title><sec><title>E. coli</title><p><italic toggle="yes">E. coli</italic> is a common flora in the intestinal tract, and certain strains carry virulence genes that have become important pathogens, causing intestinal infection and various diseases (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>). In recent years, the production of <italic toggle="yes">ESBL</italic>s in <italic toggle="yes">E. coli</italic> has received considerable attention, and the association between resistance and virulence has become a major research focus (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>,<xref rid="b7-ijmm-56-05-05614" ref-type="bibr">7</xref>,<xref rid="b89-ijmm-56-05-05614" ref-type="bibr">89</xref>). A study on clinical isolates of <italic toggle="yes">ESBL</italic>-producing and non-<italic toggle="yes">ESBL</italic>-producing <italic toggle="yes">E. coli</italic> showed significant differences in the distribution of virulence genes (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>). When producing <italic toggle="yes">ESBL</italic>s strains, common virulence genes such as <italic toggle="yes">fimH</italic> (encoding type I fimbriae, mediating bacterial adhesion to host cells), pyelonephritis-associated pilus assembly protein C [associated with P pilus synthesis (where P denotes pyelonephritis), enhancing the adhesion of epithelial cells of bacteria in the urethra] and &#945;-hemolysin (<italic toggle="yes">hla</italic>; encoding hemolysin, with a host cell membrane damage detection rate higher than that in non-ESBL-producing strains) were observed. Compared with <italic toggle="yes">ESBL</italic>-producing strains, the virulence gene carry rate in non-<italic toggle="yes">ESBL</italic>-producing strains is relatively low (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>,<xref rid="b23-ijmm-56-05-05614" ref-type="bibr">23</xref>,<xref rid="b93-ijmm-56-05-05614" ref-type="bibr">93</xref>). Further studies have found that the drug resistance and virulence genes of <italic toggle="yes">ESBL</italic>-producing <italic toggle="yes">E. coli</italic> are typically located on the same plasmid, suggesting that drug resistance and virulence may co-evolve at the plasmid level, so the bacteria can still maintain strong pathogenicity while facing the pressure of antibiotics, which brings challenges for clinical treatment (<xref rid="b7-ijmm-56-05-05614" ref-type="bibr">7</xref>,<xref rid="b89-ijmm-56-05-05614" ref-type="bibr">89</xref>).</p><p>The <italic toggle="yes">T3SS</italic>, a needle-like structure in <italic toggle="yes">EPEC</italic>, injects effector proteins (such as <italic toggle="yes">Tir</italic>) into host intestinal cells (<xref rid="b26-ijmm-56-05-05614" ref-type="bibr">26</xref>,<xref rid="b94-ijmm-56-05-05614" ref-type="bibr">94</xref>). These effectors hijack host signaling pathways, inducing actin rearrangement and forming pedestal-like structures that anchor bacteria to the epithelium, disrupting the barrier function and causing diarrhea (<xref rid="b27-ijmm-56-05-05614" ref-type="bibr">27</xref>,<xref rid="b95-ijmm-56-05-05614" ref-type="bibr">95</xref>). For example, the <italic toggle="yes">esc</italic> gene cluster of EPEC encodes structural proteins of <italic toggle="yes">T3SS</italic>, and the <italic toggle="yes">E. coli</italic> attaching and effacing gene encodes intimin, an outer membrane adhesin that mediates tight bacterial attachment to host intestinal cells. These virulence genes work together to promote tight adherence of bacteria to the surface of intestinal epithelial cells, trigger cytoskeletal rearrangement and form characteristic base structures that disrupt intestinal barrier function and cause intestinal infectious symptoms such as diarrhea and abdominal pain (<xref rid="b26-ijmm-56-05-05614" ref-type="bibr">26</xref>,<xref rid="b94-ijmm-56-05-05614" ref-type="bibr">94</xref>,<xref rid="b95-ijmm-56-05-05614" ref-type="bibr">95</xref>). In addition, recent studies have found that virulence genes carried by certain <italic toggle="yes">E. coli</italic> strains sense changes in the intestinal environment, such as changes in nutrient concentration, pH and composition of the intestinal microbial community, and dynamically regulate the expression of virulence genes (<xref rid="tIII-ijmm-56-05-05614" ref-type="table">Table III</xref>) (<xref rid="b27-ijmm-56-05-05614" ref-type="bibr">27</xref>,<xref rid="b95-ijmm-56-05-05614" ref-type="bibr">95</xref>). When the intestinal environment changes, such as due to a decline in host immunity or a change in dietary structure, these virulence genes are activated, which converts the relatively harmless commensal bacteria into pathogenic bacteria and causes infection (<xref rid="b27-ijmm-56-05-05614" ref-type="bibr">27</xref>,<xref rid="b96-ijmm-56-05-05614" ref-type="bibr">96</xref>,<xref rid="b97-ijmm-56-05-05614" ref-type="bibr">97</xref>).</p><p><italic toggle="yes">S. aureus</italic> is a common pathogenic bacterium in clinical practice that causes serious infectious diseases, including skin and soft tissue infections, pneumonia and endocarditis (<xref rid="tIII-ijmm-56-05-05614" ref-type="table">Table III</xref>). Studies on clinical isolates have revealed that the virulence genes of <italic toggle="yes">S. aureus</italic> are diverse and governed by complex regulatory networks (<xref rid="b98-ijmm-56-05-05614" ref-type="bibr">98</xref>-<xref rid="b100-ijmm-56-05-05614" ref-type="bibr">100</xref>). For example, the accessory gene regulator (<italic toggle="yes">agr</italic>) locus is a key regulatory system for the expression of virulence genes in <italic toggle="yes">S. aureus</italic>. It comprises <italic toggle="yes">agrA</italic>, <italic toggle="yes">agrB</italic>, <italic toggle="yes">agrC</italic> and <italic toggle="yes">agrD</italic>. The <italic toggle="yes">agr</italic> system can detect changes in bacterial population density. When the bacterial population reaches a certain threshold, the autoinducible peptide encoded by the <italic toggle="yes">agrD</italic> gene is secreted and accumulates, and binds the <italic toggle="yes">agrC</italic> receptor and activates the <italic toggle="yes">agrA</italic> protein, thereby regulating the expression of downstream virulence genes. In the early stages of infection, when the number of bacteria is low, the <italic toggle="yes">agr</italic> system is in a low-activity state, which is conducive to bacterial adhesion and colonization, and the expression levels of surface adhesion protein genes (<italic toggle="yes">fnbA</italic> and clumping factor A) are upregulated. With the progression of infection, bacterial proliferation activates the agr system, enhancing expression of toxin genes including <italic toggle="yes">hla</italic> and &#948;-hemolysin (encoding pore-forming hemolysins), and <italic toggle="yes">sea</italic> and <italic toggle="yes">seb</italic> (encoding the superantigenic staphylococcal enterotoxins A and B, respectively, which induce vomiting and diarrhea). Bacteria release a large number of toxins during adhesion, invasion and diffusion, causing serious damage to host tissue (<xref rid="b98-ijmm-56-05-05614" ref-type="bibr">98</xref>,<xref rid="b101-ijmm-56-05-05614" ref-type="bibr">101</xref>,<xref rid="b102-ijmm-56-05-05614" ref-type="bibr">102</xref>).</p><p>The ability of <italic toggle="yes">S. aureus</italic> to form biofilms, in which the <italic toggle="yes">ica</italic> gene cluster serves a key role, is an important factor in its pathogenicity. Genes such as <italic toggle="yes">icaA</italic> and <italic toggle="yes">icaD</italic> encode products involved in the synthesis of exopolysaccharides, the primary matrix components of biofilms (<xref rid="b103-ijmm-56-05-05614" ref-type="bibr">103</xref>-<xref rid="b105-ijmm-56-05-05614" ref-type="bibr">105</xref>). Biofilms not only provide a physical protective barrier for bacteria to resist the killing of antibiotics and phagocytosis of host immune cells but also enhance the ability of bacteria to adhere to the surface of medical devices (such as catheters and artificial joints), leading to the occurrence of chronic infection and increasing the difficulty and cost of treatment (<xref rid="b103-ijmm-56-05-05614" ref-type="bibr">103</xref>-<xref rid="b105-ijmm-56-05-05614" ref-type="bibr">105</xref>). For example, in cases of infection associated with implanted medical devices, following the formation of an <italic toggle="yes">S. aureus</italic> biofilm, it is difficult to completely eliminate the bacteria using conventional antibiotic treatment, and the implants often need to be removed to control the infection, which causes pain and economic burden to patients (<xref rid="b100-ijmm-56-05-05614" ref-type="bibr">100</xref>). In addition, expression of virulence genes in <italic toggle="yes">S. aureus</italic> is regulated by internal environmental signals (such as cytokines secreted by host cells and local oxygen concentration) (<xref rid="b99-ijmm-56-05-05614" ref-type="bibr">99</xref>,<xref rid="b101-ijmm-56-05-05614" ref-type="bibr">101</xref>,<xref rid="b106-ijmm-56-05-05614" ref-type="bibr">106</xref>). Bacteria adjust virulence strategies according to their microenvironment to adapt to different stages of the infection process, highlighting the complexity of their pathogenic mechanisms (<xref rid="b99-ijmm-56-05-05614" ref-type="bibr">99</xref>,<xref rid="b100-ijmm-56-05-05614" ref-type="bibr">100</xref>).</p><p><italic toggle="yes">S. aureus</italic> carries a number of virulence genes that confer strong pathogenic ability and can cause various infectious diseases. Nuc (staphylococcal thermonuclease) encodes a thermostable nuclease essential for immune evasion and biofilm dispersion. Nuc is a key marker for determining the pathogenicity of <italic toggle="yes">S. aureus</italic> (<xref rid="b107-ijmm-56-05-05614" ref-type="bibr">107</xref>,<xref rid="b108-ijmm-56-05-05614" ref-type="bibr">108</xref>). The Panton-Valentine leukocidin (PVL) gene encodes a cytotoxin that specifically lyses phagocytes (neutrophils and macrophages), depleting frontline immune defenses, disrupting neutrophil extracellular trap formation, and creating favorable conditions for bacterial dissemination (<xref rid="b109-ijmm-56-05-05614" ref-type="bibr">109</xref>-<xref rid="b111-ijmm-56-05-05614" ref-type="bibr">111</xref>).</p><p>In food poisoning, <italic toggle="yes">S. aureus</italic> secretes a large number of enterotoxins, such as those encoded by <italic toggle="yes">sea</italic>-<italic toggle="yes">see</italic> (encoding the superantigenic staphylococcal enterotoxins A and E, respectively) genes. These enterotoxins are thermostable and cannot be inactivated at conventional cooking temperatures. Following human ingestion of contaminated food, enterotoxins act on the intestinal nervous system, stimulate the vomiting center and cause severe vomiting, diarrhea and other symptoms that endanger health (<xref rid="b112-ijmm-56-05-05614" ref-type="bibr">112</xref>,<xref rid="b113-ijmm-56-05-05614" ref-type="bibr">113</xref>).</p><p>Skin infections are a common type of <italic toggle="yes">S. aureus</italic> infection. The proteins encoded by the fibronectin-binding protein genes (<italic toggle="yes">fnbA</italic> and <italic toggle="yes">fnbB</italic>) help bacteria adhere to the extracellular matrix of skin tissue, and coagulase encoded by the coagulase gene (<italic toggle="yes">coa</italic>) and von Willebrand factor-binding protein encoded by the coagulase-like gene (<italic toggle="yes">cal</italic>) promote plasma coagulation to form a fibrin barrier, resisting phagocytosis by immune cells. <italic toggle="yes">S. aureus</italic> can cause skin and soft tissue infections, such as furuncles, carbuncles and cellulitis, as well as other typical symptoms, such as local redness, swelling, elevated temperature, pain, and suppuration (<xref rid="b24-ijmm-56-05-05614" ref-type="bibr">24</xref>,<xref rid="b25-ijmm-56-05-05614" ref-type="bibr">25</xref>,<xref rid="b106-ijmm-56-05-05614" ref-type="bibr">106</xref>).</p></sec><sec><title>M. tuberculosis</title><p><italic toggle="yes">M. tuberculosis</italic>, a pathogen that causes tuberculosis, causes infections worldwide (<xref rid="b1-ijmm-56-05-05614" ref-type="bibr">1</xref>,<xref rid="b2-ijmm-56-05-05614" ref-type="bibr">2</xref>). Virulence genes serve key roles in latent infections, drug resistance and pathogenesis (<xref rid="tIII-ijmm-56-05-05614" ref-type="table">Table III</xref>) (<xref rid="b86-ijmm-56-05-05614" ref-type="bibr">86</xref>). Virulence genes of the <italic toggle="yes">dosR</italic> regulatory system serve an important role in the latent infection stage of <italic toggle="yes">M. tuberculosis</italic>. When the bacterium enters the host and is exposed to stressful environments such as hypoxia and nutrient deprivation, the <italic toggle="yes">dosR</italic> gene is activated, which regulates the expression of a series of downstream genes and causes the bacterium to enter a dormant state (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>). The <italic toggle="yes">dosR</italic>-regulated genes <italic toggle="yes">Rv2627</italic> (HspX) and <italic toggle="yes">Rv2628</italic> (universal stress protein) maintain bacterial quiescence and resist immune clearance (<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b87-ijmm-56-05-05614" ref-type="bibr">87</xref>), reactivating bacteria under defined host immunosuppressive conditions including TNF-&#945; level decrease, CD4+ T cell depletion, or hypoxia alleviation to cause reinfection (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>). For example, in latently infected macrophages, <italic toggle="yes">M. tuberculosis</italic> expressing <italic toggle="yes">dosR</italic>-regulated genes survive for a long time and evade host immune surveillance. Once host immunity decreases, the bacteria recover and restart the infection process, leading to tuberculosis recurrence (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>).</p><p>The emergence of drug-resistant <italic toggle="yes">M. tuberculosis</italic> strains poses a challenge for the prevention and control of tuberculosis. There is a complex association between bacterial virulence and drug resistance. Studies have shown that certain drug-resistant gene mutations may indirectly affect the regulation of virulence gene expression (<xref rid="b85-ijmm-56-05-05614" ref-type="bibr">85</xref>,<xref rid="b114-ijmm-56-05-05614" ref-type="bibr">114</xref>-<xref rid="b116-ijmm-56-05-05614" ref-type="bibr">116</xref>), such as the RNA polymerase beta subunit gene (<italic toggle="yes">rpoB</italic>) gene mutation leads to rifampicin resistance. The <italic toggle="yes">rpoB</italic> protein, which is the &#946;-subunit of RNA polymerase, is involved in transcription initiation. Mutation of the <italic toggle="yes">rpoB</italic> protein not only makes bacteria resistant to rifampicin, but may also change the global expression profile of the transcriptome, thereby affecting the transcription levels of virulence genes (<xref rid="b85-ijmm-56-05-05614" ref-type="bibr">85</xref>,<xref rid="b114-ijmm-56-05-05614" ref-type="bibr">114</xref>-<xref rid="b116-ijmm-56-05-05614" ref-type="bibr">116</xref>). In addition, virulence genes associated with cell wall synthesis in <italic toggle="yes">M. tuberculosis</italic>, such as the <italic toggle="yes">pks</italic> gene cluster, which is involved in the synthesis of lipid components in the cell wall, are key for the survival and pathogenesis of this species. These genes confer specialized structural and biophysical properties to the cell wall, notably through the production of phenolic glycolipids (PGLs) that form a hydrophobic barrier blocking lysozyme access to peptidoglycan, phthiocerol dimycocerosates (PDIMs) creating a waxy layer impermeable to cationic antimicrobial peptides like defensins, sulfolipids (SL-1) neutralizing reactive oxygen species and inhibiting phagolysosomal fusion, and mycolic acids constituting a rigid mycomembrane that restricts permeability to bactericidal enzymes (<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>,<xref rid="b32-ijmm-56-05-05614" ref-type="bibr">32</xref>). Collectively, these adaptations enable resistance to host immune effectors and facilitate persistence within macrophages and granulomas (<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>,<xref rid="b32-ijmm-56-05-05614" ref-type="bibr">32</xref>,<xref rid="b86-ijmm-56-05-05614" ref-type="bibr">86</xref>). At the same time, they affect the interaction between bacteria and host cells, which is conducive to the colonization and spread of bacteria in host tissue, leading to typical pathological changes in tuberculosis, such as lung tissue damage and cavity formation (<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>,<xref rid="b86-ijmm-56-05-05614" ref-type="bibr">86</xref>). Tuberculosis endangers the function of the respiratory system and the life and health of patients (<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>,<xref rid="b32-ijmm-56-05-05614" ref-type="bibr">32</xref>,<xref rid="b86-ijmm-56-05-05614" ref-type="bibr">86</xref>). In addition, <italic toggle="yes">M. tuberculosis</italic> secretes small-molecule effectors during infection to regulate signaling pathways in host cells, inhibit the host immune response and create favorable conditions for bacterial survival and proliferation (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>,<xref rid="b87-ijmm-56-05-05614" ref-type="bibr">87</xref>). This is associated with the regulation of virulence gene expression (<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b87-ijmm-56-05-05614" ref-type="bibr">87</xref>).</p></sec><sec><title>Helicobacter pylori</title><p><italic toggle="yes">H. pylori</italic> is a key pathogen in gastric disease and its virulence gene spectrum is associated with its pathogenicity (<xref rid="tIII-ijmm-56-05-05614" ref-type="table">Table III</xref>) (<xref rid="b117-ijmm-56-05-05614" ref-type="bibr">117</xref>,<xref rid="b118-ijmm-56-05-05614" ref-type="bibr">118</xref>). <italic toggle="yes">H. pylori</italic> encodes the cytotoxin-associated gene A (<italic toggle="yes">cagA</italic>) that produces the CagA effector protein translocated into gastric epithelial cells via the type IV secretion system (<xref rid="b117-ijmm-56-05-05614" ref-type="bibr">117</xref>), and the vacuolating cytotoxin gene A (<italic toggle="yes">vacA</italic>) that encodes the VacA toxin capable of inducing vacuolar degeneration and apoptosis in host cells (<xref rid="b118-ijmm-56-05-05614" ref-type="bibr">118</xref>). Specifically, the CagA protein is phosphorylated by intracellular kinases and interacts with Src homology 2 (SH2) domain-containing proteins to activate downstream signals, which leads to cytoskeletal rearrangement, cell proliferation and migration abnormality, loss of cell polarity and cell dispersion in gastric mucosal epithelial cells, thereby aggravating inflammation and promoting the development of precancerous lesions (<xref rid="b117-ijmm-56-05-05614" ref-type="bibr">117</xref>). Several studies have shown that patients infected with CagA-positive <italic toggle="yes">H. pylori</italic> strains have a higher risk of gastric cancer and duodenal ulcers than those infected with CagA-negative strains (<xref rid="b76-ijmm-56-05-05614" ref-type="bibr">76</xref>,<xref rid="b117-ijmm-56-05-05614" ref-type="bibr">117</xref>).</p><p>VacA toxin encoded by the <italic toggle="yes">vacA</italic> gene, as an active-binding (AB) toxin composed of a cell-binding B subunit and an enzymatically active A subunit, can cause vacuolization of gastric epithelial cells. The B subunit mediates the binding of the toxin to the cell surface receptor, and the A subunit enters the cell and acts on organelles, such as the mitochondria, to interfere with the intracellular ion balance and induce apoptosis. The cytotoxicity of distinct VacA subtypes exhibits variability. Specifically, s1/m1 strains typically demonstrate higher virulence compared to s2/m2 strains and are more prone to inducing severe gastric lesions (<xref rid="b117-ijmm-56-05-05614" ref-type="bibr">117</xref>,<xref rid="b118-ijmm-56-05-05614" ref-type="bibr">118</xref>).</p><p>In addition to <italic toggle="yes">cagA</italic> and <italic toggle="yes">vacA</italic>, genes such as inducible catalase (<italic toggle="yes">iceA</italic>), outer membrane inflammatory protein (<italic toggle="yes">oipA</italic>) and blood group antigen-binding addin (<italic toggle="yes">babA</italic>) serve key roles in <italic toggle="yes">H. pylori</italic> pathogenesis. The <italic toggle="yes">iceA</italic> gene is associated with bacterial colonization and inflammation of the gastric mucosa. The expression of <italic toggle="yes">oipA</italic> affects the interaction between bacteria and host cells and participates in immune regulation in the host. The <italic toggle="yes">babA</italic> gene helps bacteria adhere to specific blood group antigens on the surface of gastric epithelial cells, enhances colonization and creates conditions for subsequent infection. These virulence genes cooperate with each other so that <italic toggle="yes">H. pylori</italic> can survive and reproduce in the harsh environment of the stomach, gradually inducing gastritis, gastric ulcers and gastric cancer (<xref rid="b119-ijmm-56-05-05614" ref-type="bibr">119</xref>,<xref rid="b120-ijmm-56-05-05614" ref-type="bibr">120</xref>).</p></sec><sec><title>Klebsiella pneumoniae</title><p><italic toggle="yes">K. pneumoniae</italic> is divided into hypervirulent (hv) and classical <italic toggle="yes">K. pneumoniae</italic> (cKP) according to virulence and drug resistance. hvKP, the hypervirulent form of <italic toggle="yes">K. pneumoniae</italic>, usually carries a virulence plasmid that contains siderophore synthesis genes, including the aerobactin synthesis gene <italic toggle="yes">iucA</italic> encoding lysine N6-hydroxylase, together with key virulence genes such as the regulator of mucoid phenotype A (<italic toggle="yes">rmpA</italic>). The <italic toggle="yes">iucA</italic> gene encodes proteins associated with siderophore synthesis, which help bacteria compete for iron to meet growth and reproduction needs in a host environment where iron uptake is limited. The <italic toggle="yes">rmpA</italic> gene enhances the anti-phagocytic ability and pathogenicity of bacteria by regulating the synthesis of bacterial polysaccharides and capsule formation, which confers a hypermucoviscous phenotype that facilitates colonization and spread in the host (<xref rid="b9-ijmm-56-05-05614" ref-type="bibr">9</xref>,<xref rid="b121-ijmm-56-05-05614" ref-type="bibr">121</xref>-<xref rid="b123-ijmm-56-05-05614" ref-type="bibr">123</xref>).</p><p>By contrast, cKP, an opportunistic pathogen, is relatively weak in terms of virulence but has a strong ability to acquire drug-resistant genes. It typically integrates drug resistance genes through HGT (such as plasmid conjugative transfer and transposon skipping) to form multidrug-resistant phenotypes. Common resistance genes include ESBL genes (such as &#946;-lactamase Temoniera), <italic toggle="yes">blaSHV</italic> (beta-lactamase sulfhydryl variable) and &#946;-lactamase cefotaxime-Munich), carbapenemase genes [such as <italic toggle="yes">KPC</italic> (<italic toggle="yes">K. pneumoniae</italic> carbapenemase), <italic toggle="yes">VIM</italic> (Verona integron-encoded metallo-&#946;-lactamase) and <italic toggle="yes">NDM</italic> (New Delhi metallo-&#946;-lactamase)] and quinolode resistance genes [such as <italic toggle="yes">qnrA</italic> (quinolone resistance A), <italic toggle="yes">qnrB</italic> (quinolone resistance B) and <italic toggle="yes">qnrS</italic> (quinolone resistance S)]. Consequently, it is resistant to numerous antibiotics, such as &#946;-lactams, carbapenems and fluoroquinolones, which poses challenges to clinical treatment (<xref rid="b124-ijmm-56-05-05614" ref-type="bibr">124</xref>-<xref rid="b126-ijmm-56-05-05614" ref-type="bibr">126</xref>).</p><p>In recent years, <italic toggle="yes">K. pneumoniae</italic> strains with high virulence and multi-drug resistance characteristics have emerged (<xref rid="b9-ijmm-56-05-05614" ref-type="bibr">9</xref>,<xref rid="b13-ijmm-56-05-05614" ref-type="bibr">13</xref>,<xref rid="b124-ijmm-56-05-05614" ref-type="bibr">124</xref>,<xref rid="b127-ijmm-56-05-05614" ref-type="bibr">127</xref>) (<xref rid="tIII-ijmm-56-05-05614" ref-type="table">Table III</xref>). These strains not only infect healthy individuals, causing liver and lung abscesses, endophthalmitis and other invasive infections, but also limit the choice of treatment drugs due to drug resistance, prolong the course of the disease and increase mortality rates. In mainland China, Southeast Asia, and healthcare-constrained settings, multidrug-resistant strains account for a notable proportion of hospital-acquired <italic toggle="yes">K. pneumoniae</italic> infection, among which the 30-day mortality rate of infection caused by hypervirulent and drug-resistant strains is notably higher than that of non-drug-resistant strains, highlighting the need for enhanced prevention and control of <italic toggle="yes">K. pneumoniae</italic> infections (<xref rid="b9-ijmm-56-05-05614" ref-type="bibr">9</xref>,<xref rid="b128-ijmm-56-05-05614" ref-type="bibr">128</xref>).</p></sec></sec><sec><title>Viral pathogens</title><sec><title>Novel coronavirus</title><p>SARS-CoV-2 is the main causative agent of the coronavirus disease (COVID-19) pandemic. Its virulence genes serve a key role in the transmission and pathogenesis of the virus and have become the focus of research worldwide (<xref rid="b129-ijmm-56-05-05614" ref-type="bibr">129</xref>). The <italic toggle="yes">S</italic> gp gene of SARS-CoV-2 encodes S gp, a trimeric structure on the viral surface that mediates host cell entry. The S protein binds the ACE2 receptor, a membrane protein highly expressed in lung alveolar epithelial cells, heart and intestines, via its RBD. This interaction triggers membrane fusion, enabling the viral RNA genome to enter host cells and initiate replication (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b130-ijmm-56-05-05614" ref-type="bibr">130</xref>). The role of ACE2 in regulating blood pressure and inflammation explains why SARS-CoV-2 infection typically leads to extrapulmonary complications, including acute respiratory distress syndrome and cardiovascular injury (<xref rid="b131-ijmm-56-05-05614" ref-type="bibr">131</xref>). The S protein gene frequently mutates. Certain variants, such as &#916; and &#959;, have amino acid mutations in the RBD region that enhance the affinity of the virus for the ACE2 receptor, facilitating viral entry into cells and improving the infectivity of the virus (<xref rid="b132-ijmm-56-05-05614" ref-type="bibr">132</xref>). A study on variants showed that the RBD mutation of the S protein in the &#959; variant increases the binding affinity of &#959; to the ACE2 receptor compared with the original strain, which was closely related to the rapid spread of this variant worldwide and the peak of infection (<xref rid="b39-ijmm-56-05-05614" ref-type="bibr">39</xref>,<xref rid="b133-ijmm-56-05-05614" ref-type="bibr">133</xref>).</p><p>Other accessory protein genes of SARS-CoV-2 also serve important roles in pathogenesis. For example, the protein encoded by the Open Reading Frame 3a (<italic toggle="yes">ORF3a</italic>) gene induces an inflammatory response in host cells, disrupts the intracellular ion balance and triggers apoptosis, leading to tissue damage and aggravation of the disease. Studies have found that <italic toggle="yes">ORF3a</italic> gene expression is increased in patients with severe COVID-19, and associated with the occurrence of inflammatory factor storm, indicating that it serves a role in the progression of the disease (<xref rid="b134-ijmm-56-05-05614" ref-type="bibr">134</xref>,<xref rid="b135-ijmm-56-05-05614" ref-type="bibr">135</xref>) (<xref rid="tIV-ijmm-56-05-05614" ref-type="table">Table IV</xref>).</p></sec><sec><title>Influenza viruses</title><p>The influenza virus, a seasonal circulating RNA virus, frequently causes global influenza epidemics, posing a threat to human health. Variations in virulence genes are associated with antigenic drift and host adaptation of influenza viruses, which are key factors in the continuous evolution of viruses and changes in pathogenicity (<xref rid="tIV-ijmm-56-05-05614" ref-type="table">Table IV</xref>). Influenza viruses are divided into three types according to the antigenicity of the nucleoprotein and matrix protein components. Among these, the influenza A virus is the most pathogenic, prone to mutation and the main pathogen responsible for influenza pandemics (<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>,<xref rid="b136-ijmm-56-05-05614" ref-type="bibr">136</xref>).</p><p>The <italic toggle="yes">HA</italic> and neuraminidase (<italic toggle="yes">NA</italic>) genes of the influenza A virus are key virulence genes. The HA protein recognizes and binds to host cell surface receptors, mediating virus invasion. Mutations in this gene change in the antigenicity of the HA protein, causing antigenic drift. For example, there are certain point mutations in the <italic toggle="yes">HA</italic> gene of seasonal influenza virus strains circulating each year, which allow the virus to evade the immune response induced by previous infection or vaccination, leading to recurrent outbreaks (<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b46-ijmm-56-05-05614" ref-type="bibr">46</xref>,<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>). Studies have shown that mutations in key antigenic sites of the HA protein of influenza A (H3N2) viruses decrease the protective efficacy of influenza vaccines and increase the infection rate (<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b46-ijmm-56-05-05614" ref-type="bibr">46</xref>).</p><p>Neuraminidase, encoded by the <italic toggle="yes">NA</italic> gene, serves a key role in viral release. By cleaving sialic acid residues, progeny virions can be separated from the surface of infected cells and spread. Variations in the <italic toggle="yes">NA</italic> gene also affect the pathogenicity and transmission of viruses. Some highly pathogenic avian influenza viruses, such as <italic toggle="yes">H5N1</italic> and <italic toggle="yes">H7N9</italic>, have a mutation in the <italic toggle="yes">NA</italic> gene that not only enhances the viral reproduction and transmission efficiency in poultry but also confers the ability to cross the species barrier to infect humans, causing a public health crisis (<xref rid="b137-ijmm-56-05-05614" ref-type="bibr">137</xref>-<xref rid="b139-ijmm-56-05-05614" ref-type="bibr">139</xref>).</p><p>In addition to the <italic toggle="yes">HA</italic> and <italic toggle="yes">NA</italic> genes, the influenza A virus polymerase genes <italic toggle="yes">PB1</italic>, <italic toggle="yes">PB2</italic>, and <italic toggle="yes">PA</italic> encode the three subunits of the RNA-dependent RNA polymerase complex. <italic toggle="yes">PB1</italic> functions as the core RNA polymerase <italic toggle="yes">PB2</italic> supplies capped RNA primers and <italic toggle="yes">PA</italic> provides endonuclease activity for cap snatching together ensuring efficient viral RNA synthesis and replication. The polymerase complex encoded by these genes is responsible for the transcription and replication of the viral genome, and its variation can affect the adaptation of the virus to different host cells. For example, certain mutations in the <italic toggle="yes">PB2</italic> gene enable influenza viruses to better adapt to the intracellular environment of human cells, enhance the replication efficiency of the virus in the body and aggravate infection. During the 2009 influenza A (H1N1) pandemic, specific mutations in the <italic toggle="yes">PB2</italic> gene of epidemic strains were associated with the high pathogenicity of the virus and its rapid spread in the population (<xref rid="b140-ijmm-56-05-05614" ref-type="bibr">140</xref>,<xref rid="b141-ijmm-56-05-05614" ref-type="bibr">141</xref>).</p></sec><sec><title>HIV</title><p>HIV is the causative agent of acquired immune deficiency syndrome (AIDS), and its virulence genes serve a central role in immune evasion and disease progression (<xref rid="tIV-ijmm-56-05-05614" ref-type="table">Table IV</xref>). HIV is a retroviral RNA virus that primarily attacks CD4<sup>+</sup> T lymphocytes in the human immune system and gradually destroys the human immune defense, making patients vulnerable to a variety of opportunistic infections and tumor invasion (<xref rid="b45-ijmm-56-05-05614" ref-type="bibr">45</xref>,<xref rid="b142-ijmm-56-05-05614" ref-type="bibr">142</xref>).</p><p>Envelope gp120 and gp41, encoded by the HIV <italic toggle="yes">env</italic> gene, are key virulence factors. gp120 is responsible for recognizing and binding CD4 receptors and co-receptors (such as C-C motif chemokine receptor 5 and C-X-C motif chemokine receptor 4) on the surface of host immune cells (such as CD4<sup>+</sup> T lymphocytes), mediating the fusion of the viral envelope with the host cell membrane, enabling entry of the viral core into the cell, and initiating the infection process (<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>,<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>,<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>). During infection, the <italic toggle="yes">env</italic> gene frequently mutates, particularly in the V3 loop region of the gp120 protein (<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>). The high variability in the amino acid sequence allows the virus to evade recognition by neutralizing antibodies produced by the immune system and achieve immune escape (<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>,<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>,<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>). Studies have shown that in HIV-infected individuals, <italic toggle="yes">env</italic> gene mutations gradually accumulate as the disease progresses (<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>,<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>,<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>,<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>). The neutralizing antibodies generated against early HIV strains are no longer able to effectively neutralize later variants, resulting in the continued replication of the virus and continued impairment of the immune system (<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>,<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>).</p><p>HIV regulatory genes, such as transactivator of transcription (<italic toggle="yes">tat</italic>) and regulator of expression of virion proteins (<italic toggle="yes">rev</italic>), serve pivotal roles in temporal regulation of viral gene expression. The Tat protein, encoded by the <italic toggle="yes">tat</italic> gene, enhances viral transcription, promotes efficient viral gene expression and ensures viral replication within host cells (<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>). The Rev protein, encoded by the <italic toggle="yes">rev</italic> gene, regulates the splicing and transport of viral mRNA, ensuring the production of complete viral genomic RNA and structural proteins, thereby maintaining persistent infection and pathogenicity (<xref rid="b43-ijmm-56-05-05614" ref-type="bibr">43</xref>). Aberrant expression of these regulatory genes is associated with the progression of HIV infection. For example, in patients with AIDS, elevated expression of the <italic toggle="yes">tat</italic> gene is frequently observed, leading to increased viral replication in immune cells, accelerated depletion of CD4<sup>+</sup> T lymphocytes and a compromised immune system (<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>).</p><p>In addition, the negative regulatory factor (Nef) protein encoded by the HIV <italic toggle="yes">nef</italic> gene has a variety of functions that interfere with the signal transduction pathways of host cells, downregulate the expression of CD4 receptors and major histocompatibility complex class I molecules on the cell surface, and reduce the binding opportunity of neutralizing antibodies when the virus infects the cells. This decreases the probability of infected cells being recognized and killed by cytotoxic T lymphocytes, facilitating viral immune escape and persistent infection (<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>,<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>). Virulence of HIV strains with <italic toggle="yes">nef</italic> deletion was weakened in in BLTS-humanized mice challenged with HIV-1 and in C57BL/6 mice infected intracranially with EcoHIV-&#916;Nef, indicating that the Nef protein serves a key role in the pathogenesis of HIV (<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>,<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>,<xref rid="b143-ijmm-56-05-05614" ref-type="bibr">143</xref>,<xref rid="b144-ijmm-56-05-05614" ref-type="bibr">144</xref>).</p></sec></sec><sec><title>Emerging viral pathogens and virulence evolution</title><sec><title>Zika virus (ZIKV)</title><p>ZIKV is a significant global health threat because of its association with congenital microcephaly and Guillain-Barr&#233; syndrome (<xref rid="b145-ijmm-56-05-05614" ref-type="bibr">145</xref>). Non-structural protein 5 (NS5) protein, encoded by the <italic toggle="yes">NS5</italic> gene, is a key virulence factor (<xref rid="b145-ijmm-56-05-05614" ref-type="bibr">145</xref>). <italic toggle="yes">NS5</italic> mediates immune evasion by degrading host STAT2, a key component of the type I IFN signaling pathway (<xref rid="b145-ijmm-56-05-05614" ref-type="bibr">145</xref>). Structural studies have revealed that <italic toggle="yes">NS5</italic> binds to the STAT2 SH2 domain, triggering its ubiquitination and proteasomal degradation (<xref rid="b145-ijmm-56-05-05614" ref-type="bibr">145</xref>-<xref rid="b147-ijmm-56-05-05614" ref-type="bibr">147</xref>). This suppression of IFN responses allows ZIKV to cross the placental barrier, as demonstrated in murine models, where <italic toggle="yes">NS5</italic>-mutant strains (such as <italic toggle="yes">R99K</italic>) showed decreased fetal infection rates (<xref rid="b146-ijmm-56-05-05614" ref-type="bibr">146</xref>,<xref rid="b147-ijmm-56-05-05614" ref-type="bibr">147</xref>). Recent outbreaks in Southeast Asia have highlighted <italic toggle="yes">NS5</italic> mutations that enhance viral persistence in placental tissue, underscoring the need for targeted antiviral strategies (<xref rid="b147-ijmm-56-05-05614" ref-type="bibr">147</xref>,<xref rid="b148-ijmm-56-05-05614" ref-type="bibr">148</xref>).</p></sec><sec><title>Ebola virus</title><p>The Ebola virus gp, encoded by the <italic toggle="yes">GP</italic> gene, is key to hemorrhagic pathogenesis. gp facilitates viral entry by binding host T-cell immunoglobulin and mucin domain-1 and Niemann-Pick C1 (NPC1) receptors on endothelial cells, inducing vascular leakage and systemic inflammation (<xref rid="b149-ijmm-56-05-05614" ref-type="bibr">149</xref>). A single amino acid mutation (T544I) in the <italic toggle="yes">GP</italic> receptor-binding domain increases viral entry efficiency, as shown in pseudovirus assays (<xref rid="b150-ijmm-56-05-05614" ref-type="bibr">150</xref>). This mutation was associated with higher case fatality rates in recent outbreaks in the Democratic Republic of the Congo (<xref rid="b150-ijmm-56-05-05614" ref-type="bibr">150</xref>). Additionally, the mucin-like domain of <italic toggle="yes">GP</italic> masks viral epitopes, evading neutralizing antibodies and complicating vaccine design (<xref rid="b150-ijmm-56-05-05614" ref-type="bibr">150</xref>).</p></sec><sec><title>Nipah virus (NiV)</title><p>NiV, a paramyxovirus with high zoonotic potential, uses its fusion (F) protein (encoded by the <italic toggle="yes">F</italic> gene) to mediate cell-cell fusion and neuronal spread (<xref rid="b151-ijmm-56-05-05614" ref-type="bibr">151</xref>). Cryo-electron microscopy studies have demonstrated that the <italic toggle="yes">F</italic> protein undergoes conformational changes to expose a hydrophobic fusion peptide, enabling syncytia formation in the respiratory epithelium and in neurons (<xref rid="b151-ijmm-56-05-05614" ref-type="bibr">151</xref>,<xref rid="b152-ijmm-56-05-05614" ref-type="bibr">152</xref>). The E447K mutation in the receptor-binding domain of the F protein enhances the affinity for ephrin-B2/B3 receptors in human hosts, thereby increasing the spillover risk from bat reservoirs (<xref rid="b151-ijmm-56-05-05614" ref-type="bibr">151</xref>). Outbreaks in Malaysia and Bangladesh have highlighted the capacity of <italic toggle="yes">NiV</italic> for rapid adaptation, necessitating surveillance of <italic toggle="yes">F</italic> gene evolution in animal reservoirs.</p></sec></sec><sec><title>Fungal pathogens</title><sec><title>C. albicans</title><p>As a common opportunistic pathogenic fungus, <italic toggle="yes">C. albicans</italic> can easily cause superficial and deep infections in patients with low immune function or microecological imbalances. The regulation of virulence gene expression is associated with morphological transformation, host immune escape and drug resistance, which are key entry points for studying the pathogenic mechanisms of fungi (<xref rid="tV-ijmm-56-05-05614" ref-type="table">Table V</xref>) (<xref rid="b18-ijmm-56-05-05614" ref-type="bibr">18</xref>,<xref rid="b153-ijmm-56-05-05614" ref-type="bibr">153</xref>).</p><p><italic toggle="yes">C. albicans</italic> is characterized by a unique biphasic transition between the yeast and hyphal phases, which is regulated by various virulence factors. For example, EFG1 gene is a key transcription factor in the regulation of morphological transition. The encoded protein binds the promoter region of hyphal-specific genes, activates the expression of hyphal-associated genes and promotes the transition from the yeast phase to the hyphal phase. When the host environment changes, such as the temperature rising to 37&#176;C, nutrient composition changes or serum presence, the expression of the EFG1 gene is upregulated, which triggers the morphological transformation of <italic toggle="yes">C. albicans</italic> (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b18-ijmm-56-05-05614" ref-type="bibr">18</xref>,<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>,<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>,<xref rid="b67-ijmm-56-05-05614" ref-type="bibr">67</xref>). Hyphae penetrate the epithelial cell layer and invade deep tissue, resulting in the spread of infection (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>).</p><p>The virulence genes of <italic toggle="yes">C. albicans</italic> also serve a key role in immune escape. The products encoded by Sap family genes secreted by <italic toggle="yes">C. albicans</italic> degrade immune molecules, such as immunoglobulin and complement components, on the surface of host cells, thereby destroying the host immune defense system (<xref rid="b154-ijmm-56-05-05614" ref-type="bibr">154</xref>). Studies have found that the expression of the Sap gene is upregulated during <italic toggle="yes">C. albicans</italic> infection (<xref rid="b154-ijmm-56-05-05614" ref-type="bibr">154</xref>-<xref rid="b156-ijmm-56-05-05614" ref-type="bibr">156</xref>). Secreted proteases hydrolyze host antimicrobial peptides, decrease local immune activity and create favorable conditions for fungal survival (<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>,<xref rid="b157-ijmm-56-05-05614" ref-type="bibr">157</xref>). In addition, <italic toggle="yes">C. albicans</italic> modifies the components of the cell wall, including increasing the phosphorylation of mannan or changing the synthesis of chitin, decreasing the immunogenicity of the cell wall, and avoiding recognition by the host immune system to achieve immune escape (<xref rid="b56-ijmm-56-05-05614" ref-type="bibr">56</xref>).</p><p>Drug resistance in <italic toggle="yes">C. albicans</italic> is a problem worldwide. There are complex interactions between virulence and drug resistance genes. Several studies have shown that virulence genes involved in biofilm formation, such as <italic toggle="yes">Bcr1</italic> and Cyanobacterial phytochrome 1, are associated with drug resistance (<xref rid="b63-ijmm-56-05-05614" ref-type="bibr">63</xref>,<xref rid="b158-ijmm-56-05-05614" ref-type="bibr">158</xref>). As a protective structure formed by <italic toggle="yes">C. albicans</italic> at the site of infection, biofilms not only block the penetration of antifungal drugs but also change the drug metabolism pathway in fungal cells, leading to drug resistance. When the <italic toggle="yes">Bcr1</italic> gene is activated, it upregulates the expression of biofilm-associated genes, promotes the synthesis of extracellular polysaccharides, enhances the stability of biofilms and improves the tolerance of fungal cells to antifungal drugs (<xref rid="b18-ijmm-56-05-05614" ref-type="bibr">18</xref>). In-depth exploration of the mechanism of <italic toggle="yes">C. albicans</italic> virulence genes in morphological transformation, immune escape and drug resistance is expected to provide key targets for the development of novel antifungal drugs and treatment strategies that effectively address the challenges posed by <italic toggle="yes">C. albicans</italic> infection.</p></sec><sec><title>Aspergillus spp</title><p><italic toggle="yes">Aspergillus</italic> is a filamentous fungus widely distributed in nature. <italic toggle="yes">A. fumigatus</italic> is one of the most common pathogenic species and causes invasive aspergillosis, especially in immunocompromised patients, with a high mortality rate. For example, in Quebec, Canada, from March 2018 to December 2018, over 500 cases of invasive aspergillosis were reported annually at McGill University Health Centre, with an overall mortality rate of approximately 25%. However, in cases involving azole-resistant <italic toggle="yes">A. fumigatus</italic> (ARAF), the mortality rate exceeded 60%. Globally, it is estimated that there are at least 300,000 cases of invasive pulmonary aspergillosis (IPA) annually, with mortality rates ranging from 44% to 80%. In China, a systematic review reported that <italic toggle="yes">A. fumigatus</italic> accounted for 75.14% of all <italic toggle="yes">Aspergillus</italic> isolates, highlighting its prevalence as a pathogen. The virulence of <italic toggle="yes">Aspergillus</italic> species is affected by various environmental factors, such as temperature, pH, humidity, nutrient availability, oxygen levels, and the presence of organic matter. The pathogenic mechanism of invasive <italic toggle="yes">Aspergillus</italic> infection involves multiple factors, such as interaction with host cells, immune escape and toxin secretion (<xref rid="b159-ijmm-56-05-05614" ref-type="bibr">159</xref>).</p><p>Environmental factors serve a key role in the regulation of <italic toggle="yes">Aspergillus</italic> virulence gene expression. When the ambient temperature is close to the human body temperature (37&#176;C), the expression of several virulence genes in <italic toggle="yes">A. fumigatus</italic> changes. For example, the expression levels of the chitin synthase gene, which is involved in cell wall synthesis, are upregulated, promoting cell wall thickening and enhancing the resistance of the fungus to host immune responses. Conidium germination and mycelial growth-associated genes, such as bristle A and abacus A (<italic toggle="yes">abaA</italic>), are also activated, accelerating fungal colonization and diffusion in the host (<xref rid="b159-ijmm-56-05-05614" ref-type="bibr">159</xref>). In addition, changes in nutrient composition affect virulence gene expression. The expression of certain virulence genes, such as the hexokinase gene involved in glucose metabolism and the catalase (<italic toggle="yes">cat</italic>) gene regulating the oxidative stress response, changes to adapt to nutrient deficiency and oxidative stress to ensure the survival and proliferation of <italic toggle="yes">A. fumigatus</italic> under low-glucose and hypoxic environments in the host (<xref rid="b73-ijmm-56-05-05614" ref-type="bibr">73</xref>,<xref rid="b160-ijmm-56-05-05614" ref-type="bibr">160</xref>).</p><p>Invasive infection by <italic toggle="yes">Aspergillus</italic> involves a pathogenic link between the fungus and host cells. Adhesion molecules, such as the hydrophobic protein <italic toggle="yes">RodA</italic>, recognize and bind receptors on the surface of host epithelial and endothelial cells to mediate fungal adhesion, which is the initial step of host infection (<xref rid="b61-ijmm-56-05-05614" ref-type="bibr">61</xref>). Once adhesion is successful, <italic toggle="yes">Aspergillus</italic> hyphae destroy host cell barriers and invade tissues through mechanical stress and the secretion of hydrolases, such as proteases and phospholipids (<xref rid="b70-ijmm-56-05-05614" ref-type="bibr">70</xref>). The invasive ability of <italic toggle="yes">Aspergillus</italic> mutants lacking hydrolase genes is reduced in murine models of infection, indicating that these hydrolases serve a key role in the pathogenic process (<xref rid="b61-ijmm-56-05-05614" ref-type="bibr">61</xref>,<xref rid="b161-ijmm-56-05-05614" ref-type="bibr">161</xref>).</p><p><italic toggle="yes">Aspergillus</italic> also possesses the ability to escape and evade clearance by the host immune system. Melanin in the cell wall of <italic toggle="yes">Aspergillus</italic> has an immunosuppressive effect, which can shield fungal cell surface antigens, decrease the recognition of host immune cells and resist the attack of ROS produced by macrophages. In addition, some secondary metabolites secreted by <italic toggle="yes">Aspergillus</italic>, such as gliotoxin, inhibit the activation, proliferation and function of host immune cells, induce immune cell apoptosis, further weaken host immune defense and create favorable conditions for persistent fungal infection (<xref rid="b79-ijmm-56-05-05614" ref-type="bibr">79</xref>). An in-depth study of the association between <italic toggle="yes">Aspergillus</italic> virulence genes and environmental factors, as well as its pathogenic mechanism, is key for the development of precise anti-<italic toggle="yes">Aspergillus</italic> treatment strategies and decreasing the mortality associated with invasive <italic toggle="yes">Aspergillus</italic> (<xref rid="tV-ijmm-56-05-05614" ref-type="table">Table V</xref>).</p></sec><sec><title>C. auris</title><p><italic toggle="yes">C. auris</italic> is a fungal pathogen that uniquely combines multidrug resistance and enhanced virulence (<xref rid="b77-ijmm-56-05-05614" ref-type="bibr">77</xref>). Its rapid global spread and persistence in healthcare settings underscore the need to elucidate the molecular interplay between its resistance and pathogenicity (<xref rid="b78-ijmm-56-05-05614" ref-type="bibr">78</xref>). A hallmark of <italic toggle="yes">C. auris</italic> is the <italic toggle="yes">ERG11</italic> gene, which encodes lanosterol 14&#945;-demethylase, a target of azole antifungals (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). Mutations in <italic toggle="yes">ERG11</italic>, such as Y132F and K143R, alter the topology of the enzyme active site, thereby reducing azole binding affinity (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). Molecular dynamics simulations have revealed that the Y132F substitution introduces steric hindrance, displacing the triazole ring and increasing binding free energy (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). Clinically, these mutations are associated with elevated minimum inhibitory concentration values and high treatment failure rates (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). Notably, <italic toggle="yes">ERG11</italic>-mutant strains also exhibit thickened biofilms, further impeding drug penetration (<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>).</p><p>The evolution of resistance extends beyond that against azole drugs. Mutations in &#946;-1,3-glucan synthase gene (<italic toggle="yes">FKS1</italic>) drive echinocandin resistance by distorting the catalytic pocket of the enzyme (<xref rid="b162-ijmm-56-05-05614" ref-type="bibr">162</xref>). The S639F substitution elevates the IC<sub>50</sub> of caspofungin (<xref rid="b163-ijmm-56-05-05614" ref-type="bibr">163</xref>). <italic toggle="yes">FKS1</italic> mutations are mechanistically linked to enhanced virulence in <italic toggle="yes">C. neoformans</italic>. RNA-sequencing analysis of clinical isolates has demonstrated that <italic toggle="yes">FKS1</italic>-mutant strains upregulate <italic toggle="yes">SAP5</italic>, an aspartic protease, via the activation of the High-Osmolarity Glycerol Mitogen-Activated Protein Kinase (HOG-MAPK) stress-response pathway. This co-regulation translates to a notable increase in epithelial invasion efficiency <italic toggle="yes">in vitro</italic>, as shown by Transwell assays (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>). This interaction between resistance and virulence underscores the adaptability of <italic toggle="yes">C. auris</italic> under therapeutic pressure (<xref rid="b78-ijmm-56-05-05614" ref-type="bibr">78</xref>).</p><p>Environmental persistence is a key aspect of <italic toggle="yes">C. auris</italic> pathogenicity, which is mediated by the <italic toggle="yes">ssa1</italic> gene. Hsp70 enables thermotolerance and biofilm stability (<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>). Ssa1 expression increases at 42&#176;C, allowing survival on surfaces for &gt;30 days. This thermotolerance is likely due to the activation of heat-shock proteins and other stress-response mechanisms in C. auris (<xref rid="b162-ijmm-56-05-05614" ref-type="bibr">162</xref>). Functional studies of <italic toggle="yes">ssa1</italic>-knockout strains have revealed a substantial reduction in biofilm &#946;-1,3-glucan content and a marked increase in susceptibility to hydrogen peroxide disinfectant (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>,<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>). Furthermore, <italic toggle="yes">ssa1</italic> stabilizes drug efflux pumps (such as <italic toggle="yes">CDR1</italic>), amplifying fluconazole resistance by enhancing efflux capacity (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>).</p><p>Genomic studies have highlighted the role of mobile genetic elements in the dissemination of resistance-virulence modules (<xref rid="b164-ijmm-56-05-05614" ref-type="bibr">164</xref>,<xref rid="b165-ijmm-56-05-05614" ref-type="bibr">165</xref>). In the predominant Clade I lineage, <italic toggle="yes">ERG11</italic> and the hyphal adhesin gene <italic toggle="yes">ALS3</italic> co-localize on conjugative plasmids with efficient HGT (<xref rid="b166-ijmm-56-05-05614" ref-type="bibr">166</xref>). Murine infection models have demonstrated that plasmid-bearing strains exhibit higher mortality and resistance to combination therapies (such as fluconazole combined with caspofungin) (<xref rid="b163-ijmm-56-05-05614" ref-type="bibr">163</xref>,<xref rid="b164-ijmm-56-05-05614" ref-type="bibr">164</xref>). This genetic architecture suggests that traditional antifungal strategies, which focus solely on resistance mechanisms, may inadvertently select hypervirulent clones (<xref rid="b164-ijmm-56-05-05614" ref-type="bibr">164</xref>).</p><p>The <italic toggle="yes">HSP90</italic>-calcineurin axis bridges stress adaptation and immune evasion. Under neutrophil-derived ROS stress, <italic toggle="yes">HSP90</italic> stabilizes calcineurin, promoting hyphal morphogenesis and escape from phagolysosomal killing (<xref rid="b167-ijmm-56-05-05614" ref-type="bibr">167</xref>). Pharmacological inhibition of <italic toggle="yes">HSP90</italic> with geldanamycin restores fluconazole susceptibility in resistant strains (<xref rid="b168-ijmm-56-05-05614" ref-type="bibr">168</xref>). <italic toggle="yes">C. auris</italic> employs this pathway more aggressively than <italic toggle="yes">C. albicans</italic>, with higher <italic toggle="yes">HSP90</italic> expression in host niches, enabling persistence in immunocompromised patients (<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>).</p></sec></sec></sec><sec sec-type="other"><label>4.</label><title>Application of pathogen virulence gene research in antimicrobial resistance prevention and control</title><sec><title>Mechanisms of association between virulence genes and antimicrobial resistance</title><sec><title>HGT mediates drug resistance</title><p>HGT is a key driver of drug resistance and virulence enhancement in pathogens. Mobile elements, such as plasmids and transposons, spread resistance and virulence genes (<xref rid="b10-ijmm-56-05-05614" ref-type="bibr">10</xref>,<xref rid="b11-ijmm-56-05-05614" ref-type="bibr">11</xref>). For example, <italic toggle="yes">S. aureus Tn554</italic> transposons carry both erythromycin resistance and toxin genes, increasing the transfer efficiency compared with single-gene elements (<xref rid="b12-ijmm-56-05-05614" ref-type="bibr">12</xref>). This demonstrates that transposon-mediated resistance-virulence coupling is not a passive process but is actively driven by transposase-mediated DNA recombination (<xref rid="b11-ijmm-56-05-05614" ref-type="bibr">11</xref>).</p><p>As circular double-stranded DNA molecules independent of bacterial chromosomes, plasmids autonomously replicate and carry a variety of drug resistance (such as &#946;-lactamase genes that confer bacterial resistance to &#946;-lactam antibiotics) and virulence genes (such as enterotoxin genes of <italic toggle="yes">E. coli</italic> that enhance pathogenicity) (<xref rid="b11-ijmm-56-05-05614" ref-type="bibr">11</xref>). Transposons, which are DNA fragments that can jump in the genome, also carry drug resistance and virulence genes. Transposons are randomly inserted into bacterial chromosomes or plasmids, destroying the original gene function or activating silent genes, thereby causing notable changes in bacterial phenotypes. The <italic toggle="yes">Tn554</italic> transposon in <italic toggle="yes">S. aureus</italic> is a mobile genetic element that co-transfers <italic toggle="yes">erm</italic> and <italic toggle="yes">etb</italic>. Erm encodes a methyltransferase that modifies bacterial ribosomes and confers resistance to macrolide antibiotics (such as erythromycin) (<xref rid="b75-ijmm-56-05-05614" ref-type="bibr">75</xref>). Etb produces a toxin that cleaves desmoglein-1, a key protein for epidermal cell adhesion, causing staphylococcal scalded skin syndrome (<xref rid="b12-ijmm-56-05-05614" ref-type="bibr">12</xref>). This dual gene cargo promotes the spread of multidrug-resistant hypervirulent strains, complicating the clinical management of infection (<xref rid="b6-ijmm-56-05-05614" ref-type="bibr">6</xref>,<xref rid="b12-ijmm-56-05-05614" ref-type="bibr">12</xref>).</p><p>HGT not only accelerates the generation and spread of drug-resistant bacteria but also complicates the virulence spectrum of pathogens, posing numerous obstacles to clinical anti-infection treatment (<xref rid="tVI-ijmm-56-05-05614" ref-type="table">Table VI</xref>).</p></sec><sec><title>Biofilm formation and drug resistance regulation</title><p>A biofilm is a group survival strategy fortress built by bacteria to cope with harsh environments, particularly in response to antibiotic stress. Biofilm structures are complex, and composed of bacterial cells, extracellular polysaccharides (EPS), proteins, nucleic acids and other components interwoven to form a three-dimensional network structure (<xref rid="b35-ijmm-56-05-05614" ref-type="bibr">35</xref>,<xref rid="b169-ijmm-56-05-05614" ref-type="bibr">169</xref>).</p><p>For example, <italic toggle="yes">P. aeruginosa</italic> is a common clinically refractory infectious pathogen, and its biofilm formation is regulated by various virulence genes such as Pellicle (<italic toggle="yes">Pel</italic>) and Pseudomonas surface polysaccharide I (<italic toggle="yes">PsI</italic>) (<xref rid="tVI-ijmm-56-05-05614" ref-type="table">Table VI</xref>). <italic toggle="yes">Pel</italic> genes encode products involved in exopolysaccharide synthesis and biofilm skeleton construction. The <italic toggle="yes">PsI</italic> gene directs protein secretion, promotes bacterial cell adhesion and aggregation, and stabilizes the biofilm structure. Following biofilm formation, the permeability barrier effect of the biofilm prevents antibiotics from reaching bacteria. Inside the bacteria, the drug concentration is decreased, greatly weakening the antibiotic effect of the drug. Simultaneously, bacteria within biofilms exhibit a sluggish metabolism, reshaping of their gene expression profiles, and activation of resistance genes. These changes further enhance antibiotic resistance and contribute to the formation of persistent, localized infections. This often leads to chronic, recurrent infections in the respiratory and urinary tracts, which are difficult to treat (<xref rid="b36-ijmm-56-05-05614" ref-type="bibr">36</xref>,<xref rid="b170-ijmm-56-05-05614" ref-type="bibr">170</xref>).</p></sec></sec><sec><title>Co-selection of virulence genes and drug resistance</title><sec><title>Virulence-resistance colocalization in carbapenem-resistant K. pneumoniae (CRKP)</title><p>The co-selection of virulence and resistance genes has become increasingly common in multidrug-resistant pathogens (<xref rid="b127-ijmm-56-05-05614" ref-type="bibr">127</xref>). For example, hvKP strains of CRKP carry the pLVPK plasmid, which integrates both the <italic toggle="yes">rmpA</italic> (regulating mucoid phenotype to enhance antiphagocytic ability) and the beta-lactamase gene encoding Klebsiella pneumoniae carbapenemase gene (encoding carbapenemase) (<xref rid="b9-ijmm-56-05-05614" ref-type="bibr">9</xref>,<xref rid="b171-ijmm-56-05-05614" ref-type="bibr">171</xref>). The colocalization of the <italic toggle="yes">blaKPC</italic> gene and the <italic toggle="yes">pLVPK</italic>-like virulence plasmid in carbapenem-resistant <italic toggle="yes">K. pneumoniae</italic> (CR-KP) strains has been shown to increase mortality rates in patients with bloodstream infections (<xref rid="b13-ijmm-56-05-05614" ref-type="bibr">13</xref>). Specifically, a study conducted between December 2017 and April 2018 in China reported that out of 24 CR-KP isolates recovered from patients with bacteremia, the mortality rate was 66.7%. This highlights the significant impact of the colocalization of resistance and virulence genes on patient outcomes (<xref rid="b172-ijmm-56-05-05614" ref-type="bibr">172</xref>). A multicenter study in China showed a strong positive association between the intensity of carbapenem antibiotic use in intensive care units and the spread of the pLVPK plasmid, indicating that antibiotic pressure directly drives 'virulence-resistance' co-evolution in <italic toggle="yes">K. pneumoniae</italic> (<xref rid="b127-ijmm-56-05-05614" ref-type="bibr">127</xref>).</p></sec><sec><title>Virulence-resistance synergy module in methicillin-resistant S. aureus (MRSA)</title><p>The Staphylococcal Cassette Chromosome mec (SCCmec) element, carrying the methicillin resistance gene methicillin resistance determinant A (<italic toggle="yes">mecA</italic>) in MRSA often co-integrates with the <italic toggle="yes">PVL</italic> gene (encoding leukocidin) on the chromosome (<xref rid="b173-ijmm-56-05-05614" ref-type="bibr">173</xref>). <italic toggle="yes">PVL</italic> toxins weaken innate immunity by disrupting neutrophil extracellular traps, whereas <italic toggle="yes">mecA</italic> confers &#946;-lactam resistance via the variant penicillin-binding protein 2a (<xref rid="b174-ijmm-56-05-05614" ref-type="bibr">174</xref>). Data from the European Centre for Disease Prevention and Control showed a notable increase in necrotizing pneumonia cases caused by community-acquired MRSA carrying both PVL and SCCmec IV in 2023, with a higher vancomycin treatment failure rate than that of non-PVL strains (<xref rid="b111-ijmm-56-05-05614" ref-type="bibr">111</xref>).</p></sec><sec><title>Stress pathway-driven co-evolution in Enterococci</title><p>In <italic toggle="yes">Enterococcus faecalis</italic>, the vancomycin resistance gene vancomycin resistance gene A (<italic toggle="yes">vanA</italic>) and the virulence gene gelatinase gene (<italic toggle="yes">gelE</italic>) are co-regulated by the stress factor RNA polymerase sigma factor S (RpoS). Under vancomycin pressure, RpoS activates both the resistance phenotype of <italic toggle="yes">vanA</italic> and the colonization function of <italic toggle="yes">gelE</italic> (which degrades the extracellular matrix). This dual activation increases the intestinal colonization rate of vancomycin-resistant strains in patients with inflammatory bowel disease and enables <italic toggle="yes">Enterococci</italic> to occupy niches in immunocompromised hosts more effectively (<xref rid="b91-ijmm-56-05-05614" ref-type="bibr">91</xref>).</p></sec></sec><sec><title>Resistance prevention and control strategies based on virulence genes</title><sec><title>Targeted drug development</title><p>The research and development of drugs targeting virulence factors have provided novel methods to overcome the problem of pathogen resistance in aquaculture. For example, the <italic toggle="yes">agr</italic> quorum-sensing inhibitor savirin selectively suppresses <italic toggle="yes">hla</italic> expression in <italic toggle="yes">S. aureus</italic>, decreasing necrotic skin lesions in murine models without affecting bacterial viability (<xref rid="b14-ijmm-56-05-05614" ref-type="bibr">14</xref>,<xref rid="b175-ijmm-56-05-05614" ref-type="bibr">175</xref>). This approach minimizes the selective pressure for resistance compared with that of traditional bactericidal antibiotics. Artificial intelligence (AI)-driven quantum mechanics/molecular dynamics (QM/MD) simulations have been used to optimize the design of a peptide inhibitor targeting <italic toggle="yes">S. pneumoniae</italic> adhesin pneumococcal surface protein C, which decreases bacterial colonization in human nasopharyngeal organoids (<xref rid="b57-ijmm-56-05-05614" ref-type="bibr">57</xref>). Unlike traditional antibiotics, which act through broad, multi-target mechanisms such as inhibiting cell-wall synthesis, protein translation, or DNA replication, these drugs selectively disrupt specific pathogen-host interactions without globally affecting bacterial viability. By specifically inhibiting their function, the pathogenicity of pathogens is weakened and the harm of infection is decreased, while avoiding the emergence and spread of antibiotic-resistant bacteria (<xref rid="b176-ijmm-56-05-05614" ref-type="bibr">176</xref>,<xref rid="b177-ijmm-56-05-05614" ref-type="bibr">177</xref>).</p><p>A number of studies have focused on developing small-molecule compounds or biological agents that neutralize the activity of bacterial toxins (<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>,<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>,<xref rid="b179-ijmm-56-05-05614" ref-type="bibr">179</xref>). The primary pathogenic factors of severe diarrhea caused by <italic toggle="yes">Clostridium difficile</italic> are toxins A (<italic toggle="yes">TcdA</italic>) and B (<italic toggle="yes">TcdB</italic>). <italic toggle="yes">TcdA</italic> is an enterotoxin that binds to intestinal epithelial cells, causing cytoskeletal disruption, cell rounding, and detachment, leading to severe inflammation and tissue damage (<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>,<xref rid="b180-ijmm-56-05-05614" ref-type="bibr">180</xref>). <italic toggle="yes">TcdB</italic> is a cytotoxin that is more potent than TcdA, binding to cell receptors and inducing apoptosis, affecting a broader range of cell types and contributing significantly to the cytotoxic effects observed in infections (<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>,<xref rid="b180-ijmm-56-05-05614" ref-type="bibr">180</xref>). Researchers have used structural biology to analyze the three-dimensional structure of <italic toggle="yes">C. difficile</italic> toxins and designed small-molecule inhibitors that mimic the toxin receptor-binding site (<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>). Preclinical studies in hamster models have shown that these inhibitors effectively blocked the binding of toxins to intestinal epithelial cells, and decreased the inflammatory response and disease mortality (<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>,<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>,<xref rid="b179-ijmm-56-05-05614" ref-type="bibr">179</xref>,<xref rid="b181-ijmm-56-05-05614" ref-type="bibr">181</xref>). Long-term use of the inhibitor did not induce the emergence of drug-resistant strains of <italic toggle="yes">C. difficile</italic>, which brings hope for clinical treatment (<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>).</p><p>In terms of adhesin targets, researchers have screened peptide drugs that interfere with the interactions between <italic toggle="yes">S. pneumoniae</italic> surface adhesins and host cell receptors (<xref rid="b179-ijmm-56-05-05614" ref-type="bibr">179</xref>,<xref rid="b182-ijmm-56-05-05614" ref-type="bibr">182</xref>,<xref rid="b183-ijmm-56-05-05614" ref-type="bibr">183</xref>). By competitively binding key adhesin sites, these peptides prevent bacterial colonization of the respiratory epithelium to prevent infection (<xref rid="b179-ijmm-56-05-05614" ref-type="bibr">179</xref>). Preclinical studies in mouse models of nasopharyngeal colonization have shown that treatment with peptides rapidly reduced S. pneumoniae load and airway inflammation without selecting for resistant mutants (<xref rid="tVI-ijmm-56-05-05614" ref-type="table">Table VI</xref>) (<xref rid="b179-ijmm-56-05-05614" ref-type="bibr">179</xref>,<xref rid="b182-ijmm-56-05-05614" ref-type="bibr">182</xref>).</p></sec><sec><title>Optimization of combination therapy</title><p>Based on the association between virulence gene regulation and resistance mechanisms, therapeutic strategies targeting virulence pathways have emerged as promising alternatives to conventional antibiotic therapy (<xref rid="f2-ijmm-56-05-05614" ref-type="fig">Fig. 2</xref>), which illustrates transposon and plasmid transfer linking virulence with resistance, <italic toggle="yes">Pel</italic> and <italic toggle="yes">Psl</italic> driven biofilm tolerance, and inhibitor based strategies targeting toxin or adhesin pathways to block infection without promoting resistance. For example, small-molecule inhibitors targeting bacterial toxins have demonstrated efficacy in preclinical models (<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>,<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>,<xref rid="b183-ijmm-56-05-05614" ref-type="bibr">183</xref>). The compound MI-888 disrupts the binding of <italic toggle="yes">C. difficile TcdA</italic>/<italic toggle="yes">B</italic> toxins to host receptors by mimicking the carbohydrate moiety of their target, markedly decreasing mortality in hamster models without inducing resistance mutations (<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>,<xref rid="b184-ijmm-56-05-05614" ref-type="bibr">184</xref>). Peptide Pep-19 blocks <italic toggle="yes">S. pneumoniae</italic> FnbA adhesin binding to host fibronectin, decreasing bacterial colonization when combined with amoxicillin in phase II trials (<xref rid="b179-ijmm-56-05-05614" ref-type="bibr">179</xref>,<xref rid="b185-ijmm-56-05-05614" ref-type="bibr">185</xref>). For biofilm-associated infection, alginate lyase enhances tobramycin penetration into <italic toggle="yes">P. aeruginosa</italic> biofilms, achieving a notable increase in bacterial clearance compared with monotherapy (<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>). These approaches leverage virulence-specific vulnerabilities to minimize collateral resistance induction, in contrast to traditional antibiotics, which target conserved bacterial machinery.</p><p>The combination of antibiotics and anti-virulence substances is common and effective for the treatment of infection. In the treatment of <italic toggle="yes">H. pylori</italic> infection, traditional single-antibiotic therapy faces a high drug resistance rate. Studies have found that a combination of amoxicillin and anti-virulence peptides, which inhibit the virulence of <italic toggle="yes">H. pylori</italic>, improves the therapeutic effect (<xref rid="b183-ijmm-56-05-05614" ref-type="bibr">183</xref>,<xref rid="b186-ijmm-56-05-05614" ref-type="bibr">186</xref>,<xref rid="b187-ijmm-56-05-05614" ref-type="bibr">187</xref>). Anti-virulence peptides enhance the penetration and bactericidal ability of amoxicillin to the <italic toggle="yes">H. pylori</italic> cell wall by interfering with the function of the bacterial cell membrane and inhibiting the secretion of virulence factors such as urease. Clinical studies have shown that combined treatment had a higher eradication rate, lower recurrence rate and reduced drug-resistant strain isolation compared with monotherapy, which demonstrated the superiority of the combined treatment (<xref rid="b183-ijmm-56-05-05614" ref-type="bibr">183</xref>,<xref rid="b188-ijmm-56-05-05614" ref-type="bibr">188</xref>).</p><p>In addition, for biomembrane-associated infection, such as chronic pulmonary infection caused by <italic toggle="yes">P. aeruginosa</italic>, the combination of bioactive enzymes that can destroy the biofilm structure and sensitive antibiotics has synergistic potential (<xref rid="b189-ijmm-56-05-05614" ref-type="bibr">189</xref>). Biofilms, structured bacterial communities encased in a protective extracellular polymeric matrix, are resistant to antibiotics and immune clearance (<xref rid="b190-ijmm-56-05-05614" ref-type="bibr">190</xref>). Disruption of EPS components (such as alginate in <italic toggle="yes">P. aeruginosa</italic>) with enzymes (such as alginate lyase) enhances antibiotic penetration, offering a synergistic approach to treat chronic infection (<xref rid="b191-ijmm-56-05-05614" ref-type="bibr">191</xref>). Biological enzymes break down the EPS of biofilms and open penetration channels for antibiotics, exposing the bacteria to drug attack (<xref rid="b192-ijmm-56-05-05614" ref-type="bibr">192</xref>).</p><p>Experimental studies have shown that compared with single antibiotic treatment, combination therapy notably increases the bacterial clearance rate, improves lung inflammation indicators and delays the emergence of drug-resistant bacteria, providing novel ideas for the treatment of chronic refractory infection (<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>,<xref rid="b193-ijmm-56-05-05614" ref-type="bibr">193</xref>) (<xref rid="tVI-ijmm-56-05-05614" ref-type="table">Table VI</xref>).</p></sec></sec><sec><title>Clinical translation challenges</title><sec><title>Off-target effects and resistance risks of anti-virulence drugs</title><p>Targeting host-pathogen interactions risks disrupting host physiology, as seen in therapies against SARS-CoV-2 and HIV-1. For example, ACE2 inhibitors interfere with the renin-angiotensin system, causing a rise in blood pressure in rhesus macaques (<xref rid="b194-ijmm-56-05-05614" ref-type="bibr">194</xref>). This dual role of ACE2 as a viral receptor and a regulator of blood pressure highlights the delicate balance between antiviral efficacy and host safety. To mitigate such off-target effects, researchers are developing lung-targeted nanocarriers to confine drug distribution to the infected tissue, thereby minimizing systemic exposure (<xref rid="b170-ijmm-56-05-05614" ref-type="bibr">170</xref>,<xref rid="b194-ijmm-56-05-05614" ref-type="bibr">194</xref>).</p><p>A similar challenge emerges in antiviral therapies that target variable viral proteins. The broadly neutralizing antibody VRC01 against the HIV-1 <italic toggle="yes">env</italic> protein selects for hypermutated variants with a high resistance frequency <italic toggle="yes">in vitro</italic>, driven by the high mutation rate in the V3 loop and glycan shield regions (<xref rid="b44-ijmm-56-05-05614" ref-type="bibr">44</xref>). This mirrors the challenge in bacterial anti-virulence strategies, where agents such as the antimicrobial peptide P113 face termination due to host toxicity. P113 disrupts <italic toggle="yes">P. aeruginosa</italic> biofilms by targeting polysaccharide synthesis locus (Psl) polysaccharides but induces hemolysis due to sequence similarity with human phosphatidylserine (<xref rid="b169-ijmm-56-05-05614" ref-type="bibr">169</xref>). Similarly, the <italic toggle="yes">S. aureus hla</italic> inhibitor RU-58 demonstrates a trade-off between efficacy and safety; while notably decreasing skin necrosis in mice, it binds host Kv1.3 channels, triggering arrhythmias at high doses (<xref rid="b176-ijmm-56-05-05614" ref-type="bibr">176</xref>,<xref rid="b177-ijmm-56-05-05614" ref-type="bibr">177</xref>).</p><p>These examples, spanning viruses, bacteria and hosts, reveal a common paradox in anti-virulence design: Targeting conserved virulence mechanisms often intersects with key host pathways, while targeting variable pathogen epitopes invites rapid resistance. Whether through nanocarrier-mediated spatial confinement for ACE2 inhibitors or multi-epitope vaccination for HIV-1, solutions must address both the species-specific vulnerabilities of pathogens and the evolutionary pressures they exert.</p></sec><sec><title>Standardization and clinical applicability of virulence gene detection</title><p>Accurate and rapid detection of virulence genes in clinical samples is key for precision medicine; however, there are hurdles in assay standardization and technical consistency (<xref rid="b195-ijmm-56-05-05614" ref-type="bibr">195</xref>). For example, detecting the <italic toggle="yes">dosR</italic> gene in <italic toggle="yes">M. tuberculosis</italic>, which governs the bacteria dormancy and reactivation within granuloma, requires reliable quantification in blood or sputum specimens (<xref rid="b195-ijmm-56-05-05614" ref-type="bibr">195</xref>). However, existing techniques, such as quantitative (q)PCR and nanopore sequencing, produce inconsistent outcomes. qPCR may miss <italic toggle="yes">dosR</italic> transcripts in hypoxic environments where bacterial metabolism slows, while nanopore sequencing, despite its sensitivity to low-abundance transcripts, exhibits variability in library preparation and base-calling accuracy (<xref rid="b196-ijmm-56-05-05614" ref-type="bibr">196</xref>). Similar issues affect the detection of other pathogen virulence genes. For example, identifying the <italic toggle="yes">PVL</italic> gene in <italic toggle="yes">S. aureus</italic> often yields discordant results between PCR and next-generation sequencing, with discrepancies reported in a notable proportion of clinical isolates due to primer mismatch, contamination during extraction and inconsistent positive-result thresholds (<xref rid="b111-ijmm-56-05-05614" ref-type="bibr">111</xref>). In antifungal diagnostics, detecting the <italic toggle="yes">ssa1</italic>-<italic toggle="yes">ERG11</italic> virulence-resistance module of <italic toggle="yes">C. auris</italic> via point-of-care tests risks false positives in a notable number of cases because of cross-reactivity with non-pathogenic species (<xref rid="b195-ijmm-56-05-05614" ref-type="bibr">195</xref>).</p><p>These challenges have direct implications for clinical decision making. In bloodstream infection caused by <italic toggle="yes">K. pneumoniae</italic>, delayed or inaccurate detection of the <italic toggle="yes">rmpA</italic> virulence gene can postpone combination therapy, potentially increasing the mortality risk (<xref rid="b13-ijmm-56-05-05614" ref-type="bibr">13</xref>,<xref rid="b127-ijmm-56-05-05614" ref-type="bibr">127</xref>). To overcome these obstacles, international initiatives aim to establish unified standards for virulence gene assays. The World Health Organization has promoted certified reference strains for <italic toggle="yes">M. tuberculosis</italic> and <italic toggle="yes">S. aureus</italic> to facilitate interlaboratory calibration (<xref rid="b17-ijmm-56-05-05614" ref-type="bibr">17</xref>,<xref rid="b195-ijmm-56-05-05614" ref-type="bibr">195</xref>). Researchers are also exploring multimodal approaches, combining qPCR for rapid screening with next-generation sequencing for confirmation, a strategy that notably decreases <italic toggle="yes">P. aeruginosa</italic> virulence gene detection errors (<xref rid="b169-ijmm-56-05-05614" ref-type="bibr">169</xref>,<xref rid="b170-ijmm-56-05-05614" ref-type="bibr">170</xref>). Additionally, AI-driven models show promise in reconciling platform-specific biases, such as correcting nanopore sequencing errors when analyzing hypervariable genes, including HIV-1 <italic toggle="yes">env</italic> (<xref rid="b196-ijmm-56-05-05614" ref-type="bibr">196</xref>,<xref rid="b197-ijmm-56-05-05614" ref-type="bibr">197</xref>). However, resource-limited regions face barriers due to a lack of standardized reagents and trained personnel (<xref rid="b14-ijmm-56-05-05614" ref-type="bibr">14</xref>,<xref rid="b91-ijmm-56-05-05614" ref-type="bibr">91</xref>). While emerging technologies, such as CRISPR-based specific high-sensitivity enzymatic reporter unlocking assays, offer potential for point-of-care applications, their widespread adoption requires development of globally consistent performance metrics (<xref rid="b198-ijmm-56-05-05614" ref-type="bibr">198</xref>,<xref rid="b199-ijmm-56-05-05614" ref-type="bibr">199</xref>). Bridging the gap between technological innovation and clinical utility requires interdisciplinary efforts.</p></sec><sec><title>Inadequate coverage of virulence gene polymorphisms in multivalent vaccines</title><p>The high variability of viral proteins, such as the <italic toggle="yes">env</italic> gene products of HIV-1, poses a challenge to targeted therapies and vaccine efficacy (<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>). For HIV-1, the broadly neutralizing antibody VRC01 targets the CD4-binding site of gp120; however, the virus rapidly evolves escape variants through mutations in the hypervariable V3 loop of the <italic toggle="yes">env</italic> gene, such as the addition of N160K glycosylation sites, which decreases antibody binding efficiency (<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>). <italic toggle="yes">In vitro</italic> studies have shown a high resistance frequency to VRC01, and a 2023 phase III trial revealed that the majority of patients developed resistant strains following monotherapy, underscoring the need for multi-epitope strategies (<xref rid="b45-ijmm-56-05-05614" ref-type="bibr">45</xref>,<xref rid="b200-ijmm-56-05-05614" ref-type="bibr">200</xref>). This phenomenon is not exclusive to HIV-1 infection. Influenza vaccines designed to target the HA protein frequently fail to neutralize strains with antigenic drift, such as mutations in the HA1 domain of H3N2 viruses (<xref rid="b46-ijmm-56-05-05614" ref-type="bibr">46</xref>). Similarly, under immune pressure, the RBD of the SARS-CoV-2 S protein undergoes evolution, as evidenced by the &#959; variant (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b129-ijmm-56-05-05614" ref-type="bibr">129</xref>). This highlights the widespread challenges posed by the variability of viral epitopes.</p><p>The common thread linking these challenges is the ability of pathogens to exploit genetic and structural plasticity to evade immune recognition. For vaccines, this means designing multivalent formulations that cover hypervariable virulence epitopes, a task requiring breakthroughs in epitope prediction algorithms and delivery systems (<xref rid="b201-ijmm-56-05-05614" ref-type="bibr">201</xref>). Just as HIV-1 <italic toggle="yes">env</italic> variability necessitates multi-epitope antibody cocktails, influenza and SARS-CoV-2 vaccine development must confront HA and RBD mutational hotspots (<xref rid="b202-ijmm-56-05-05614" ref-type="bibr">202</xref>). Emerging technologies, such as AI-driven epitope mapping and self-assembling nanoparticle platforms, hold promise for identifying conserved regions (such as the HA stem in influenza or the RBD base in SARS-CoV-2) while accommodating variant-specific epitopes (<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>). These approaches mirror the those used for HIV-1: Single-target strategies are inherently vulnerable to viral evolution, whereas multi-pronged designs that anticipate variability, whether through computational prediction or dynamic antigen presentation, may provide durable protection against evolving pathogens (<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>).</p></sec><sec><title>Conservation limitations of fungal targets: C. albicans <italic toggle="yes">EFG1</italic></title><p>The development of broad-spectrum antifungal therapies is hampered by the limited conservation of virulence targets across different fungal species. An example is the transcription factor EFG1 in <italic toggle="yes">C. albicans</italic>, which is a key regulator of hyphal development and virulence (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>). The small-molecule inhibitor EFG1-IN-1 demonstrates notable efficacy in mouse models of systemic candidiasis, markedly decreasing mortality rates by blocking EFG1-dependent gene expression and inhibiting hyphal transition (<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>). However, to the best of our knowledge, this success has not been observed in fungal pathogens. Comparative genomics has revealed that the DNA-binding domain of EFG1 exhibits marked sequence divergence in species such as <italic toggle="yes">A. fumigatus</italic> and <italic toggle="yes">Cryptococcus neoformans</italic>. These structural disparities prevent EFG1-IN-1 binding to orthologous proteins in non-<italic toggle="yes">Candida</italic> fungi, rendering the inhibitor ineffective against invasive aspergillosis and cryptococcal meningitis (<xref rid="b82-ijmm-56-05-05614" ref-type="bibr">82</xref>,<xref rid="b153-ijmm-56-05-05614" ref-type="bibr">153</xref>). This lack of conservation is not exclusive to the EFG1 protein. Numerous fungal virulence factors, such as cell wall synthases and iron acquisition protein, exhibit species-specific structural characteristics that impede the development of pan-fungal drugs (<xref rid="b82-ijmm-56-05-05614" ref-type="bibr">82</xref>).</p><p>The consequences of such variability extend beyond individual compounds. Clinical trials of novel antifungals often fail when testing against diverse fungal pathogens, despite promising results in single-species models. For example, drugs targeting the &#946;-1,3-glucan synthase complex, a key cell wall component, show efficacy against <italic toggle="yes">Candida</italic> but have limited activity against <italic toggle="yes">Aspergillus</italic> due to differences in enzyme subunit composition (<xref rid="b82-ijmm-56-05-05614" ref-type="bibr">82</xref>,<xref rid="b203-ijmm-56-05-05614" ref-type="bibr">203</xref>,<xref rid="b204-ijmm-56-05-05614" ref-type="bibr">204</xref>). To overcome these challenges, researchers are exploring two strategies: Identifying highly conserved domains within functionally key proteins, such as the catalytic core of fungal kinases, and designing inhibitors that tolerate minor sequence variations and developing combination therapies that target multiple species-specific virulence pathways (<xref rid="b203-ijmm-56-05-05614" ref-type="bibr">203</xref>,<xref rid="b204-ijmm-56-05-05614" ref-type="bibr">204</xref>). However, both approaches face challenges. The former requires extensive structural biology and computational modeling to predict binding modes across diverse homologs, whereas the latter requires understanding of pathogen-specific virulence mechanisms, making the development of broad-spectrum antifungal agents challenging (<xref rid="b203-ijmm-56-05-05614" ref-type="bibr">203</xref>,<xref rid="b204-ijmm-56-05-05614" ref-type="bibr">204</xref>).</p></sec></sec></sec><sec sec-type="other"><label>5.</label><title>Future prospects</title><sec><title>Technological innovation</title><p>Integration of multi-omics data remains challenging. For example, determining the association between transcriptomic changes in <italic toggle="yes">C. albicans</italic> hyphae with proteomic dynamics during host invasion is complicated by temporal mismatches. Emerging spatial transcriptomics and single-cell CRISPR screens offer solutions but require standardized workflows to avoid data bias (<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>). The organic integration of genomics, transcriptomics, proteomics and metabolomics is used to analyze the molecular characteristics of pathogens during infection. For example, by simultaneously monitoring the transcriptional changes in virulence genes during bacterial infection, the expression regulation of corresponding virulence proteins and the fluctuations in host cell metabolites, a more refined and comprehensive pathogenic network can be constructed, and the mechanisms of virulence genes can be accurately revealed (<xref rid="b205-ijmm-56-05-05614" ref-type="bibr">205</xref>). The development of spatiotemporal omics technology may facilitate real-time tracking of the spatiotemporal dynamic distribution and gene expression changes of pathogens in infected tissue and organs. Combination of high-resolution imaging and single-cell sequencing technology may demonstrate how virulence genes are activated in specific cell subsets at specific time points in different infection stages of the virus in the host cell, providing understanding of the microscopic process of viral infection and facilitating the research and development of targeted therapeutic drugs to accurately locate key links (<xref rid="b197-ijmm-56-05-05614" ref-type="bibr">197</xref>).</p><p>Spatial transcriptomics and AI-driven modeling are accelerating the translation of virulence gene insights into clinical applications. In <italic toggle="yes">C. albicans</italic> keratitis, spatial omics-guided delivery of voriconazole-loaded nanogels to <italic toggle="yes">Sap2</italic>-expressing hyphae at infection foci improves drug accumulation compared with systemic administration (<xref rid="b206-ijmm-56-05-05614" ref-type="bibr">206</xref>,<xref rid="b207-ijmm-56-05-05614" ref-type="bibr">207</xref>). Meanwhile, AI models such as AlphaFold2 predict virulence protein-host receptor interactions, like the binding of <italic toggle="yes">S. pneumoniae</italic> capsular polysaccharide (Cps) to complement C3b (C3b), with atomic precision. This not only accelerates target identification but also informs the design of multivalent vaccines that cover the majority of clinical serotypes (<xref rid="b208-ijmm-56-05-05614" ref-type="bibr">208</xref>). Preclinical studies have shown that such vaccines induce notably higher opsonophagocytic antibody titers than current polysaccharide vaccines (<xref rid="b209-ijmm-56-05-05614" ref-type="bibr">209</xref>,<xref rid="b210-ijmm-56-05-05614" ref-type="bibr">210</xref>).</p><p>The integration of multi-omics approaches with single-cell resolution may facilitate the study of virulence genes. For example, single-cell transcriptomics enables the real-time tracking of virulence gene dynamics during infection. A previous study applied this technology to <italic toggle="yes">Salmonella</italic>-infected macrophages, revealing subpopulations of bacteria with upregulated <italic toggle="yes">SPI-2</italic> (virulence island) genes under host ROS stress, which is associated with enhanced intracellular survival and systemic dissemination (<xref rid="b29-ijmm-56-05-05614" ref-type="bibr">29</xref>,<xref rid="b211-ijmm-56-05-05614" ref-type="bibr">211</xref>). Similarly, spatial transcriptomics is used to map virulence gene expression within infected tissue. In a murine model of <italic toggle="yes">C. albicans</italic> keratitis, spatial omics has identified hypha-specific <italic toggle="yes">SAP</italic> protease hotspots at the corneal invasion front, guiding targeted antifungal therapy (<xref rid="b67-ijmm-56-05-05614" ref-type="bibr">67</xref>). CRISPR-based functional screens offer precise tools to determine virulence-immune interactions. A pooled CRISPR interference screen in <italic toggle="yes">P. aeruginosa</italic> revealed luxR family transcriptional regulator lasR (a quorum-sensing regulator) as a key node balancing biofilm formation and immune evasion, with knockout strains showing notably reduced resistance to neutrophil killing (<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>). These approaches can prioritize therapeutic targets in pathogen-specific contexts.</p><sec><title>Interdisciplinary cooperation</title><p>Research on pathogen virulence genes may highlight the importance of interdisciplinary cooperation and a collaborative innovation research model in medicine, biology, computer science and other disciplines. With clinical experience, medical experts accurately identify key problems in infectious diseases and guide basic research. Biological researchers have explored the functions and regulatory mechanisms of virulence genes to identify potential therapeutic targets. Computer scientists use advanced algorithms and big data processing capabilities to overcome the problems associated with the analysis of large amounts of biological data and build accurate predictive models. For example, in the development of novel antibacterial drugs, pharmaceutical chemists have designed targeted small-molecule inhibitors based on the virulence protein structure revealed by biological research and computer simulations of the drug-target combination process to optimize the molecular structure. Clinical trials are conducted to verify the efficacy and safety of these novel therapies. Through close collaboration among researchers, these trials help to accelerate the translation of scientific research findings from the laboratory to clinical application, thereby improving patient well-being and enhancing global health (<xref rid="b79-ijmm-56-05-05614" ref-type="bibr">79</xref>).</p><p>The complexity of infectious disease research necessitates integration of medicine, computational science and engineering. AI-driven platforms can predict the transmission risk of hypervirulent-resistant clones with high accuracy (<xref rid="b2-ijmm-56-05-05614" ref-type="bibr">2</xref>). In drug development, QM/MD co-simulations have optimized the design of broadly neutralizing antibodies targeting conformational changes in HIV-1 Env proteins, achieving an increase in neutralization potency against &#959; subvariants (<xref rid="b42-ijmm-56-05-05614" ref-type="bibr">42</xref>). The convergence of synthetic biology and microfluidics has revolutionized pathogen-host interaction models. For example, a lung-immune organ-on-a-chip integrates human alveolar epithelium, endothelial cells and primary neutrophils to dynamically simulate <italic toggle="yes">A. fumigatus</italic> invasion and capture hyphal penetration of vascular barriers. This model has revealed that hypoxia upregulates <italic toggle="yes">SidA</italic> expression, leading to a marked increase in fungal load (<xref rid="b69-ijmm-56-05-05614" ref-type="bibr">69</xref>-<xref rid="b71-ijmm-56-05-05614" ref-type="bibr">71</xref>). Such platforms may replace animal testing and accelerate the preclinical evaluation of anti-virulence therapies.</p></sec><sec><title>Applications</title><p>Precision therapies based on virulence gene profiling have already impacted clinical decisions. In <italic toggle="yes">ESBL</italic>-producing <italic toggle="yes">E. coli</italic> infection, strains carrying the <italic toggle="yes">fimH</italic>-<italic toggle="yes">blaCTX-M</italic> plasmid are associated with high carbapenem resistance (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>,<xref rid="b7-ijmm-56-05-05614" ref-type="bibr">7</xref>). Phage therapy using the engineered phage &#934;ECM1, which is armed with CRISPR-Cas9 to target plasmid-encoded virulence-resistance modules, has demonstrated higher bactericidal efficiency than meropenem in <italic toggle="yes">ex vivo</italic> human plasma models (<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>,<xref rid="b212-ijmm-56-05-05614" ref-type="bibr">212</xref>). For viral pathogens, the mRNA vaccine mRNA-1273.214 targets six hypervariable mutations in the SARS-CoV-2 RBD, inducing neutralizing antibodies against the majority of circulating variants in phase III trials (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b213-ijmm-56-05-05614" ref-type="bibr">213</xref>). Similarly, a <italic toggle="yes">C. albicans SAP</italic> protease conjugate vaccine decreased the incidence of invasive candidiasis in immunocompromised patients during phase III testing (<xref rid="b18-ijmm-56-05-05614" ref-type="bibr">18</xref>). In precision therapy, the synergistic combination of engineered phages and antibiotics exhibits potential. By using CRISPR to silence the quorum-sensing regulator gene <italic toggle="yes">lasR</italic> in <italic toggle="yes">P. aeruginosa</italic>, engineered phages weaken biofilm barriers, markedly enhancing the bactericidal efficiency of meropenem in chronic lung infection, with safety validated in sputum samples from patients with cystic fibrosis (<xref rid="b212-ijmm-56-05-05614" ref-type="bibr">212</xref>). Epigenetic editing tools such as CRISPR-dCas9 offer novel strategies against fungal infection (<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>,<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>). Targeted suppression of <italic toggle="yes">EFG1</italic> in <italic toggle="yes">C. albicans</italic> blocks hyphal transition, increasing survival rates in murine systemic infection models without observable off-target toxicity (<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>,<xref rid="b159-ijmm-56-05-05614" ref-type="bibr">159</xref>).</p><p>Smart diagnostics and early warning systems are reshaping global infectious disease surveillance. Portable nanosensor arrays functionalized with gold nanoparticles simultaneously detect <italic toggle="yes">Vibrio cholerae</italic> cholera toxin A-B subunit (<italic toggle="yes">ctxAB</italic>) and New Delhi metallo-&#946;-lactamase-1 (<italic toggle="yes">blaNDM</italic>) resistance genes, achieving high sensitivity in wastewater samples, thereby enabling early cholera outbreak alerts (<xref rid="b198-ijmm-56-05-05614" ref-type="bibr">198</xref>,<xref rid="b199-ijmm-56-05-05614" ref-type="bibr">199</xref>). Furthermore, a blockchain-powered global virulence gene database has successfully traced the cross-border transmission of <italic toggle="yes">E. coli</italic> clones carrying <italic toggle="yes">fimH</italic>-<italic toggle="yes">blaCTX-M</italic> plasmids across Asia and Africa, providing a data-driven foundation for regional antimicrobial resistance policies (<xref rid="b10-ijmm-56-05-05614" ref-type="bibr">10</xref>).</p><p>Vaccine development is overcoming traditional limitations using cutting-edge technology. A broad-spectrum mRNA vaccine for <italic toggle="yes">SARS-CoV-2</italic>, designed to cover most known variants by integrating S protein mutation hotspots from &#959; BA.5 and XBB.1.5, has demonstrated a notable increase in neutralizing antibody titers compared with conventional vaccines in phase II trials (<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b214-ijmm-56-05-05614" ref-type="bibr">214</xref>). For fungal pathogens, a polysaccharide-protein conjugate vaccine targeting immunodominant epitopes of <italic toggle="yes">C. albicans SAP</italic> proteases activates T helper 17 cell responses, substantially reducing invasive candidiasis incidence in phase III trials, particularly in immunocompromised patients (<xref rid="b18-ijmm-56-05-05614" ref-type="bibr">18</xref>,<xref rid="b215-ijmm-56-05-05614" ref-type="bibr">215</xref>).</p><p>These advances mark a shift from reactive treatment to precision intervention, underscoring the key role of multidisciplinary convergence in addressing global health challenges. By integrating frontier technologies, clinical needs and public health data, future research may transform personalized therapy, outbreak prediction and vaccine coverage to alleviate the global burden of infectious disease.</p></sec></sec></sec><sec sec-type="conclusions"><label>6.</label><title>Conclusion</title><p>Notable achievements have been made in research on pathogen virulence genes. From a basic theoretical level, the diversity, classification and complex mechanism of virulence genes of bacteria, viruses, fungi and other pathogens have been revealed, which provides an understanding of how pathogens use these to invade the host, evade immunity and cause diseases. These studies provide a foundation for developing precision medicine (<xref rid="b216-ijmm-56-05-05614" ref-type="bibr">216</xref>-<xref rid="b218-ijmm-56-05-05614" ref-type="bibr">218</xref>). Although there are challenges, including research gaps such as the molecular mechanisms of cross-kingdom virulence gene transfer, the spatiotemporal regulation of virulence genes in complex host microenvironments, the lack of standardization in virulence-based precision diagnostics, technical bottlenecks (such as multi-omics data integration) and ethical considerations, pathogen virulence gene research may be facilitated by advancements in frontier technologies (such as multi- and spatial-temporal omics) and interdisciplinary collaboration. Virulence gene research has transitioned from mechanistic identification to clinical implementation, yielding tangible applications in targeted anti-virulence therapy, precision diagnostics and next-generation vaccines. Compounds such as MI-888 and Pep-19 demonstrate the feasibility of inhibiting pathogen-host interactions without selecting for resistance, while blockchain-enabled global databases tracking <italic toggle="yes">fimH</italic>-<italic toggle="yes">blaCTX-M</italic> plasmids have identified cross-continental transmission hotspots to inform antibiotic stewardship policies (<xref rid="b10-ijmm-56-05-05614" ref-type="bibr">10</xref>). Multi-omics-driven vaccine designs, such as the SARS-CoV-2 pan-variant mRNA vaccine, address the challenges of antigenic diversity and set a precedent for adaptive immunization strategies. These advancements underscore the potential of this field to transform infectious disease management by offering data-driven solutions to decrease morbidity and mortality from drug-resistant pathogens and enhance global health. Development of multi-omics joint analysis, space-time omics and other frontier technology may facilitate interdisciplinary collaborative pathogen virulence gene research to resist pathogen invasion and maintain global health.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><sec sec-type="data-availability"><title>Availability of data and materials</title><p>Not applicable.</p></sec><sec sec-type="other"><title>Authors' contributions</title><p>YC performed the literature review and wrote the manuscript. XW, CX and JH designed the study. LZ, PQ, DZ and WC conceived the study. SZ revised the manuscript. Data authentication is not applicable. All authors have read and approved the final manuscript.</p></sec><sec sec-type="other"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec sec-type="other"><title>Patient consent for publication</title><p>Not applicable.</p></sec><sec sec-type="COI-statement"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><ref-list><title>References</title><ref id="b1-ijmm-56-05-05614"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>YS</given-names></name><name name-style="western"><surname>Sun</surname><given-names>ZS</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>JX</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>SX</given-names></name><name name-style="western"><surname>Yin</surname><given-names>JX</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>HQ</given-names></name><name name-style="western"><surname>Shen</surname><given-names>HM</given-names></name><name name-style="western"><surname>Baneth</surname><given-names>G</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kassegne</surname><given-names>K</given-names></name></person-group><article-title>Prevalence and attributable health burdens of vector-borne parasitic infectious diseases of poverty, 1990-2021: Findings from the global burden of disease study 2021</article-title><source>Infect Dis Poverty</source><volume>13</volume><fpage>96</fpage><year>2024</year><pub-id pub-id-type="doi">10.1186/s40249-024-01260-x</pub-id><pub-id pub-id-type="pmid">39658783</pub-id><pub-id pub-id-type="pmcid">PMC11633012</pub-id></element-citation></ref><ref id="b2-ijmm-56-05-05614"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2019 Antimicrobial Resistance Collaborators</collab></person-group><article-title>Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the global burden of disease study 2019</article-title><source>Lancet</source><volume>400</volume><fpage>2221</fpage><lpage>2248</lpage><year>2022</year><pub-id pub-id-type="doi">10.1016/S0140-6736(22)02185-7</pub-id><pub-id pub-id-type="pmid">36423648</pub-id><pub-id pub-id-type="pmcid">PMC9763654</pub-id></element-citation></ref><ref id="b3-ijmm-56-05-05614"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casadevall</surname><given-names>A</given-names></name><name name-style="western"><surname>Pirofski</surname><given-names>LA</given-names></name></person-group><article-title>The damage-response framework of microbial pathogenesis</article-title><source>Nat Rev Microbiol</source><volume>1</volume><fpage>17</fpage><lpage>24</lpage><year>2003</year><pub-id pub-id-type="doi">10.1038/nrmicro732</pub-id><pub-id pub-id-type="pmid">15040176</pub-id><pub-id pub-id-type="pmcid">PMC7097162</pub-id></element-citation></ref><ref id="b4-ijmm-56-05-05614"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siscar-Lewin</surname><given-names>S</given-names></name><name name-style="western"><surname>Hube</surname><given-names>B</given-names></name><name name-style="western"><surname>Brunke</surname><given-names>S</given-names></name></person-group><article-title>Emergence and evolution of virulence in human pathogenic fungi</article-title><source>Trends Microbiol</source><volume>30</volume><fpage>693</fpage><lpage>704</lpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.tim.2021.12.013</pub-id><pub-id pub-id-type="pmid">35058122</pub-id></element-citation></ref><ref id="b5-ijmm-56-05-05614"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ullah</surname><given-names>N</given-names></name><name name-style="western"><surname>Assawakongkarat</surname><given-names>T</given-names></name><name name-style="western"><surname>Akeda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chaichanawongsaroj</surname><given-names>N</given-names></name></person-group><article-title>Detection of Extended-spectrum &#946;-lactamase-producing Escherichia coli isolates by isothermal amplification and association of their virulence genes and phylogroups with extraintestinal infection</article-title><source>Sci Rep</source><volume>13</volume><fpage>12022</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41598-023-39228-w</pub-id><pub-id pub-id-type="pmid">37491387</pub-id><pub-id pub-id-type="pmcid">PMC10368679</pub-id></element-citation></ref><ref id="b6-ijmm-56-05-05614"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orlek</surname><given-names>A</given-names></name><name name-style="western"><surname>Anjum</surname><given-names>MF</given-names></name><name name-style="western"><surname>Mather</surname><given-names>AE</given-names></name><name name-style="western"><surname>Stoesser</surname><given-names>N</given-names></name><name name-style="western"><surname>Walker</surname><given-names>AS</given-names></name></person-group><article-title>Factors associated with plasmid antibiotic resistance gene carriage revealed using large-scale multivariable analysis</article-title><source>Sci Rep</source><volume>13</volume><fpage>2500</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41598-023-29530-y</pub-id><pub-id pub-id-type="pmid">36781908</pub-id><pub-id pub-id-type="pmcid">PMC9925765</pub-id></element-citation></ref><ref id="b7-ijmm-56-05-05614"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jackson</surname><given-names>N</given-names></name><name name-style="western"><surname>Belmont</surname><given-names>CR</given-names></name><name name-style="western"><surname>Tarlton</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Allegretti</surname><given-names>YH</given-names></name><name name-style="western"><surname>Adams-Sapper</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>YY</given-names></name><name name-style="western"><surname>Borges</surname><given-names>CA</given-names></name><name name-style="western"><surname>Frazee</surname><given-names>BW</given-names></name><name name-style="western"><surname>Florence-Petrovic</surname><given-names>D</given-names></name><name name-style="western"><surname>Hufana</surname><given-names>C</given-names></name><etal/></person-group><article-title>Genetic predictive factors for nonsusceptible phenotypes and multidrug resistance in expanded-spectrum cephalosporin-resistant uropathogenic Escherichia coli from a multicenter cohort: Insights into the phenotypic and genetic basis of coresistance</article-title><source>mSphere</source><volume>7</volume><fpage>e0047122</fpage><year>2022</year><pub-id pub-id-type="doi">10.1128/msphere.00471-22</pub-id><pub-id pub-id-type="pmid">36377882</pub-id><pub-id pub-id-type="pmcid">PMC9769571</pub-id></element-citation></ref><ref id="b8-ijmm-56-05-05614"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Spychala</surname><given-names>CN</given-names></name><name name-style="western"><surname>Hu</surname><given-names>F</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>JF</given-names></name><name name-style="western"><surname>Doi</surname><given-names>Y</given-names></name></person-group><article-title>Complete nucleotide sequences of bla (CTX-M)-harboring IncF plasmids from community-associated Escherichia coli strains in the United States</article-title><source>Antimicrob Agents Chemother</source><volume>59</volume><fpage>3002</fpage><lpage>3007</lpage><year>2015</year><pub-id pub-id-type="doi">10.1128/AAC.04772-14</pub-id><pub-id pub-id-type="pmid">25753630</pub-id><pub-id pub-id-type="pmcid">PMC4432217</pub-id></element-citation></ref><ref id="b9-ijmm-56-05-05614"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>S</given-names></name><name name-style="western"><surname>Yang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>R</given-names></name><name name-style="western"><surname>Yin</surname><given-names>D</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>L</given-names></name><name name-style="western"><surname>Bai</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Yin</surname><given-names>W</given-names></name><etal/></person-group><article-title>Adaptive evolution of carbapenem-resistant hypervirulent Klebsiella pneumoniae in the urinary tract of a single patient</article-title><source>Proc Natl Acad Sci USA</source><volume>121</volume><fpage>e2400446121</fpage><year>2024</year><pub-id pub-id-type="doi">10.1073/pnas.2400446121</pub-id><pub-id pub-id-type="pmid">39150777</pub-id><pub-id pub-id-type="pmcid">PMC11363291</pub-id></element-citation></ref><ref id="b10-ijmm-56-05-05614"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kuang</surname><given-names>D</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ou</surname><given-names>HY</given-names></name><name name-style="western"><surname>Qu</surname><given-names>J</given-names></name></person-group><article-title>Mobilizable plasmids drive the spread of antimicrobial resistance genes and virulence genes in Klebsiella pneumoniae</article-title><source>Genome Med</source><volume>15</volume><fpage>106</fpage><year>2023</year><pub-id pub-id-type="doi">10.1186/s13073-023-01260-w</pub-id><pub-id pub-id-type="pmid">38041146</pub-id><pub-id pub-id-type="pmcid">PMC10691111</pub-id></element-citation></ref><ref id="b11-ijmm-56-05-05614"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emamalipour</surname><given-names>M</given-names></name><name name-style="western"><surname>Seidi</surname><given-names>K</given-names></name><name name-style="western"><surname>Zununi Vahed</surname><given-names>S</given-names></name><name name-style="western"><surname>Jahanban-Esfahlan</surname><given-names>A</given-names></name><name name-style="western"><surname>Jaymand</surname><given-names>M</given-names></name><name name-style="western"><surname>Majdi</surname><given-names>H</given-names></name><name name-style="western"><surname>Amoozgar</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chitkushev</surname><given-names>LT</given-names></name><name name-style="western"><surname>Javaheri</surname><given-names>T</given-names></name><name name-style="western"><surname>Jahanban-Esfahlan</surname><given-names>R</given-names></name><name name-style="western"><surname>Zare</surname><given-names>P</given-names></name></person-group><article-title>Horizontal gene transfer: From evolutionary flexibility to disease progression</article-title><source>Front Cell Dev Biol</source><volume>8</volume><fpage>229</fpage><year>2020</year><pub-id pub-id-type="doi">10.3389/fcell.2020.00229</pub-id><pub-id pub-id-type="pmid">32509768</pub-id><pub-id pub-id-type="pmcid">PMC7248198</pub-id></element-citation></ref><ref id="b12-ijmm-56-05-05614"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Guan</surname><given-names>J</given-names></name><name name-style="western"><surname>Liang</surname><given-names>W</given-names></name><name name-style="western"><surname>Petassi</surname><given-names>MT</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W</given-names></name><name name-style="western"><surname>Ou</surname><given-names>HY</given-names></name><name name-style="western"><surname>Peters</surname><given-names>JE</given-names></name></person-group><article-title>Transposition with Tn3-family elements occurs through interaction with the host &#946;-sliding clamp processivity factor</article-title><source>Nucleic Acids Res</source><volume>52</volume><fpage>10416</fpage><lpage>10430</lpage><year>2024</year><pub-id pub-id-type="doi">10.1093/nar/gkae674</pub-id><pub-id pub-id-type="pmid">39119921</pub-id><pub-id pub-id-type="pmcid">PMC11417375</pub-id></element-citation></ref><ref id="b13-ijmm-56-05-05614"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Su</surname><given-names>J</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Global emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae driven by an IncFII<sub>K34</sub> KPC-2 plasmid</article-title><source>EBioMedicine</source><volume>113</volume><fpage>105627</fpage><year>2025</year><pub-id pub-id-type="doi">10.1016/j.ebiom.2025.105627</pub-id><pub-id pub-id-type="pmid">40024096</pub-id><pub-id pub-id-type="pmcid">PMC11919442</pub-id></element-citation></ref><ref id="b14-ijmm-56-05-05614"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><name name-style="western"><surname>Pan</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><name name-style="western"><surname>Huang</surname><given-names>R</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Modulation of MRSA virulence gene expression by the wall teichoic acid enzyme TarO</article-title><source>Nat Commun</source><volume>14</volume><fpage>1594</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41467-023-37310-5</pub-id><pub-id pub-id-type="pmid">36949052</pub-id><pub-id pub-id-type="pmcid">PMC10032271</pub-id></element-citation></ref><ref id="b15-ijmm-56-05-05614"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finlay</surname><given-names>BB</given-names></name><name name-style="western"><surname>Falkow</surname><given-names>S</given-names></name></person-group><article-title>Common themes in microbial pathogenicity revisited</article-title><source>Microbiol Mol Biol Rev</source><volume>61</volume><fpage>136</fpage><lpage>169</lpage><year>1997</year><pub-id pub-id-type="pmid">9184008</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mmbr.61.2.136-169.1997</pub-id><pub-id pub-id-type="pmcid">PMC232605</pub-id></element-citation></ref><ref id="b16-ijmm-56-05-05614"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glazier</surname><given-names>VE</given-names></name></person-group><article-title>EFG1, everyone's favorite gene in Candida albicans: A comprehensive literature review</article-title><source>Front Cell Infect Microbiol</source><volume>12</volume><fpage>855229</fpage><year>2022</year><pub-id pub-id-type="doi">10.3389/fcimb.2022.855229</pub-id><pub-id pub-id-type="pmid">35392604</pub-id><pub-id pub-id-type="pmcid">PMC8980467</pub-id></element-citation></ref><ref id="b17-ijmm-56-05-05614"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GBD 2021 Antimicrobial Resistance Collaborators</collab></person-group><article-title>Global burden of bacterial antimicrobial resistance 1990-2021: A systematic analysis with forecasts to 2050</article-title><source>Lancet</source><volume>404</volume><fpage>1199</fpage><lpage>1226</lpage><year>2024</year><pub-id pub-id-type="doi">10.1016/S0140-6736(24)01867-1</pub-id><pub-id pub-id-type="pmid">39299261</pub-id><pub-id pub-id-type="pmcid">PMC11718157</pub-id></element-citation></ref><ref id="b18-ijmm-56-05-05614"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ponde</surname><given-names>NO</given-names></name><name name-style="western"><surname>Lortal</surname><given-names>L</given-names></name><name name-style="western"><surname>Ramage</surname><given-names>G</given-names></name><name name-style="western"><surname>Naglik</surname><given-names>JR</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>JP</given-names></name></person-group><article-title>Candida albicans biofilms and polymicrobial interactions</article-title><source>Crit Rev Microbiol</source><volume>47</volume><fpage>91</fpage><lpage>111</lpage><year>2021</year><pub-id pub-id-type="doi">10.1080/1040841X.2020.1843400</pub-id><pub-id pub-id-type="pmid">33482069</pub-id><pub-id pub-id-type="pmcid">PMC7903066</pub-id></element-citation></ref><ref id="b19-ijmm-56-05-05614"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Addetia</surname><given-names>A</given-names></name><name name-style="western"><surname>Piccoli</surname><given-names>L</given-names></name><name name-style="western"><surname>Case</surname><given-names>JB</given-names></name><name name-style="western"><surname>Park</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Beltramello</surname><given-names>M</given-names></name><name name-style="western"><surname>Guarino</surname><given-names>B</given-names></name><name name-style="western"><surname>Dang</surname><given-names>H</given-names></name><name name-style="western"><surname>de Melo</surname><given-names>GD</given-names></name><name name-style="western"><surname>Pinto</surname><given-names>D</given-names></name><name name-style="western"><surname>Sprouse</surname><given-names>K</given-names></name><etal/></person-group><article-title>Neutralization, effector function and immune imprinting of Omicron variants</article-title><source>Nature</source><volume>621</volume><fpage>592</fpage><lpage>601</lpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41586-023-06487-6</pub-id><pub-id pub-id-type="pmid">37648855</pub-id><pub-id pub-id-type="pmcid">PMC10511321</pub-id></element-citation></ref><ref id="b20-ijmm-56-05-05614"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Louwen</surname><given-names>R</given-names></name><name name-style="western"><surname>Staals</surname><given-names>RH</given-names></name><name name-style="western"><surname>Endtz</surname><given-names>HP</given-names></name><name name-style="western"><surname>van Baarlen</surname><given-names>P</given-names></name><name name-style="western"><surname>van der Oost</surname><given-names>J</given-names></name></person-group><article-title>The role of CRISPR-Cas systems in virulence of pathogenic bacteria</article-title><source>Microbiol Mol Biol Rev</source><volume>78</volume><fpage>74</fpage><lpage>88</lpage><year>2024</year><pub-id pub-id-type="doi">10.1128/MMBR.00039-13</pub-id><pub-id pub-id-type="pmcid">PMC3957734</pub-id><pub-id pub-id-type="pmid">24600041</pub-id></element-citation></ref><ref id="b21-ijmm-56-05-05614"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kushwaha</surname><given-names>SK</given-names></name><name name-style="western"><surname>Bhavesh</surname><given-names>NLS</given-names></name><name name-style="western"><surname>Abdella</surname><given-names>B</given-names></name><name name-style="western"><surname>Lahiri</surname><given-names>C</given-names></name><name name-style="western"><surname>Marathe</surname><given-names>SA</given-names></name></person-group><article-title>The phylogenomics of CRISPR-Cas system and revelation of its features in Salmonella</article-title><source>Sci Rep</source><volume>10</volume><fpage>21156</fpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41598-020-77890-6</pub-id><pub-id pub-id-type="pmid">33273523</pub-id><pub-id pub-id-type="pmcid">PMC7712790</pub-id></element-citation></ref><ref id="b22-ijmm-56-05-05614"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sampson</surname><given-names>TR</given-names></name><name name-style="western"><surname>Napier</surname><given-names>BA</given-names></name><name name-style="western"><surname>Schroeder</surname><given-names>MR</given-names></name><name name-style="western"><surname>Louwen</surname><given-names>R</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Chin</surname><given-names>CY</given-names></name><name name-style="western"><surname>Ratner</surname><given-names>HK</given-names></name><name name-style="western"><surname>Llewellyn</surname><given-names>AC</given-names></name><name name-style="western"><surname>Jones</surname><given-names>CL</given-names></name><name name-style="western"><surname>Laroui</surname><given-names>H</given-names></name><etal/></person-group><article-title>A CRISPR-Cas system enhances envelope integrity mediating antibiotic resistance and inflammasome evasion</article-title><source>Proc Natl Acad Sci USA</source><volume>111</volume><fpage>11163</fpage><lpage>11168</lpage><year>2014</year><pub-id pub-id-type="doi">10.1073/pnas.1323025111</pub-id><pub-id pub-id-type="pmid">25024199</pub-id><pub-id pub-id-type="pmcid">PMC4121812</pub-id></element-citation></ref><ref id="b23-ijmm-56-05-05614"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haghighatpanah</surname><given-names>M</given-names></name><name name-style="western"><surname>Mojtahedi</surname><given-names>A</given-names></name></person-group><article-title>Characterization of antibiotic resistance and virulence factors of Escherichia coli strains isolated from Iranian inpatients with urinary tract infections</article-title><source>Infect Drug Resist</source><volume>12</volume><fpage>2747</fpage><lpage>2754</lpage><year>2019</year><pub-id pub-id-type="doi">10.2147/IDR.S219696</pub-id><pub-id pub-id-type="pmid">31564925</pub-id><pub-id pub-id-type="pmcid">PMC6731957</pub-id></element-citation></ref><ref id="b24-ijmm-56-05-05614"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Speziale</surname><given-names>P</given-names></name><name name-style="western"><surname>Pietrocola</surname><given-names>G</given-names></name></person-group><article-title>The multivalent role of fibronectin-binding proteins A and B (FnBPA and FnBPB) of Staphylococcus aureus in host infections</article-title><source>Front Microbiol</source><volume>11</volume><fpage>2054</fpage><year>2020</year><pub-id pub-id-type="doi">10.3389/fmicb.2020.02054</pub-id><pub-id pub-id-type="pmid">32983039</pub-id><pub-id pub-id-type="pmcid">PMC7480013</pub-id></element-citation></ref><ref id="b25-ijmm-56-05-05614"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Claes</surname><given-names>J</given-names></name><name name-style="western"><surname>Liesenborghs</surname><given-names>L</given-names></name><name name-style="western"><surname>Peetermans</surname><given-names>M</given-names></name><name name-style="western"><surname>Veloso</surname><given-names>TR</given-names></name><name name-style="western"><surname>Missiakas</surname><given-names>D</given-names></name><name name-style="western"><surname>Schneewind</surname><given-names>O</given-names></name><name name-style="western"><surname>Mancini</surname><given-names>S</given-names></name><name name-style="western"><surname>Entenza</surname><given-names>JM</given-names></name><name name-style="western"><surname>Hoylaerts</surname><given-names>MF</given-names></name><name name-style="western"><surname>Heying</surname><given-names>R</given-names></name><etal/></person-group><article-title>Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall</article-title><source>J Thromb Haemost</source><volume>15</volume><fpage>1009</fpage><lpage>1019</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/jth.13653</pub-id><pub-id pub-id-type="pmid">28182324</pub-id><pub-id pub-id-type="pmcid">PMC6232194</pub-id></element-citation></ref><ref id="b26-ijmm-56-05-05614"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavalcante</surname><given-names>PA</given-names></name><name name-style="western"><surname>Prata</surname><given-names>MMG</given-names></name><name name-style="western"><surname>Medeiros</surname><given-names>PHQS</given-names></name><name name-style="western"><surname>Alves da Silva</surname><given-names>AV</given-names></name><name name-style="western"><surname>Quetz</surname><given-names>JS</given-names></name><name name-style="western"><surname>Reyes</surname><given-names>MAV</given-names></name><name name-style="western"><surname>Rodrigues</surname><given-names>TS</given-names></name><name name-style="western"><surname>Santos</surname><given-names>AKS</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>SA</given-names></name><name name-style="western"><surname>Veras</surname><given-names>HN</given-names></name><etal/></person-group><article-title>Intestinal cell migration damage induced by enteropathogenic Escherichia coli strains</article-title><source>Braz J Med Biol Res</source><volume>51</volume><fpage>e7423</fpage><year>2018</year><pub-id pub-id-type="doi">10.1590/1414-431x20187423</pub-id><pub-id pub-id-type="pmid">30066727</pub-id><pub-id pub-id-type="pmcid">PMC6065879</pub-id></element-citation></ref><ref id="b27-ijmm-56-05-05614"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>D</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiao</surname><given-names>P</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cai</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>G</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W</given-names></name></person-group><article-title>Genomic island-encoded histidine kinase and response regulator coordinate mannose utilization with virulence in Enterohemorrhagic Escherichia coli</article-title><source>mBio</source><volume>14</volume><fpage>e0315222</fpage><year>2023</year><pub-id pub-id-type="doi">10.1128/mbio.03152-22</pub-id><pub-id pub-id-type="pmid">36786613</pub-id><pub-id pub-id-type="pmcid">PMC10128022</pub-id></element-citation></ref><ref id="b28-ijmm-56-05-05614"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chun</surname><given-names>YY</given-names></name><name name-style="western"><surname>Tan</surname><given-names>KS</given-names></name><name name-style="western"><surname>Yu</surname><given-names>L</given-names></name><name name-style="western"><surname>Pang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wong</surname><given-names>MHM</given-names></name><name name-style="western"><surname>Nakamoto</surname><given-names>R</given-names></name><name name-style="western"><surname>Chua</surname><given-names>WZ</given-names></name><name name-style="western"><surname>Huee-Ping Wong</surname><given-names>A</given-names></name><name name-style="western"><surname>Lew</surname><given-names>ZZR</given-names></name><name name-style="western"><surname>Ong</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Influence of glycan structure on the colonization of Streptococcus pneumoniae on human respiratory epithelial cells</article-title><source>Proc Natl Acad Sci USA</source><volume>120</volume><fpage>e2213584120</fpage><year>2023</year><pub-id pub-id-type="doi">10.1073/pnas.2213584120</pub-id><pub-id pub-id-type="pmid">36943879</pub-id><pub-id pub-id-type="pmcid">PMC10068763</pub-id></element-citation></ref><ref id="b29-ijmm-56-05-05614"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korshoj</surname><given-names>LE</given-names></name><name name-style="western"><surname>Kielian</surname><given-names>T</given-names></name></person-group><article-title>Bacterial single-cell RNA sequencing captures biofilm transcriptional heterogeneity and differential responses to immune pressure</article-title><source>Nat Commun</source><volume>15</volume><fpage>10184</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41467-024-54581-8</pub-id><pub-id pub-id-type="pmid">39580490</pub-id><pub-id pub-id-type="pmcid">PMC11585574</pub-id></element-citation></ref><ref id="b30-ijmm-56-05-05614"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>H</given-names></name><name name-style="western"><surname>Ji</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Tang</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F</given-names></name><name name-style="western"><surname>Peng</surname><given-names>C</given-names></name><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Mycobacterium tuberculosis produces D-serine under hypoxia to limit CD8<sup>+</sup> T cell-dependent immunity in mice</article-title><source>Nat Microbiol</source><volume>9</volume><fpage>1856</fpage><lpage>1872</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41564-024-01701-1</pub-id><pub-id pub-id-type="pmid">38806671</pub-id><pub-id pub-id-type="pmcid">PMC11222154</pub-id></element-citation></ref><ref id="b31-ijmm-56-05-05614"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>F</given-names></name><name name-style="western"><surname>Gurcha</surname><given-names>SS</given-names></name><name name-style="western"><surname>Batt</surname><given-names>SM</given-names></name><name name-style="western"><surname>Besra</surname><given-names>GS</given-names></name><name name-style="western"><surname>Rao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name></person-group><article-title>Structural analysis of phosphoribosyltransferase-mediated cell wall precursor synthesis in Mycobacterium tuberculosis</article-title><source>Nat Microbiol</source><volume>9</volume><fpage>976</fpage><lpage>987</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41564-024-01643-8</pub-id><pub-id pub-id-type="pmid">38491273</pub-id><pub-id pub-id-type="pmcid">PMC10994848</pub-id></element-citation></ref><ref id="b32-ijmm-56-05-05614"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrakchi</surname><given-names>H</given-names></name><name name-style="western"><surname>Lan&#233;elle</surname><given-names>MA</given-names></name><name name-style="western"><surname>Daff&#233;</surname><given-names>M</given-names></name></person-group><article-title>Mycolic acids: Structures, biosynthesis, and beyond</article-title><source>Chem Biol</source><volume>21</volume><fpage>67</fpage><lpage>85</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.chembiol.2013.11.011</pub-id><pub-id pub-id-type="pmid">24374164</pub-id></element-citation></ref><ref id="b33-ijmm-56-05-05614"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schnappinger</surname><given-names>D</given-names></name><name name-style="western"><surname>Ehrt</surname><given-names>S</given-names></name><name name-style="western"><surname>Voskuil</surname><given-names>MI</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mangan</surname><given-names>JA</given-names></name><name name-style="western"><surname>Monahan</surname><given-names>IM</given-names></name><name name-style="western"><surname>Dolganov</surname><given-names>G</given-names></name><name name-style="western"><surname>Efron</surname><given-names>B</given-names></name><name name-style="western"><surname>Butcher</surname><given-names>PD</given-names></name><name name-style="western"><surname>Nathan</surname><given-names>C</given-names></name><name name-style="western"><surname>Schoolnik</surname><given-names>GK</given-names></name></person-group><article-title>Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment</article-title><source>J Exp Med</source><volume>198</volume><fpage>693</fpage><lpage>704</lpage><year>2003</year><pub-id pub-id-type="doi">10.1084/jem.20030846</pub-id><pub-id pub-id-type="pmid">12953091</pub-id><pub-id pub-id-type="pmcid">PMC2194186</pub-id></element-citation></ref><ref id="b34-ijmm-56-05-05614"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Dai</surname><given-names>D</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name><name name-style="western"><surname>Liang</surname><given-names>Z</given-names></name></person-group><article-title>Gene regulatory mechanism of Mycobacterium tuberculosis during dormancy</article-title><source>Curr Issues Mol Biol</source><volume>46</volume><fpage>5825</fpage><lpage>5844</lpage><year>2024</year><pub-id pub-id-type="doi">10.3390/cimb46060348</pub-id><pub-id pub-id-type="pmid">38921019</pub-id><pub-id pub-id-type="pmcid">PMC11203133</pub-id></element-citation></ref><ref id="b35-ijmm-56-05-05614"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Dong</surname><given-names>W</given-names></name><name name-style="western"><surname>Sun</surname><given-names>N</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W</given-names></name></person-group><article-title>A review of biofilm formation of Staphylococcus aureus and its regulation mechanism</article-title><source>Antibiotics (Basel)</source><volume>12</volume><fpage>12</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/antibiotics12010012</pub-id><pub-id pub-id-type="pmid">36671212</pub-id><pub-id pub-id-type="pmcid">PMC9854888</pub-id></element-citation></ref><ref id="b36-ijmm-56-05-05614"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Le</surname><given-names>S</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Tian</surname><given-names>F</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Bacteriophage protein Dap1 regulates evasion of antiphage immunity and Pseudomonas aeruginosa virulence impacting phage therapy in mice</article-title><source>Nat Microbiol</source><volume>9</volume><fpage>1828</fpage><lpage>1841</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41564-024-01719-5</pub-id><pub-id pub-id-type="pmid">38886583</pub-id></element-citation></ref><ref id="b37-ijmm-56-05-05614"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chauhan</surname><given-names>RP</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>ML</given-names></name></person-group><article-title>An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates</article-title><source>Virus Genes</source><volume>58</volume><fpage>255</fpage><lpage>269</lpage><year>2022</year><pub-id pub-id-type="doi">10.1007/s11262-022-01904-w</pub-id><pub-id pub-id-type="pmid">35471490</pub-id></element-citation></ref><ref id="b38-ijmm-56-05-05614"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emert-Sedlak</surname><given-names>LA</given-names></name><name name-style="western"><surname>Tice</surname><given-names>CM</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><name name-style="western"><surname>Alvarado</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Shu</surname><given-names>ST</given-names></name><name name-style="western"><surname>Reitz</surname><given-names>AB</given-names></name><name name-style="western"><surname>Smithgall</surname><given-names>TE</given-names></name></person-group><article-title>PROTAC-mediated degradation of HIV-1 Nef efficiently restores cell-surface CD4 and MHC-I expression and blocks HIV-1 replication</article-title><source>Cell Chem Biol</source><volume>31</volume><fpage>658</fpage><lpage>668.e14</lpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.chembiol.2024.02.004</pub-id><pub-id pub-id-type="pmid">38508197</pub-id><pub-id pub-id-type="pmcid">PMC11031313</pub-id></element-citation></ref><ref id="b39-ijmm-56-05-05614"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>A</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Lai</surname><given-names>L</given-names></name><name name-style="western"><surname>Chakravarthy</surname><given-names>C</given-names></name><name name-style="western"><surname>Valanparambil</surname><given-names>R</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>ES</given-names></name><name name-style="western"><surname>Gottimukkala</surname><given-names>K</given-names></name><name name-style="western"><surname>Bajpai</surname><given-names>P</given-names></name><name name-style="western"><surname>Raju</surname><given-names>DR</given-names></name><name name-style="western"><surname>Edara</surname><given-names>VV</given-names></name><etal/></person-group><article-title>Molecular basis of SARS-CoV-2 Omicron variant evasion from shared neutralizing antibody response</article-title><source>Structure</source><volume>31</volume><fpage>801</fpage><lpage>811.e5</lpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.str.2023.04.010</pub-id><pub-id pub-id-type="pmid">37167972</pub-id><pub-id pub-id-type="pmcid">PMC10171968</pub-id></element-citation></ref><ref id="b40-ijmm-56-05-05614"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korber</surname><given-names>B</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>WM</given-names></name><name name-style="western"><surname>Gnanakaran</surname><given-names>S</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>H</given-names></name><name name-style="western"><surname>Theiler</surname><given-names>J</given-names></name><name name-style="western"><surname>Abfalterer</surname><given-names>W</given-names></name><name name-style="western"><surname>Hengartner</surname><given-names>N</given-names></name><name name-style="western"><surname>Giorgi</surname><given-names>EE</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>T</given-names></name><name name-style="western"><surname>Foley</surname><given-names>B</given-names></name><etal/></person-group><article-title>Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 virus</article-title><source>Cell</source><volume>182</volume><fpage>812</fpage><lpage>827.e19</lpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.cell.2020.06.043</pub-id><pub-id pub-id-type="pmid">32697968</pub-id><pub-id pub-id-type="pmcid">PMC7332439</pub-id></element-citation></ref><ref id="b41-ijmm-56-05-05614"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>HT</given-names></name><name name-style="western"><surname>Chen</surname><given-names>HC</given-names></name><name name-style="western"><surname>Chiu</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Smith</surname><given-names>AB</given-names><suffix>III</suffix></name><name name-style="western"><surname>Sodroski</surname><given-names>JG</given-names></name></person-group><article-title>Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation</article-title><source>J Virol</source><volume>97</volume><fpage>e0059223</fpage><year>2023</year><pub-id pub-id-type="doi">10.1128/jvi.00592-23</pub-id><pub-id pub-id-type="pmid">37696048</pub-id><pub-id pub-id-type="pmcid">PMC10537687</pub-id></element-citation></ref><ref id="b42-ijmm-56-05-05614"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lin</surname><given-names>YC</given-names></name><name name-style="western"><surname>Steichen</surname><given-names>JM</given-names></name><name name-style="western"><surname>Ozorowski</surname><given-names>G</given-names></name><name name-style="western"><surname>Kratochvil</surname><given-names>S</given-names></name><name name-style="western"><surname>Ray</surname><given-names>R</given-names></name><name name-style="western"><surname>Torres</surname><given-names>JL</given-names></name><name name-style="western"><surname>Liguori</surname><given-names>A</given-names></name><name name-style="western"><surname>Kalyuzhniy</surname><given-names>O</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group><article-title>mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies</article-title><source>Science</source><volume>384</volume><fpage>eadk0582</fpage><year>2024</year><pub-id pub-id-type="doi">10.1126/science.adk0582</pub-id><pub-id pub-id-type="pmid">38753770</pub-id><pub-id pub-id-type="pmcid">PMC11488660</pub-id></element-citation></ref><ref id="b43-ijmm-56-05-05614"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>L</given-names></name><name name-style="western"><surname>Weiskopf</surname><given-names>EN</given-names></name><name name-style="western"><surname>Akkermans</surname><given-names>O</given-names></name><name name-style="western"><surname>Swanson</surname><given-names>NA</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Schwartz</surname><given-names>TU</given-names></name><name name-style="western"><surname>G&#246;rlich</surname><given-names>D</given-names></name></person-group><article-title>HIV-1 capsids enter the FG phase of nuclear pores like a transport receptor</article-title><source>Nature</source><volume>626</volume><fpage>843</fpage><lpage>851</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41586-023-06966-w</pub-id><pub-id pub-id-type="pmid">38267583</pub-id><pub-id pub-id-type="pmcid">PMC10881386</pub-id></element-citation></ref><ref id="b44-ijmm-56-05-05614"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bennett</surname><given-names>AL</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>R</given-names></name></person-group><article-title>HIV-1 envelope conformation, allostery, and dynamics</article-title><source>Viruses</source><volume>13</volume><fpage>852</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/v13050852</pub-id><pub-id pub-id-type="pmid">34067073</pub-id><pub-id pub-id-type="pmcid">PMC8150877</pub-id></element-citation></ref><ref id="b45-ijmm-56-05-05614"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qian</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><name name-style="western"><surname>Xin</surname><given-names>B</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name><name name-style="western"><surname>Han</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><etal/></person-group><article-title>Glutamylation of an HIV-1 protein inhibits the immune response by hijacking STING</article-title><source>Cell Rep</source><volume>42</volume><fpage>112442</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112442</pub-id><pub-id pub-id-type="pmid">37099423</pub-id></element-citation></ref><ref id="b46-ijmm-56-05-05614"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Miranda</surname><given-names>HA</given-names></name><name name-style="western"><surname>Burke</surname><given-names>KN</given-names></name><name name-style="western"><surname>Spurrier</surname><given-names>MA</given-names></name><name name-style="western"><surname>Berry</surname><given-names>M</given-names></name><name name-style="western"><surname>Stover</surname><given-names>EL</given-names></name><name name-style="western"><surname>Spreng</surname><given-names>RL</given-names></name><name name-style="western"><surname>Waitt</surname><given-names>G</given-names></name><name name-style="western"><surname>Soderblom</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Macintyre</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Vaccination with antigenically complex hemagglutinin mixtures confers broad protection from influenza disease</article-title><source>Sci Transl Med</source><volume>16</volume><fpage>eadj4685</fpage><year>2024</year><pub-id pub-id-type="doi">10.1126/scitranslmed.adj4685</pub-id><pub-id pub-id-type="pmid">38691617</pub-id><pub-id pub-id-type="pmcid">PMC12333966</pub-id></element-citation></ref><ref id="b47-ijmm-56-05-05614"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Na</surname><given-names>TY</given-names></name><name name-style="western"><surname>Ka</surname><given-names>NL</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>H</given-names></name><name name-style="western"><surname>Kyeong</surname><given-names>D</given-names></name><name name-style="western"><surname>Kim</surname><given-names>MH</given-names></name><name name-style="western"><surname>Seong</surname><given-names>JK</given-names></name><name name-style="western"><surname>Park</surname><given-names>YN</given-names></name><name name-style="western"><surname>Lee</surname><given-names>MO</given-names></name></person-group><article-title>Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma</article-title><source>Oncogene</source><volume>35</volume><fpage>5435</fpage><lpage>5445</lpage><year>2016</year><pub-id pub-id-type="doi">10.1038/onc.2016.82</pub-id><pub-id pub-id-type="pmid">27041572</pub-id></element-citation></ref><ref id="b48-ijmm-56-05-05614"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frost</surname><given-names>JR</given-names></name><name name-style="western"><surname>Olanubi</surname><given-names>O</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>SKH</given-names></name><name name-style="western"><surname>Soriano</surname><given-names>A</given-names></name><name name-style="western"><surname>Crisostomo</surname><given-names>L</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>A</given-names></name><name name-style="western"><surname>Pelka</surname><given-names>P</given-names></name></person-group><article-title>The interaction of adenovirus E1A with the mammalian protein Ku70/XRCC6</article-title><source>Virology</source><volume>500</volume><fpage>11</fpage><lpage>21</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.virol.2016.10.004</pub-id><pub-id pub-id-type="pmid">27769014</pub-id></element-citation></ref><ref id="b49-ijmm-56-05-05614"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radko</surname><given-names>S</given-names></name><name name-style="western"><surname>Koleva</surname><given-names>M</given-names></name><name name-style="western"><surname>James</surname><given-names>KM</given-names></name><name name-style="western"><surname>Jung</surname><given-names>R</given-names></name><name name-style="western"><surname>Mymryk</surname><given-names>JS</given-names></name><name name-style="western"><surname>Pelka</surname><given-names>P</given-names></name></person-group><article-title>Adenovirus E1A targets the DREF nuclear factor to regulate virus gene expression, DNA replication, and growth</article-title><source>J Virol</source><volume>88</volume><fpage>13469</fpage><lpage>13481</lpage><year>2014</year><pub-id pub-id-type="doi">10.1128/JVI.02538-14</pub-id><pub-id pub-id-type="pmid">25210186</pub-id><pub-id pub-id-type="pmcid">PMC4249066</pub-id></element-citation></ref><ref id="b50-ijmm-56-05-05614"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yin</surname><given-names>Q</given-names></name><name name-style="western"><surname>Ni</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><name name-style="western"><surname>Song</surname><given-names>C</given-names></name><name name-style="western"><surname>Liao</surname><given-names>L</given-names></name><name name-style="western"><surname>Xing</surname><given-names>H</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>S</given-names></name><name name-style="western"><surname>Shao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Dynamics of HIV-1 quasispecies diversity of participants on long-term antiretroviral therapy based on intrahost single-nucleotide variations</article-title><source>Int J Infect Dis</source><volume>104</volume><fpage>306</fpage><lpage>314</lpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.ijid.2021.01.015</pub-id><pub-id pub-id-type="pmid">33444750</pub-id></element-citation></ref><ref id="b51-ijmm-56-05-05614"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jia</surname><given-names>L</given-names></name><name name-style="western"><surname>Su</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Han</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group><article-title>The genetic diversity of HIV-1 quasispecies within primary infected individuals</article-title><source>AIDS Res Hum Retroviruses</source><volume>36</volume><fpage>440</fpage><lpage>449</lpage><year>2020</year><pub-id pub-id-type="doi">10.1089/aid.2019.0242</pub-id><pub-id pub-id-type="pmid">31766855</pub-id></element-citation></ref><ref id="b52-ijmm-56-05-05614"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Fujinaga</surname><given-names>K</given-names></name><name name-style="western"><surname>Gross</surname><given-names>JD</given-names></name><name name-style="western"><surname>Frankel</surname><given-names>AD</given-names></name></person-group><article-title>Enhanced NF-&#954;B activation via HIV-1 Tat-TRAF6 cross-talk</article-title><source>Sci Adv</source><volume>10</volume><fpage>eadi4162</fpage><year>2024</year><pub-id pub-id-type="doi">10.1126/sciadv.adi4162</pub-id><pub-id pub-id-type="pmid">38241362</pub-id><pub-id pub-id-type="pmcid">PMC10798561</pub-id></element-citation></ref><ref id="b53-ijmm-56-05-05614"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ding</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>T</given-names></name><name name-style="western"><surname>Wu</surname><given-names>A</given-names></name></person-group><article-title>Transmission restriction and genomic evolution co-shape the genetic diversity patterns of influenza A virus</article-title><source>Virol Sin</source><volume>39</volume><fpage>525</fpage><lpage>536</lpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.virs.2024.02.005</pub-id><pub-id pub-id-type="pmid">38423254</pub-id><pub-id pub-id-type="pmcid">PMC11401451</pub-id></element-citation></ref><ref id="b54-ijmm-56-05-05614"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Sircaik</surname><given-names>S</given-names></name><name name-style="western"><surname>Dainis</surname><given-names>J</given-names></name><name name-style="western"><surname>Kakade</surname><given-names>P</given-names></name><name name-style="western"><surname>Penumutchu</surname><given-names>S</given-names></name><name name-style="western"><surname>McDonough</surname><given-names>LD</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YH</given-names></name><name name-style="western"><surname>Frazer</surname><given-names>C</given-names></name><name name-style="western"><surname>Schille</surname><given-names>TB</given-names></name><name name-style="western"><surname>Allert</surname><given-names>S</given-names></name><etal/></person-group><article-title>The hyphal-specific toxin candidalysin promotes fungal gut commensalism</article-title><source>Nature</source><volume>627</volume><fpage>620</fpage><lpage>627</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41586-024-07142-4</pub-id><pub-id pub-id-type="pmid">38448595</pub-id><pub-id pub-id-type="pmcid">PMC11230112</pub-id></element-citation></ref><ref id="b55-ijmm-56-05-05614"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>J</given-names></name><name name-style="western"><surname>Mao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qin</surname><given-names>R</given-names></name><name name-style="western"><surname>Deng</surname><given-names>J</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>X</given-names></name><name name-style="western"><surname>Hou</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>C</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Sequence variation of Candida albicans Sap2 enhances fungal pathogenicity via complement evasion and macrophage M2-like phenotype induction</article-title><source>Adv Sci (Weinh)</source><volume>10</volume><fpage>e2206713</fpage><year>2023</year><pub-id pub-id-type="doi">10.1002/advs.202206713</pub-id><pub-id pub-id-type="pmid">37211685</pub-id><pub-id pub-id-type="pmcid">PMC10369283</pub-id></element-citation></ref><ref id="b56-ijmm-56-05-05614"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klis</surname><given-names>FM</given-names></name><name name-style="western"><surname>Brul</surname><given-names>S</given-names></name></person-group><article-title>Adaptations of the secretome of Candida albicans in response to host-related environmental conditions</article-title><source>Eukaryot Cell</source><volume>14</volume><fpage>1165</fpage><lpage>1172</lpage><year>2015</year><pub-id pub-id-type="doi">10.1128/EC.00142-15</pub-id><pub-id pub-id-type="pmid">26453650</pub-id><pub-id pub-id-type="pmcid">PMC4664879</pub-id></element-citation></ref><ref id="b57-ijmm-56-05-05614"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>TY</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YQ</given-names></name><name name-style="western"><surname>Tan</surname><given-names>JC</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>JA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>WN</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>T</given-names></name><name name-style="western"><surname>Zha</surname><given-names>JY</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>XK</given-names></name><name name-style="western"><surname>Li</surname><given-names>BW</given-names></name><name name-style="western"><surname>Wei</surname><given-names>LQ</given-names></name><etal/></person-group><article-title>Global fungal-host interactome mapping identifies host targets of candidalysin</article-title><source>Nat Commun</source><volume>15</volume><fpage>1757</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41467-024-46141-x</pub-id><pub-id pub-id-type="pmid">38413612</pub-id><pub-id pub-id-type="pmcid">PMC10899660</pub-id></element-citation></ref><ref id="b58-ijmm-56-05-05614"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>SM</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>LT</given-names></name><name name-style="western"><surname>Lodge</surname><given-names>JK</given-names></name></person-group><article-title>Cryptococcus neoformans, a fungus under stress</article-title><source>Curr Opin Microbiol</source><volume>10</volume><fpage>320</fpage><lpage>325</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.mib.2007.05.014</pub-id><pub-id pub-id-type="pmid">17707685</pub-id><pub-id pub-id-type="pmcid">PMC2570326</pub-id></element-citation></ref><ref id="b59-ijmm-56-05-05614"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Meara</surname><given-names>TR</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Selvig</surname><given-names>KM</given-names></name><name name-style="western"><surname>O'Meara</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>AP</given-names></name><name name-style="western"><surname>Alspaugh</surname><given-names>JA</given-names></name></person-group><article-title>The Cryptococcus neoformans Rim101 transcription factor directly regulates genes required for adaptation to the host</article-title><source>Mol Cell Biol</source><volume>34</volume><fpage>673</fpage><lpage>684</lpage><year>2014</year><pub-id pub-id-type="doi">10.1128/MCB.01359-13</pub-id><pub-id pub-id-type="pmid">24324006</pub-id><pub-id pub-id-type="pmcid">PMC3911494</pub-id></element-citation></ref><ref id="b60-ijmm-56-05-05614"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>F</given-names></name><name name-style="western"><surname>Deng</surname><given-names>L</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Kong</surname><given-names>Q</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sang</surname><given-names>H</given-names></name></person-group><article-title>Innate and adaptive immune responses induced by Aspergillus fumigatus conidia and hyphae</article-title><source>Curr Microbiol</source><volume>80</volume><fpage>28</fpage><year>2022</year><pub-id pub-id-type="doi">10.1007/s00284-022-03102-1</pub-id><pub-id pub-id-type="pmid">36474044</pub-id><pub-id pub-id-type="pmcid">PMC9734344</pub-id></element-citation></ref><ref id="b61-ijmm-56-05-05614"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carrion Sde</surname><given-names>J</given-names></name><name name-style="western"><surname>Leal</surname><given-names>SM</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Ghannoum</surname><given-names>MA</given-names></name><name name-style="western"><surname>Aimanianda</surname><given-names>V</given-names></name><name name-style="western"><surname>Latg&#233;</surname><given-names>JP</given-names></name><name name-style="western"><surname>Pearlman</surname><given-names>E</given-names></name></person-group><article-title>The RodA hydrophobin on Aspergillus fumigatus spores masks dectin-1- and dectin-2-dependent responses and enhances fungal survival in vivo</article-title><source>J Immunol</source><volume>191</volume><fpage>2581</fpage><lpage>2588</lpage><year>2013</year><pub-id pub-id-type="doi">10.4049/jimmunol.1300748</pub-id><pub-id pub-id-type="pmid">23926321</pub-id><pub-id pub-id-type="pmcid">PMC4020118</pub-id></element-citation></ref><ref id="b62-ijmm-56-05-05614"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name><name name-style="western"><surname>Iyer</surname><given-names>KR</given-names></name><name name-style="western"><surname>Pardeshi</surname><given-names>L</given-names></name><name name-style="western"><surname>Mu&#241;oz</surname><given-names>JF</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>N</given-names></name><name name-style="western"><surname>Cuomo</surname><given-names>CA</given-names></name><name name-style="western"><surname>Wong</surname><given-names>KH</given-names></name><name name-style="western"><surname>Cowen</surname><given-names>LE</given-names></name></person-group><article-title>Genetic analysis of Candida auris implicates hsp90 in morphogenesis and Azole tolerance and Cdr1 in Azole resistance</article-title><source>mBio</source><volume>10</volume><fpage>e02529</fpage><lpage>18</lpage><year>2019</year><pub-id pub-id-type="pmid">30696744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mBio.02529-18</pub-id><pub-id pub-id-type="pmcid">PMC6355988</pub-id></element-citation></ref><ref id="b63-ijmm-56-05-05614"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nobile</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Andes</surname><given-names>DR</given-names></name><name name-style="western"><surname>Nett</surname><given-names>JE</given-names></name><name name-style="western"><surname>Smith</surname><given-names>FJ</given-names></name><name name-style="western"><surname>Yue</surname><given-names>F</given-names></name><name name-style="western"><surname>Phan</surname><given-names>QT</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>JE</given-names></name><name name-style="western"><surname>Filler</surname><given-names>SG</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>AP</given-names></name></person-group><article-title>Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo</article-title><source>PLoS Pathog</source><volume>2</volume><fpage>e63</fpage><year>2006</year><pub-id pub-id-type="doi">10.1371/journal.ppat.0020063</pub-id><pub-id pub-id-type="pmid">16839200</pub-id><pub-id pub-id-type="pmcid">PMC1487173</pub-id></element-citation></ref><ref id="b64-ijmm-56-05-05614"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fanning</surname><given-names>S</given-names></name><name name-style="western"><surname>Xu</surname><given-names>W</given-names></name><name name-style="western"><surname>Solis</surname><given-names>N</given-names></name><name name-style="western"><surname>Woolford</surname><given-names>CA</given-names></name><name name-style="western"><surname>Filler</surname><given-names>SG</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>AP</given-names></name></person-group><article-title>Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo</article-title><source>Eukaryot Cell</source><volume>11</volume><fpage>896</fpage><lpage>904</lpage><year>2012</year><pub-id pub-id-type="doi">10.1128/EC.00103-12</pub-id><pub-id pub-id-type="pmid">22544909</pub-id><pub-id pub-id-type="pmcid">PMC3416506</pub-id></element-citation></ref><ref id="b65-ijmm-56-05-05614"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCall</surname><given-names>AD</given-names></name><name name-style="western"><surname>Pathirana</surname><given-names>RU</given-names></name><name name-style="western"><surname>Prabhakar</surname><given-names>A</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Edgerton</surname><given-names>M</given-names></name></person-group><article-title>Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins</article-title><source>NPJ Biofilms Microbiomes</source><volume>5</volume><fpage>21</fpage><year>2019</year><pub-id pub-id-type="doi">10.1038/s41522-019-0094-5</pub-id><pub-id pub-id-type="pmid">31452924</pub-id><pub-id pub-id-type="pmcid">PMC6707306</pub-id></element-citation></ref><ref id="b66-ijmm-56-05-05614"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Judan Cruz</surname><given-names>KG</given-names></name><name name-style="western"><surname>Alfonso</surname><given-names>ED</given-names></name><name name-style="western"><surname>Fernando</surname><given-names>SID</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>K</given-names></name></person-group><article-title>Candida albicans biofilm inhibition by ethnobotanicals and ethnobotanically-synthesized gold nanoparticles</article-title><source>Front Microbiol</source><volume>12</volume><fpage>665113</fpage><year>2021</year><pub-id pub-id-type="doi">10.3389/fmicb.2021.665113</pub-id><pub-id pub-id-type="pmid">34108950</pub-id><pub-id pub-id-type="pmcid">PMC8180598</pub-id></element-citation></ref><ref id="b67-ijmm-56-05-05614"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Rojas</surname><given-names>IG</given-names></name><name name-style="western"><surname>Edgerton</surname><given-names>M</given-names></name></person-group><article-title>Candida albicans Sap6 Initiates Oral mucosal inflammation via the protease activated receptor PAR2</article-title><source>Front Immunol</source><volume>13</volume><fpage>912748</fpage><year>2022</year><pub-id pub-id-type="doi">10.3389/fimmu.2022.912748</pub-id><pub-id pub-id-type="pmid">35844627</pub-id><pub-id pub-id-type="pmcid">PMC9277060</pub-id></element-citation></ref><ref id="b68-ijmm-56-05-05614"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iwasawa</surname><given-names>MT</given-names></name><name name-style="western"><surname>Miyachi</surname><given-names>H</given-names></name><name name-style="western"><surname>Wakabayashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Sugihira</surname><given-names>T</given-names></name><name name-style="western"><surname>Aoyama</surname><given-names>R</given-names></name><name name-style="western"><surname>Nakagawa</surname><given-names>S</given-names></name><name name-style="western"><surname>Katayama</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yoneyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Hara</surname><given-names>H</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Epidermal clearance of Candida albicans is mediated by IL-17 but independent of fungal innate immune receptors</article-title><source>Int Immunol</source><volume>34</volume><fpage>409</fpage><lpage>420</lpage><year>2022</year><pub-id pub-id-type="doi">10.1093/intimm/dxac019</pub-id><pub-id pub-id-type="pmid">35641096</pub-id><pub-id pub-id-type="pmcid">PMC9317997</pub-id></element-citation></ref><ref id="b69-ijmm-56-05-05614"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoang</surname><given-names>TNM</given-names></name><name name-style="western"><surname>Cseresny&#233;s</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hartung</surname><given-names>S</given-names></name><name name-style="western"><surname>Blickensdorf</surname><given-names>M</given-names></name><name name-style="western"><surname>Saffer</surname><given-names>C</given-names></name><name name-style="western"><surname>Rennert</surname><given-names>K</given-names></name><name name-style="western"><surname>Mosig</surname><given-names>AS</given-names></name><name name-style="western"><surname>von Lilienfeld-Toal</surname><given-names>M</given-names></name><name name-style="western"><surname>Figge</surname><given-names>MT</given-names></name></person-group><article-title>Invasive aspergillosis-on-chip: A quantitative treatment study of human Aspergillus fumigatus infection</article-title><source>Biomaterials</source><volume>283</volume><fpage>121420</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.biomaterials.2022.121420</pub-id><pub-id pub-id-type="pmid">35245733</pub-id></element-citation></ref><ref id="b70-ijmm-56-05-05614"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Shetty</surname><given-names>AC</given-names></name><name name-style="western"><surname>Ibrahim</surname><given-names>AS</given-names></name><name name-style="western"><surname>Filler</surname><given-names>SG</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>VM</given-names></name></person-group><article-title>Novel host pathways govern epithelial cell invasion of Aspergillus fumigatus</article-title><source>Microbiol Spectr</source><volume>11</volume><fpage>e0008423</fpage><year>2023</year><pub-id pub-id-type="doi">10.1128/spectrum.00084-23</pub-id><pub-id pub-id-type="pmid">37255456</pub-id><pub-id pub-id-type="pmcid">PMC10434228</pub-id></element-citation></ref><ref id="b71-ijmm-56-05-05614"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lupt&#225;kov&#225;</surname><given-names>D</given-names></name><name name-style="western"><surname>Patil</surname><given-names>RH</given-names></name><name name-style="western"><surname>Dobi&#225;&#353;</surname><given-names>R</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>DA</given-names></name><name name-style="western"><surname>Pluh&#225;&#269;ek</surname><given-names>T</given-names></name><name name-style="western"><surname>Palyzov&#225;</surname><given-names>A</given-names></name><name name-style="western"><surname>K&#225;&#328;ov&#225;</surname><given-names>M</given-names></name><name name-style="western"><surname>Navr&#225;til</surname><given-names>M</given-names></name><name name-style="western"><surname>Vrba</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hub&#225;&#269;ek</surname><given-names>P</given-names></name><etal/></person-group><article-title>Siderophore-based noninvasive differentiation of Aspergillus fumigatus colonization and invasion in pulmonary aspergillosis</article-title><source>Microbiol Spectr</source><volume>11</volume><fpage>e0406822</fpage><year>2023</year><pub-id pub-id-type="doi">10.1128/spectrum.04068-22</pub-id><pub-id pub-id-type="pmid">36719229</pub-id><pub-id pub-id-type="pmcid">PMC10100950</pub-id></element-citation></ref><ref id="b72-ijmm-56-05-05614"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>W</given-names></name><name name-style="western"><surname>Wen</surname><given-names>H</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Fan</surname><given-names>X</given-names></name></person-group><article-title>Targeting multidrug-recalcitrant Pseudomonas aeruginosa biofilms: Combined-enzyme treatment enhances antibiotic efficacy</article-title><source>Antimicrob Agents Chemother</source><volume>67</volume><fpage>e0135822</fpage><year>2023</year><pub-id pub-id-type="doi">10.1128/aac.01358-22</pub-id><pub-id pub-id-type="pmid">36602373</pub-id><pub-id pub-id-type="pmcid">PMC9872604</pub-id></element-citation></ref><ref id="b73-ijmm-56-05-05614"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kowalski</surname><given-names>CH</given-names></name><name name-style="western"><surname>Morelli</surname><given-names>KA</given-names></name><name name-style="western"><surname>Schultz</surname><given-names>D</given-names></name><name name-style="western"><surname>Nadell</surname><given-names>CD</given-names></name><name name-style="western"><surname>Cramer</surname><given-names>RA</given-names></name></person-group><article-title>Fungal biofilm architecture produces hypoxic microenvironments that drive antifungal resistance</article-title><source>Proc Natl Acad Sci USA</source><volume>117</volume><fpage>22473</fpage><lpage>22483</lpage><year>2020</year><pub-id pub-id-type="doi">10.1073/pnas.2003700117</pub-id><pub-id pub-id-type="pmid">32848055</pub-id><pub-id pub-id-type="pmcid">PMC7486789</pub-id></element-citation></ref><ref id="b74-ijmm-56-05-05614"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bing</surname><given-names>J</given-names></name><name name-style="western"><surname>Guan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>T</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fan</surname><given-names>S</given-names></name><name name-style="western"><surname>Ennis</surname><given-names>CL</given-names></name><name name-style="western"><surname>Nobile</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Huang</surname><given-names>G</given-names></name></person-group><article-title>Clinical isolates of Candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4</article-title><source>PLoS Pathog</source><volume>19</volume><fpage>e1011239</fpage><year>2023</year><pub-id pub-id-type="doi">10.1371/journal.ppat.1011239</pub-id><pub-id pub-id-type="pmid">36913408</pub-id><pub-id pub-id-type="pmcid">PMC10035925</pub-id></element-citation></ref><ref id="b75-ijmm-56-05-05614"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>X</given-names></name><name name-style="western"><surname>Kr&#252;ger</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Fe&#223;ler</surname><given-names>AT</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Schwarz</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name></person-group><article-title>Tn 560, a novel Tn 554 family transposon from porcine methicillin-resistant staphylococcus aureus ST398, carries a multiresistance gene cluster comprising a novel spc gene variant and the genes lsa(E) and lnu(B)</article-title><source>Antimicrob Agents Chemother</source><volume>66</volume><fpage>e0194721</fpage><year>2022</year><pub-id pub-id-type="doi">10.1128/aac.01947-21</pub-id><pub-id pub-id-type="pmid">35315688</pub-id><pub-id pub-id-type="pmcid">PMC9017326</pub-id></element-citation></ref><ref id="b76-ijmm-56-05-05614"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharafutdinov</surname><given-names>I</given-names></name><name name-style="western"><surname>Harrer</surname><given-names>A</given-names></name><name name-style="western"><surname>M&#252;sken</surname><given-names>M</given-names></name><name name-style="western"><surname>Rottner</surname><given-names>K</given-names></name><name name-style="western"><surname>Sticht</surname><given-names>H</given-names></name><name name-style="western"><surname>T&#228;ger</surname><given-names>C</given-names></name><name name-style="western"><surname>Naumann</surname><given-names>M</given-names></name><name name-style="western"><surname>Tegtmeyer</surname><given-names>N</given-names></name><name name-style="western"><surname>Backert</surname><given-names>S</given-names></name></person-group><article-title>Cortactin-dependent control of Par1b-regulated epithelial cell polarity in Helicobacter infection</article-title><source>Cell Insight</source><volume>3</volume><fpage>100161</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.cellin.2024.100161</pub-id><pub-id pub-id-type="pmid">38646547</pub-id><pub-id pub-id-type="pmcid">PMC11033139</pub-id></element-citation></ref><ref id="b77-ijmm-56-05-05614"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lockhart</surname><given-names>SR</given-names></name><name name-style="western"><surname>Etienne</surname><given-names>KA</given-names></name><name name-style="western"><surname>Vallabhaneni</surname><given-names>S</given-names></name><name name-style="western"><surname>Farooqi</surname><given-names>J</given-names></name><name name-style="western"><surname>Chowdhary</surname><given-names>A</given-names></name><name name-style="western"><surname>Govender</surname><given-names>NP</given-names></name><name name-style="western"><surname>Colombo</surname><given-names>AL</given-names></name><name name-style="western"><surname>Calvo</surname><given-names>B</given-names></name><name name-style="western"><surname>Cuomo</surname><given-names>CA</given-names></name><name name-style="western"><surname>Desjardins</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses</article-title><source>Clin Infect Dis</source><volume>64</volume><fpage>134</fpage><lpage>140</lpage><year>2017</year><pub-id pub-id-type="doi">10.1093/cid/ciw691</pub-id><pub-id pub-id-type="pmid">27988485</pub-id><pub-id pub-id-type="pmcid">PMC5215215</pub-id></element-citation></ref><ref id="b78-ijmm-56-05-05614"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chowdhary</surname><given-names>A</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>C</given-names></name><name name-style="western"><surname>Meis</surname><given-names>JF</given-names></name></person-group><article-title>Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally</article-title><source>PLoS Pathog</source><volume>13</volume><fpage>e1006290</fpage><year>2017</year><pub-id pub-id-type="doi">10.1371/journal.ppat.1006290</pub-id><pub-id pub-id-type="pmid">28542486</pub-id><pub-id pub-id-type="pmcid">PMC5436850</pub-id></element-citation></ref><ref id="b79-ijmm-56-05-05614"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chadwick</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Ristow</surname><given-names>LC</given-names></name><name name-style="western"><surname>Xie</surname><given-names>X</given-names></name><name name-style="western"><surname>Krysan</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name></person-group><article-title>Discovery of CO<sub>2</sub> tolerance genes associated with virulence in the fungal pathogen Cryptococcus neoformans</article-title><source>Nat Microbiol</source><volume>9</volume><fpage>2684</fpage><lpage>2695</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41564-024-01792-w</pub-id><pub-id pub-id-type="pmid">39232204</pub-id></element-citation></ref><ref id="b80-ijmm-56-05-05614"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadooka</surname><given-names>C</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hira</surname><given-names>D</given-names></name><name name-style="western"><surname>Oka</surname><given-names>T</given-names></name></person-group><article-title>Identification of a putative &#945;-galactoside &#946;-(1&#8594;3)-galactosyltransferase involved in the biosynthesis of galactomannan side chain of glucuronoxylomannogalactan in Cryptococcus neoformans</article-title><source>Front Microbiol</source><volume>15</volume><fpage>1390371</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fmicb.2024.1390371</pub-id><pub-id pub-id-type="pmid">38841067</pub-id><pub-id pub-id-type="pmcid">PMC11150766</pub-id></element-citation></ref><ref id="b81-ijmm-56-05-05614"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rhodes</surname><given-names>J</given-names></name><name name-style="western"><surname>Desjardins</surname><given-names>CA</given-names></name><name name-style="western"><surname>Sykes</surname><given-names>SM</given-names></name><name name-style="western"><surname>Beale</surname><given-names>MA</given-names></name><name name-style="western"><surname>Vanhove</surname><given-names>M</given-names></name><name name-style="western"><surname>Sakthikumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gujja</surname><given-names>S</given-names></name><name name-style="western"><surname>Saif</surname><given-names>S</given-names></name><name name-style="western"><surname>Chowdhary</surname><given-names>A</given-names></name><etal/></person-group><article-title>Traci ng genetic excha nge a nd biogeog raphy of Cryptococcus neoformans var. grubii at the global population level</article-title><source>Genetics</source><volume>207</volume><fpage>327</fpage><lpage>346</lpage><year>2017</year><pub-id pub-id-type="doi">10.1534/genetics.117.203836</pub-id><pub-id pub-id-type="pmid">28679543</pub-id><pub-id pub-id-type="pmcid">PMC5586382</pub-id></element-citation></ref><ref id="b82-ijmm-56-05-05614"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Billmyre</surname><given-names>RB</given-names></name><name name-style="western"><surname>Craig</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Lyon</surname><given-names>JW</given-names></name><name name-style="western"><surname>Reichardt</surname><given-names>C</given-names></name><name name-style="western"><surname>Kuhn</surname><given-names>AM</given-names></name><name name-style="western"><surname>Eickbush</surname><given-names>MT</given-names></name><name name-style="western"><surname>Zanders</surname><given-names>SE</given-names></name></person-group><article-title>Landscape of essential growth and fluconazole-resistance genes in the human fungal pathogen Cryptococcus neoformans</article-title><source>PLoS Boil</source><volume>23</volume><fpage>e3003184</fpage><year>2025</year><pub-id pub-id-type="doi">10.1371/journal.pbio.3003184</pub-id><pub-id pub-id-type="pmcid">PMC12136443</pub-id><pub-id pub-id-type="pmid">40402997</pub-id></element-citation></ref><ref id="b83-ijmm-56-05-05614"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coelho</surname><given-names>MA</given-names></name><name name-style="western"><surname>David-Palma</surname><given-names>M</given-names></name><name name-style="western"><surname>Shea</surname><given-names>T</given-names></name><name name-style="western"><surname>Bowers</surname><given-names>K</given-names></name><name name-style="western"><surname>McGinley-Smith</surname><given-names>S</given-names></name><name name-style="western"><surname>Mohammad</surname><given-names>AW</given-names></name><name name-style="western"><surname>Gnirke</surname><given-names>A</given-names></name><name name-style="western"><surname>Yurkov</surname><given-names>AM</given-names></name><name name-style="western"><surname>Nowrousian</surname><given-names>M</given-names></name><name name-style="western"><surname>Sun</surname><given-names>S</given-names></name><etal/></person-group><article-title>Comparative genomics of Cryptococcus and Kwoniella reveals pathogenesis evolution and contrasting karyotype dynamics via intercentromeric recombination or chromosome fusion</article-title><comment>bioRxiv [Preprint]: 2023.12.27.573464</comment><year>2024</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pbio.3002682</pub-id><pub-id pub-id-type="pmcid">PMC11185503</pub-id><pub-id pub-id-type="pmid">38843310</pub-id></element-citation></ref><ref id="b84-ijmm-56-05-05614"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Dong</surname><given-names>Q</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Rollins</surname><given-names>JA</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name><name name-style="western"><surname>Sun</surname><given-names>G</given-names></name></person-group><article-title>Pathogenic adaptations of Colletotrichum fungi revealed by genome wide gene family evolutionary analyses</article-title><source>PLoS One</source><volume>13</volume><fpage>e0196303</fpage><year>2018</year><pub-id pub-id-type="doi">10.1371/journal.pone.0196303</pub-id><pub-id pub-id-type="pmid">29689067</pub-id><pub-id pub-id-type="pmcid">PMC5915685</pub-id></element-citation></ref><ref id="b85-ijmm-56-05-05614"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>S</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>He</surname><given-names>W</given-names></name><name name-style="western"><surname>Ou</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>B</given-names></name><name name-style="western"><surname>He</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xia</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title>The catalogue of Mycobacterium tuberculosis mutations associated with drug resistance to 12 drugs in China from a nationwide survey: A genomic analysis</article-title><source>Lancet Microbe</source><volume>5</volume><fpage>100899</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/S2666-5247(24)00131-9</pub-id><pub-id pub-id-type="pmid">39353459</pub-id><pub-id pub-id-type="pmcid">PMC11543636</pub-id></element-citation></ref><ref id="b86-ijmm-56-05-05614"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahlwes</surname><given-names>KC</given-names></name><name name-style="western"><surname>Dias</surname><given-names>BRS</given-names></name><name name-style="western"><surname>Campos</surname><given-names>PC</given-names></name><name name-style="western"><surname>Alvarez-Arguedas</surname><given-names>S</given-names></name><name name-style="western"><surname>Shiloh</surname><given-names>MU</given-names></name></person-group><article-title>Pathogenicity and virulence of Mycobacterium tuberculosis</article-title><source>Virulence</source><volume>14</volume><fpage>2150449</fpage><year>2023</year><pub-id pub-id-type="doi">10.1080/21505594.2022.2150449</pub-id><pub-id pub-id-type="pmid">36419223</pub-id><pub-id pub-id-type="pmcid">PMC9817126</pub-id></element-citation></ref><ref id="b87-ijmm-56-05-05614"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Xu</surname><given-names>P</given-names></name><name name-style="western"><surname>Du</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><name name-style="western"><surname>Pang</surname><given-names>Y</given-names></name></person-group><article-title>Kynurenine-AhR reduces T-cell infiltration and induces a delayed T-cell immune response by suppressing the STAT1-CXCL9/CXCL10 axis in tuberculosis</article-title><source>Cell Mol Immunol</source><volume>21</volume><fpage>1426</fpage><lpage>1440</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41423-024-01230-1</pub-id><pub-id pub-id-type="pmid">39438693</pub-id><pub-id pub-id-type="pmcid">PMC11607402</pub-id></element-citation></ref><ref id="b88-ijmm-56-05-05614"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><name name-style="western"><surname>Dogan</surname><given-names>B</given-names></name><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name><name name-style="western"><surname>Herlekar</surname><given-names>D</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>K</given-names></name><name name-style="western"><surname>Scherl</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Simpson</surname><given-names>KW</given-names></name></person-group><article-title>Short chain fatty acids modulate the growth and virulence of pathosymbiont Escherichia coli and host response</article-title><source>Antibiotics (Basel)</source><volume>9</volume><fpage>462</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/antibiotics9080462</pub-id><pub-id pub-id-type="pmid">32751519</pub-id><pub-id pub-id-type="pmcid">PMC7460008</pub-id></element-citation></ref><ref id="b89-ijmm-56-05-05614"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liang</surname><given-names>B</given-names></name><name name-style="western"><surname>Mai</surname><given-names>J</given-names></name><name name-style="western"><surname>Lan</surname><given-names>F</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Z</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Distribution of disinfectant resistant genes in mcr-1-carrying Escherichia coli isolated from children in southern China</article-title><source>Microb Pathog</source><volume>198</volume><fpage>107114</fpage><year>2025</year><pub-id pub-id-type="doi">10.1016/j.micpath.2024.107114</pub-id><pub-id pub-id-type="pmid">39551109</pub-id></element-citation></ref><ref id="b90-ijmm-56-05-05614"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadry</surname><given-names>AA</given-names></name><name name-style="western"><surname>El-Antrawy</surname><given-names>MA</given-names></name><name name-style="western"><surname>El-Ganiny</surname><given-names>AM</given-names></name></person-group><article-title>Management of clinical infections of Escherichia coli by new &#946;-lactam/&#946;-lactamase inhibitor combinations</article-title><source>Iran J Microbiol</source><volume>14</volume><fpage>466</fpage><lpage>474</lpage><year>2022</year><pub-id pub-id-type="pmid">36721515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18502/ijm.v14i4.10232</pub-id><pub-id pub-id-type="pmcid">PMC9867644</pub-id></element-citation></ref><ref id="b91-ijmm-56-05-05614"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adegoke</surname><given-names>AA</given-names></name><name name-style="western"><surname>Madu</surname><given-names>CE</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>P</given-names></name><name name-style="western"><surname>Fatunla</surname><given-names>OK</given-names></name><name name-style="western"><surname>Stenstr&#246;m</surname><given-names>TA</given-names></name><name name-style="western"><surname>Okoh</surname><given-names>AI</given-names></name></person-group><article-title>Virulence and antibiotic resistance genes in enterococcus from wastewater for reuse and their health impact</article-title><source>Microorganisms</source><volume>13</volume><fpage>1045</fpage><year>2025</year><pub-id pub-id-type="doi">10.3390/microorganisms13051045</pub-id><pub-id pub-id-type="pmid">40431216</pub-id><pub-id pub-id-type="pmcid">PMC12114264</pub-id></element-citation></ref><ref id="b92-ijmm-56-05-05614"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamas</surname><given-names>A</given-names></name><name name-style="western"><surname>Regal</surname><given-names>P</given-names></name><name name-style="western"><surname>V&#225;zquez</surname><given-names>B</given-names></name><name name-style="western"><surname>Cepeda</surname><given-names>A</given-names></name><name name-style="western"><surname>Franco</surname><given-names>CM</given-names></name></person-group><article-title>Short chain fatty acids commonly produced by gut microbiota influence Salmonella enterica motility, biofilm formation, and gene expression</article-title><source>Antibiotics (Basel)</source><volume>8</volume><fpage>465</fpage><year>2019</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics8040265</pub-id><pub-id pub-id-type="pmcid">PMC6963744</pub-id><pub-id pub-id-type="pmid">31847278</pub-id></element-citation></ref><ref id="b93-ijmm-56-05-05614"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ballesteros-Monrreal</surname><given-names>MG</given-names></name><name name-style="western"><surname>Arenas-Hern&#225;ndez</surname><given-names>MMP</given-names></name><name name-style="western"><surname>Barrios-Villa</surname><given-names>E</given-names></name><name name-style="western"><surname>Juarez</surname><given-names>J</given-names></name><name name-style="western"><surname>&#193;lvarez-Ainza</surname><given-names>ML</given-names></name><name name-style="western"><surname>Taboada</surname><given-names>P</given-names></name><name name-style="western"><surname>De la Rosa-L&#243;pez</surname><given-names>R</given-names></name><name name-style="western"><surname>Bolado-Mart&#237;nez</surname><given-names>E</given-names></name><name name-style="western"><surname>Valencia</surname><given-names>D</given-names></name></person-group><article-title>Bacterial morphotypes as important trait for uropathogenic E. coli diagnostic; a virulence-phenotype-phylogeny study</article-title><source>Microorganisms</source><volume>9</volume><fpage>2381</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/microorganisms9112381</pub-id><pub-id pub-id-type="pmid">34835506</pub-id><pub-id pub-id-type="pmcid">PMC8621242</pub-id></element-citation></ref><ref id="b94-ijmm-56-05-05614"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watanabe</surname><given-names>Y</given-names></name><name name-style="western"><surname>Haneda</surname><given-names>T</given-names></name><name name-style="western"><surname>Kimishima</surname><given-names>A</given-names></name><name name-style="western"><surname>Kuwae</surname><given-names>A</given-names></name><name name-style="western"><surname>Suga</surname><given-names>T</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Iwabuchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Honsho</surname><given-names>M</given-names></name><name name-style="western"><surname>Honma</surname><given-names>S</given-names></name><name name-style="western"><surname>Iwatsuki</surname><given-names>M</given-names></name><etal/></person-group><article-title>PurA is the main target of aurodox, a type III secretion system inhibitor</article-title><source>Proc Natl Acad Sci USA</source><volume>121</volume><fpage>e2322363121</fpage><year>2024</year><pub-id pub-id-type="doi">10.1073/pnas.2322363121</pub-id><pub-id pub-id-type="pmid">38640341</pub-id><pub-id pub-id-type="pmcid">PMC11046696</pub-id></element-citation></ref><ref id="b95-ijmm-56-05-05614"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gobert</surname><given-names>AP</given-names></name><name name-style="western"><surname>Hawkins</surname><given-names>CV</given-names></name><name name-style="western"><surname>Williams</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Snyder</surname><given-names>LA</given-names></name><name name-style="western"><surname>Barry</surname><given-names>DP</given-names></name><name name-style="western"><surname>Asim</surname><given-names>M</given-names></name><name name-style="western"><surname>Allaman</surname><given-names>MM</given-names></name><name name-style="western"><surname>McNamara</surname><given-names>KM</given-names></name><name name-style="western"><surname>Delgado</surname><given-names>AG</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Hypusination in intestinal epithelial cells protects mice from infectious colitis</article-title><source>Gut Microbes</source><volume>16</volume><fpage>2438828</fpage><year>2024</year><pub-id pub-id-type="doi">10.1080/19490976.2024.2438828</pub-id><pub-id pub-id-type="pmid">39673545</pub-id><pub-id pub-id-type="pmcid">PMC11649231</pub-id></element-citation></ref><ref id="b96-ijmm-56-05-05614"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>ST</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Huang</surname><given-names>CW</given-names></name><name name-style="western"><surname>Lee</surname><given-names>TM</given-names></name><name name-style="western"><surname>Chen</surname><given-names>JW</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CS</given-names></name></person-group><article-title>OmpR coordinates the expression of virulence factors of Enterohemorrhagic Escherichia coli in the alimentary tract of Caenorhabditis elegans</article-title><source>Mol Microbiol</source><volume>116</volume><fpage>168</fpage><lpage>183</lpage><year>2021</year><pub-id pub-id-type="doi">10.1111/mmi.14698</pub-id><pub-id pub-id-type="pmid">33567149</pub-id></element-citation></ref><ref id="b97-ijmm-56-05-05614"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crofts</surname><given-names>AA</given-names></name><name name-style="western"><surname>Giovanetti</surname><given-names>SM</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Poly</surname><given-names>FM</given-names></name><name name-style="western"><surname>Guti&#233;rrez</surname><given-names>RL</given-names></name><name name-style="western"><surname>Talaat</surname><given-names>KR</given-names></name><name name-style="western"><surname>Porter</surname><given-names>CK</given-names></name><name name-style="western"><surname>Riddle</surname><given-names>MS</given-names></name><name name-style="western"><surname>DeNearing</surname><given-names>B</given-names></name><name name-style="western"><surname>Brubaker</surname><given-names>J</given-names></name><etal/></person-group><article-title>Enterotoxigenic E. coli virulence gene regulation in human infections</article-title><source>Proc Natl Acad Sci USA</source><volume>115</volume><fpage>E8968</fpage><lpage>E8976</lpage><year>2018</year><pub-id pub-id-type="doi">10.1073/pnas.1808982115</pub-id><pub-id pub-id-type="pmid">30126994</pub-id><pub-id pub-id-type="pmcid">PMC6156659</pub-id></element-citation></ref><ref id="b98-ijmm-56-05-05614"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Sun</surname><given-names>B</given-names></name></person-group><article-title>Rsp promotes the transcription of virulence factors in an agr-independent manner in Staphylococcus aureus</article-title><source>Emerg Microbes Infect</source><volume>9</volume><fpage>796</fpage><lpage>812</lpage><year>2020</year><pub-id pub-id-type="doi">10.1080/22221751.2020.1752116</pub-id><pub-id pub-id-type="pmid">32248753</pub-id><pub-id pub-id-type="pmcid">PMC7241556</pub-id></element-citation></ref><ref id="b99-ijmm-56-05-05614"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freiberg</surname><given-names>JA</given-names></name><name name-style="western"><surname>Reyes Ruiz</surname><given-names>VM</given-names></name><name name-style="western"><surname>Gimza</surname><given-names>BD</given-names></name><name name-style="western"><surname>Murdoch</surname><given-names>CC</given-names></name><name name-style="western"><surname>Green</surname><given-names>ER</given-names></name><name name-style="western"><surname>Curry</surname><given-names>JM</given-names></name><name name-style="western"><surname>Cassat</surname><given-names>JE</given-names></name><name name-style="western"><surname>Skaar</surname><given-names>EP</given-names></name></person-group><article-title>Restriction of arginine induces antibiotic tolerance in Staphylococcus aureus</article-title><source>Nat Commun</source><volume>15</volume><fpage>6734</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41467-024-51144-9</pub-id><pub-id pub-id-type="pmid">39112491</pub-id><pub-id pub-id-type="pmcid">PMC11306626</pub-id></element-citation></ref><ref id="b100-ijmm-56-05-05614"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cai</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Ren</surname><given-names>Z</given-names></name><name name-style="western"><surname>Han</surname><given-names>P</given-names></name></person-group><article-title>The role of staphylococcal biofilm on the surface of implants in orthopedic infection</article-title><source>Microorganisms</source><volume>10</volume><fpage>1909</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/microorganisms10101909</pub-id><pub-id pub-id-type="pmid">36296183</pub-id><pub-id pub-id-type="pmcid">PMC9612000</pub-id></element-citation></ref><ref id="b101-ijmm-56-05-05614"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Shi</surname><given-names>C</given-names></name><name name-style="western"><surname>Alharbi</surname><given-names>M</given-names></name><name name-style="western"><surname>Cui</surname><given-names>H</given-names></name><name name-style="western"><surname>Lin</surname><given-names>L</given-names></name></person-group><article-title>Phosphoproteomics analysis reveals the anti-bacterial and anti-virulence mechanism of eugenol against Staphylococcus aureus and its application in meat products</article-title><source>Int J Food Microbiol</source><volume>414</volume><fpage>110621</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.ijfoodmicro.2024.110621</pub-id><pub-id pub-id-type="pmid">38341904</pub-id></element-citation></ref><ref id="b102-ijmm-56-05-05614"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>SR</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>B</given-names></name><name name-style="western"><surname>Hu</surname><given-names>XM</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Therapeutic targeting of the Staphylococcus aureus accessory gene regulator (agr) system</article-title><source>Front Microbiol</source><volume>9</volume><fpage>55</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fmicb.2018.00055</pub-id><pub-id pub-id-type="pmid">29422887</pub-id><pub-id pub-id-type="pmcid">PMC5789755</pub-id></element-citation></ref><ref id="b103-ijmm-56-05-05614"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghaioumy</surname><given-names>R</given-names></name><name name-style="western"><surname>Tabatabaeifar</surname><given-names>F</given-names></name><name name-style="western"><surname>Mozafarinia</surname><given-names>K</given-names></name><name name-style="western"><surname>Mianroodi</surname><given-names>AA</given-names></name><name name-style="western"><surname>Isaei</surname><given-names>E</given-names></name><name name-style="western"><surname>Morones-Ram&#237;rez</surname><given-names>JR</given-names></name><name name-style="western"><surname>Afshari</surname><given-names>SAK</given-names></name><name name-style="western"><surname>Kalantar-Neyestanaki</surname><given-names>D</given-names></name></person-group><article-title>Biofilm formation and molecular analysis of intercellular adhesion gene cluster (icaABCD) among Staphylococcus aureus strains isolated from children with adenoiditis</article-title><source>Iran J Microbiol</source><volume>13</volume><fpage>458</fpage><lpage>463</lpage><year>2021</year><pub-id pub-id-type="pmid">34557273</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18502/ijm.v13i4.6969</pub-id><pub-id pub-id-type="pmcid">PMC8421587</pub-id></element-citation></ref><ref id="b104-ijmm-56-05-05614"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><name name-style="western"><surname>Lee</surname><given-names>H</given-names></name><name name-style="western"><surname>Ha</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J</given-names></name><name name-style="western"><surname>Choi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Oh</surname><given-names>H</given-names></name><name name-style="western"><surname>Yoon</surname><given-names>Y</given-names></name><name name-style="western"><surname>Choi</surname><given-names>KH</given-names></name></person-group><article-title>icaA gene of Staphylococcus aureus responds to NaCl, leading to increased biofilm formation</article-title><source>J Food Prot</source><volume>81</volume><fpage>412</fpage><lpage>416</lpage><year>2018</year><pub-id pub-id-type="doi">10.4315/0362-028X.JFP-17-238</pub-id><pub-id pub-id-type="pmid">29446687</pub-id></element-citation></ref><ref id="b105-ijmm-56-05-05614"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lister</surname><given-names>JL</given-names></name><name name-style="western"><surname>Horswill</surname><given-names>AR</given-names></name></person-group><article-title>Staphylococcus aureus biofilms: Recent developments in biofilm dispersal</article-title><source>Front Cell Infect Microbiol</source><volume>4</volume><fpage>178</fpage><year>2014</year><pub-id pub-id-type="doi">10.3389/fcimb.2014.00178</pub-id><pub-id pub-id-type="pmid">25566513</pub-id><pub-id pub-id-type="pmcid">PMC4275032</pub-id></element-citation></ref><ref id="b106-ijmm-56-05-05614"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burian</surname><given-names>M</given-names></name><name name-style="western"><surname>Plange</surname><given-names>J</given-names></name><name name-style="western"><surname>Schmitt</surname><given-names>L</given-names></name><name name-style="western"><surname>Kaschke</surname><given-names>A</given-names></name><name name-style="western"><surname>Marquardt</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huth</surname><given-names>L</given-names></name><name name-style="western"><surname>Baron</surname><given-names>JM</given-names></name><name name-style="western"><surname>Hornef</surname><given-names>MW</given-names></name><name name-style="western"><surname>Wolz</surname><given-names>C</given-names></name><name name-style="western"><surname>Yazdi</surname><given-names>AS</given-names></name></person-group><article-title>Adaptation of Staphylococcus aureus to the human skin environment identified using an ex vivo tissue model</article-title><source>Front Microbiol</source><volume>12</volume><fpage>728989</fpage><year>2021</year><pub-id pub-id-type="doi">10.3389/fmicb.2021.728989</pub-id><pub-id pub-id-type="pmid">34621255</pub-id><pub-id pub-id-type="pmcid">PMC8490888</pub-id></element-citation></ref><ref id="b107-ijmm-56-05-05614"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karimzadeh</surname><given-names>R</given-names></name><name name-style="western"><surname>Ghassab</surname><given-names>RK</given-names></name></person-group><article-title>Identification of nuc nuclease and sea enterotoxin genes in Staphylococcus aureus isolates from nasal mucosa of burn hospital staff: A cross-sectional study</article-title><source>New Microbes New Infect</source><volume>47</volume><fpage>100992</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.nmni.2022.100992</pub-id><pub-id pub-id-type="pmid">35800028</pub-id><pub-id pub-id-type="pmcid">PMC9253491</pub-id></element-citation></ref><ref id="b108-ijmm-56-05-05614"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heng</surname><given-names>P</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Song</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>He</surname><given-names>Y</given-names></name></person-group><article-title>Rapid detection of Staphylococcus aureus using a novel multienzyme isothermal rapid amplification technique</article-title><source>Front Microbiol</source><volume>13</volume><fpage>1027785</fpage><year>2022</year><pub-id pub-id-type="doi">10.3389/fmicb.2022.1027785</pub-id><pub-id pub-id-type="pmid">36312945</pub-id><pub-id pub-id-type="pmcid">PMC9606696</pub-id></element-citation></ref><ref id="b109-ijmm-56-05-05614"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hodille</surname><given-names>E</given-names></name><name name-style="western"><surname>Plesa</surname><given-names>A</given-names></name><name name-style="western"><surname>Bourrelly</surname><given-names>E</given-names></name><name name-style="western"><surname>Belmont</surname><given-names>L</given-names></name><name name-style="western"><surname>Badiou</surname><given-names>C</given-names></name><name name-style="western"><surname>Lina</surname><given-names>G</given-names></name><name name-style="western"><surname>Dumitrescu</surname><given-names>O</given-names></name></person-group><article-title>Staphylococcal panton-valentine leucocidin and gamma haemolysin target and lyse mature bone marrow leucocytes</article-title><source>Toxins (Basel)</source><volume>12</volume><fpage>725</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/toxins12110725</pub-id><pub-id pub-id-type="pmid">33233557</pub-id><pub-id pub-id-type="pmcid">PMC7699679</pub-id></element-citation></ref><ref id="b110-ijmm-56-05-05614"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Haddad</surname><given-names>L</given-names></name><name name-style="western"><surname>Moineau</surname><given-names>S</given-names></name></person-group><article-title>Characterization of a novel panton-valentine leukocidin (PVL)-encoding staphylococcal phage and its naturally PVL-lacking variant</article-title><source>Appl Environ Microbiol</source><volume>79</volume><fpage>2828</fpage><lpage>2832</lpage><year>2013</year><pub-id pub-id-type="doi">10.1128/AEM.03852-12</pub-id><pub-id pub-id-type="pmid">23396328</pub-id><pub-id pub-id-type="pmcid">PMC3623202</pub-id></element-citation></ref><ref id="b111-ijmm-56-05-05614"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names>RA</given-names></name><name name-style="western"><surname>Berhe</surname><given-names>N</given-names></name><name name-style="western"><surname>Mekuria</surname><given-names>Z</given-names></name><name name-style="western"><surname>Seyoum</surname><given-names>ET</given-names></name><name name-style="western"><surname>Balada-Llasat</surname><given-names>JM</given-names></name><name name-style="western"><surname>Abebe</surname><given-names>T</given-names></name><name name-style="western"><surname>Mariam</surname><given-names>SH</given-names></name><name name-style="western"><surname>Tsige</surname><given-names>E</given-names></name><name name-style="western"><surname>Fentaw Dinku</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SH</given-names></name></person-group><article-title>Antimicrobial resistance and virulence gene profile of clinical Staphylococcus aureus: A multi-center study from ethiopia</article-title><source>Infect Drug Resist</source><volume>16</volume><fpage>4835</fpage><lpage>4844</lpage><year>2023</year><pub-id pub-id-type="doi">10.2147/IDR.S419577</pub-id><pub-id pub-id-type="pmid">37520455</pub-id><pub-id pub-id-type="pmcid">PMC10386829</pub-id></element-citation></ref><ref id="b112-ijmm-56-05-05614"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Q</given-names></name><name name-style="western"><surname>Dou</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wen</surname><given-names>K</given-names></name><name name-style="western"><surname>Yu</surname><given-names>X</given-names></name><name name-style="western"><surname>Shen</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name></person-group><article-title>A comprehensive review on the detection of Staphylococcus aureus enterotoxins in food samples</article-title><source>Compr Rev Food Sci Food Saf</source><volume>23</volume><fpage>e13264</fpage><year>2024</year><pub-id pub-id-type="doi">10.1111/1541-4337.13264</pub-id><pub-id pub-id-type="pmid">38284582</pub-id></element-citation></ref><ref id="b113-ijmm-56-05-05614"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haghi</surname><given-names>F</given-names></name><name name-style="western"><surname>Zeighami</surname><given-names>H</given-names></name><name name-style="western"><surname>Hajiloo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Torabi</surname><given-names>N</given-names></name><name name-style="western"><surname>Derakhshan</surname><given-names>S</given-names></name></person-group><article-title>High frequency of enterotoxin encoding genes of Staphylococcus aureus isolated from food and clinical samples</article-title><source>J Health Popul Nutr</source><volume>40</volume><fpage>27</fpage><year>2021</year><pub-id pub-id-type="doi">10.1186/s41043-021-00246-x</pub-id><pub-id pub-id-type="pmid">34108048</pub-id><pub-id pub-id-type="pmcid">PMC8188718</pub-id></element-citation></ref><ref id="b114-ijmm-56-05-05614"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lauzardo</surname><given-names>M</given-names></name><name name-style="western"><surname>Peloquin</surname><given-names>CA</given-names></name></person-group><article-title>Tuberculosis therapy for 2016 and beyond</article-title><source>Expert Opin Pharmacother</source><volume>17</volume><fpage>1859</fpage><lpage>1872</lpage><year>2016</year><pub-id pub-id-type="doi">10.1080/14656566.2016.1215428</pub-id><pub-id pub-id-type="pmid">27457206</pub-id></element-citation></ref><ref id="b115-ijmm-56-05-05614"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jamieson</surname><given-names>FB</given-names></name><name name-style="western"><surname>Guthrie</surname><given-names>JL</given-names></name><name name-style="western"><surname>Neemuchwala</surname><given-names>A</given-names></name><name name-style="western"><surname>Lastovetska</surname><given-names>O</given-names></name><name name-style="western"><surname>Melano</surname><given-names>RG</given-names></name><name name-style="western"><surname>Mehaffy</surname><given-names>C</given-names></name></person-group><article-title>Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis</article-title><source>J Clin Microbiol</source><volume>52</volume><fpage>2157</fpage><lpage>2162</lpage><year>2014</year><pub-id pub-id-type="doi">10.1128/JCM.00691-14</pub-id><pub-id pub-id-type="pmid">24740074</pub-id><pub-id pub-id-type="pmcid">PMC4042728</pub-id></element-citation></ref><ref id="b116-ijmm-56-05-05614"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>MC</given-names></name><name name-style="western"><surname>Wang</surname><given-names>XY</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>TY</given-names></name><name name-style="western"><surname>Lin</surname><given-names>SQ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>HC</given-names></name><name name-style="western"><surname>Qian</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>GL</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>XQ</given-names></name><name name-style="western"><surname>Liu</surname><given-names>ZG</given-names></name><etal/></person-group><article-title>rpoB mutations are associated with variable levels of rifampin and rifabutin resistance in Mycobacterium tuberculosis</article-title><source>Infect Drug Resist</source><volume>15</volume><fpage>6853</fpage><lpage>6861</lpage><year>2022</year><pub-id pub-id-type="doi">10.2147/IDR.S386863</pub-id><pub-id pub-id-type="pmid">36465812</pub-id><pub-id pub-id-type="pmcid">PMC9717584</pub-id></element-citation></ref><ref id="b117-ijmm-56-05-05614"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi-Kanemitsu</surname><given-names>A</given-names></name><name name-style="western"><surname>Lu</surname><given-names>M</given-names></name><name name-style="western"><surname>Knight</surname><given-names>CT</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>T</given-names></name><name name-style="western"><surname>Mii</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ooki</surname><given-names>T</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>I</given-names></name><name name-style="western"><surname>Kikuchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Barker</surname><given-names>N</given-names></name><etal/></person-group><article-title>The Helicobacter pylori CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyloric gland base cells</article-title><source>Sci Signal</source><volume>16</volume><fpage>eabp9020</fpage><year>2023</year><pub-id pub-id-type="doi">10.1126/scisignal.abp9020</pub-id><pub-id pub-id-type="pmid">37463245</pub-id></element-citation></ref><ref id="b118-ijmm-56-05-05614"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Son</surname><given-names>YS</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>YH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>MS</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>O</given-names></name><name name-style="western"><surname>Jeong</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Mun</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>S</given-names></name><name name-style="western"><surname>Park</surname><given-names>JH</given-names></name><name name-style="western"><surname>Han</surname><given-names>MH</given-names></name><name name-style="western"><surname>Bae</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Helicobacter pylori VacA-induced mitochondrial damage in the gastric pit cells of the antrum and therapeutic rescue</article-title><source>Biomaterials</source><volume>314</volume><fpage>122842</fpage><year>2025</year><pub-id pub-id-type="doi">10.1016/j.biomaterials.2024.122842</pub-id><pub-id pub-id-type="pmid">39383778</pub-id></element-citation></ref><ref id="b119-ijmm-56-05-05614"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schubert</surname><given-names>JP</given-names></name><name name-style="western"><surname>Tay</surname><given-names>A</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KHC</given-names></name><name name-style="western"><surname>Leong</surname><given-names>LEX</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>CK</given-names></name><name name-style="western"><surname>Warner</surname><given-names>MS</given-names></name><name name-style="western"><surname>Roberts-Thomson</surname><given-names>IC</given-names></name><name name-style="western"><surname>Costello</surname><given-names>SP</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>RV</given-names></name></person-group><article-title>Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance, phylogenetic patterns, and virulence factors</article-title><source>J Gastroenterol Hepatol</source><volume>39</volume><fpage>1869</fpage><lpage>1875</lpage><year>2024</year><pub-id pub-id-type="doi">10.1111/jgh.16636</pub-id><pub-id pub-id-type="pmid">38812101</pub-id></element-citation></ref><ref id="b120-ijmm-56-05-05614"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sedaghat</surname><given-names>H</given-names></name><name name-style="western"><surname>Moniri</surname><given-names>R</given-names></name><name name-style="western"><surname>Jamali</surname><given-names>R</given-names></name><name name-style="western"><surname>Arj</surname><given-names>A</given-names></name><name name-style="western"><surname>Razavi Zadeh</surname><given-names>M</given-names></name><name name-style="western"><surname>Moosavi</surname><given-names>SG</given-names></name><name name-style="western"><surname>Rezaei</surname><given-names>M</given-names></name><name name-style="western"><surname>Pourbabaee</surname><given-names>M</given-names></name></person-group><article-title>Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA, babA2, and oipA genotypes in patients with upper gastrointestinal diseases</article-title><source>Iran J Microbiol</source><volume>6</volume><fpage>14</fpage><lpage>21</lpage><year>2014</year><pub-id pub-id-type="pmid">25954486</pub-id><pub-id pub-id-type="pmcid">PMC4419040</pub-id></element-citation></ref><ref id="b121-ijmm-56-05-05614"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garlasco</surname><given-names>J</given-names></name><name name-style="western"><surname>Beqiraj</surname><given-names>I</given-names></name><name name-style="western"><surname>Bolla</surname><given-names>C</given-names></name><name name-style="western"><surname>Marino</surname><given-names>EMI</given-names></name><name name-style="western"><surname>Zanelli</surname><given-names>C</given-names></name><name name-style="western"><surname>Gualco</surname><given-names>C</given-names></name><name name-style="western"><surname>Rocchetti</surname><given-names>A</given-names></name><name name-style="western"><surname>Gianino</surname><given-names>MM</given-names></name></person-group><article-title>Impact of septic episodes caused by Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa in a tertiary hospital: Clinical and economic considerations in years 2018-2020</article-title><source>J Infect Public Health</source><volume>16</volume><fpage>475</fpage><lpage>482</lpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.jiph.2023.02.007</pub-id><pub-id pub-id-type="pmid">36801627</pub-id></element-citation></ref><ref id="b122-ijmm-56-05-05614"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pu</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Chang</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhuo</surname><given-names>X</given-names></name><name name-style="western"><surname>Cao</surname><given-names>B</given-names></name></person-group><article-title>'Superbugs' with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: The rise of such emerging nosocomial pathogens in China</article-title><source>Sci Bull (Beijing)</source><volume>68</volume><fpage>2658</fpage><lpage>2670</lpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.scib.2023.09.040</pub-id><pub-id pub-id-type="pmid">37821268</pub-id></element-citation></ref><ref id="b123-ijmm-56-05-05614"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shoja</surname><given-names>S</given-names></name><name name-style="western"><surname>Ansari</surname><given-names>M</given-names></name><name name-style="western"><surname>Bengar</surname><given-names>S</given-names></name><name name-style="western"><surname>Rafiei</surname><given-names>A</given-names></name><name name-style="western"><surname>Shamseddin</surname><given-names>J</given-names></name><name name-style="western"><surname>Alizade</surname><given-names>H</given-names></name></person-group><article-title>Bacteriological characteristics of hypervirulent Klebsiella pneumoniae rmpA gene (hvKp-rmpA)-harboring strains in the south of Iran</article-title><source>Iran J Microbiol</source><volume>14</volume><fpage>475</fpage><lpage>483</lpage><year>2022</year><pub-id pub-id-type="pmid">36721517</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18502/ijm.v14i4.10233</pub-id><pub-id pub-id-type="pmcid">PMC9867641</pub-id></element-citation></ref><ref id="b124-ijmm-56-05-05614"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wang</surname><given-names>R</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>A</given-names></name><name name-style="western"><surname>Duan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Sun</surname><given-names>S</given-names></name><name name-style="western"><surname>Jin</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Expansion and transmission dynamics of high risk carbapenem-resistant Klebsiella pneumoniae subclones in China: An epidemiological, spatial, genomic analysis</article-title><source>Drug Resist Updat</source><volume>74</volume><fpage>101083</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.drup.2024.101083</pub-id><pub-id pub-id-type="pmid">38593500</pub-id></element-citation></ref><ref id="b125-ijmm-56-05-05614"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jia</surname><given-names>X</given-names></name><name name-style="western"><surname>Gong</surname><given-names>X</given-names></name><name name-style="western"><surname>Wu</surname><given-names>D</given-names></name><name name-style="western"><surname>Duan</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zou</surname><given-names>D</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Genomic characteristics of a colistin- and tigecycline-resistant Klebsiella pneumoniae strain isolated before the widespread use of these two antibiotics in China</article-title><source>Int J Antimicrob Agents</source><volume>63</volume><fpage>107037</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2023.107037</pub-id><pub-id pub-id-type="pmid">37981072</pub-id></element-citation></ref><ref id="b126-ijmm-56-05-05614"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dell'Annunziata</surname><given-names>F</given-names></name><name name-style="western"><surname>Dell'Aversana</surname><given-names>C</given-names></name><name name-style="western"><surname>Doti</surname><given-names>N</given-names></name><name name-style="western"><surname>Donadio</surname><given-names>G</given-names></name><name name-style="western"><surname>Dal Piaz</surname><given-names>F</given-names></name><name name-style="western"><surname>Izzo</surname><given-names>V</given-names></name><name name-style="western"><surname>De Filippis</surname><given-names>A</given-names></name><name name-style="western"><surname>Galdiero</surname><given-names>M</given-names></name><name name-style="western"><surname>Altucci</surname><given-names>L</given-names></name><name name-style="western"><surname>Boccia</surname><given-names>G</given-names></name><etal/></person-group><article-title>Outer membrane vesicles derived from Klebsiella pneumoniae are a driving force for horizontal gene transfer</article-title><source>Int J Mol Sci</source><volume>22</volume><fpage>8732</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/ijms22168732</pub-id><pub-id pub-id-type="pmid">34445438</pub-id><pub-id pub-id-type="pmcid">PMC8395779</pub-id></element-citation></ref><ref id="b127-ijmm-56-05-05614"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name></person-group><article-title>Emergence of hypervirulent and carbapenem-resistant Klebsiella pneumoniae from 2014-2021 in central and eastern China: A molecular, biological, and epidemiological study</article-title><source>BMC Microbiol</source><volume>24</volume><fpage>465</fpage><year>2024</year><pub-id pub-id-type="doi">10.1186/s12866-024-03614-9</pub-id><pub-id pub-id-type="pmid">39528921</pub-id><pub-id pub-id-type="pmcid">PMC11552131</pub-id></element-citation></ref><ref id="b128-ijmm-56-05-05614"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arato</surname><given-names>V</given-names></name><name name-style="western"><surname>Raso</surname><given-names>MM</given-names></name><name name-style="western"><surname>Gasperini</surname><given-names>G</given-names></name><name name-style="western"><surname>Berlanda Scorza</surname><given-names>F</given-names></name><name name-style="western"><surname>Micoli</surname><given-names>F</given-names></name></person-group><article-title>Prophylaxis and treatment against Klebsiella pneumoniae: Current insights on this emerging anti-microbial resistant global threat</article-title><source>Int J Mol Sci</source><volume>22</volume><fpage>4042</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/ijms22084042</pub-id><pub-id pub-id-type="pmid">33919847</pub-id><pub-id pub-id-type="pmcid">PMC8070759</pub-id></element-citation></ref><ref id="b129-ijmm-56-05-05614"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnes</surname><given-names>CO</given-names></name><name name-style="western"><surname>Jette</surname><given-names>CA</given-names></name><name name-style="western"><surname>Abernathy</surname><given-names>ME</given-names></name><name name-style="western"><surname>Dam</surname><given-names>KMA</given-names></name><name name-style="western"><surname>Esswein</surname><given-names>SR</given-names></name><name name-style="western"><surname>Gristick</surname><given-names>HB</given-names></name><name name-style="western"><surname>Malyutin</surname><given-names>AG</given-names></name><name name-style="western"><surname>Sharaf</surname><given-names>NG</given-names></name><name name-style="western"><surname>Huey-Tubman</surname><given-names>KE</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YE</given-names></name><etal/></person-group><article-title>SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies</article-title><source>Nature</source><volume>588</volume><fpage>682</fpage><lpage>687</lpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41586-020-2852-1</pub-id><pub-id pub-id-type="pmid">33045718</pub-id><pub-id pub-id-type="pmcid">PMC8092461</pub-id></element-citation></ref><ref id="b130-ijmm-56-05-05614"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Cao</surname><given-names>X</given-names></name><name name-style="western"><surname>Gu</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><etal/></person-group><article-title>Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins</article-title><source>Cell Res</source><volume>32</volume><fpage>609</fpage><lpage>620</lpage><year>2022</year><pub-id pub-id-type="doi">10.1038/s41422-022-00672-4</pub-id><pub-id pub-id-type="pmid">35641567</pub-id><pub-id pub-id-type="pmcid">PMC9152305</pub-id></element-citation></ref><ref id="b131-ijmm-56-05-05614"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>R</given-names></name><name name-style="western"><surname>Yamasoba</surname><given-names>D</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>I</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Kishimoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Ito</surname><given-names>J</given-names></name><name name-style="western"><surname>Morioka</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nao</surname><given-names>N</given-names></name><name name-style="western"><surname>Nasser</surname><given-names>H</given-names></name><name name-style="western"><surname>Uriu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant</article-title><source>Nature</source><volume>603</volume><fpage>700</fpage><lpage>705</lpage><year>2022</year><pub-id pub-id-type="doi">10.1038/s41586-022-04462-1</pub-id><pub-id pub-id-type="pmid">35104835</pub-id><pub-id pub-id-type="pmcid">PMC8942852</pub-id></element-citation></ref><ref id="b132-ijmm-56-05-05614"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uriu</surname><given-names>K</given-names></name><name name-style="western"><surname>Ito</surname><given-names>J</given-names></name><name name-style="western"><surname>Kosugi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>YL</given-names></name><name name-style="western"><surname>Mugita</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hinay</surname><given-names>AA</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Putri</surname><given-names>O</given-names></name><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shimizu</surname><given-names>R</given-names></name><etal/></person-group><article-title>Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant</article-title><source>Lancet Infect Dis</source><volume>23</volume><fpage>e460</fpage><lpage>e461</lpage><year>2023</year><pub-id pub-id-type="doi">10.1016/S1473-3099(23)00575-3</pub-id><pub-id pub-id-type="pmid">37734391</pub-id></element-citation></ref><ref id="b133-ijmm-56-05-05614"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bdeir</surname><given-names>N</given-names></name><name name-style="western"><surname>L&#252;ddecke</surname><given-names>T</given-names></name><name name-style="western"><surname>Maa&#223;</surname><given-names>H</given-names></name><name name-style="western"><surname>Schmelz</surname><given-names>S</given-names></name><name name-style="western"><surname>Rand</surname><given-names>U</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>H</given-names></name><name name-style="western"><surname>Metzdorf</surname><given-names>K</given-names></name><name name-style="western"><surname>Kulkarni</surname><given-names>U</given-names></name><name name-style="western"><surname>Cossmann</surname><given-names>A</given-names></name><name name-style="western"><surname>Stankov</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Reverse mutational scanning of SARS-CoV-2 spike BA.2.86 identifies epitopes contributing to immune escape from polyclonal sera</article-title><source>Nat Commun</source><volume>16</volume><fpage>809</fpage><year>2025</year><pub-id pub-id-type="doi">10.1038/s41467-025-55871-5</pub-id><pub-id pub-id-type="pmid">39827186</pub-id><pub-id pub-id-type="pmcid">PMC11743207</pub-id></element-citation></ref><ref id="b134-ijmm-56-05-05614"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>S</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>S</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Cai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wei</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yu</surname><given-names>XF</given-names></name></person-group><article-title>SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function</article-title><source>J Med Virol</source><volume>95</volume><fpage>e28175</fpage><year>2023</year><pub-id pub-id-type="doi">10.1002/jmv.28175</pub-id><pub-id pub-id-type="pmid">36163413</pub-id><pub-id pub-id-type="pmcid">PMC9538343</pub-id></element-citation></ref><ref id="b135-ijmm-56-05-05614"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miao</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ji</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name></person-group><article-title>ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation</article-title><source>Dev Cell</source><volume>56</volume><fpage>427</fpage><lpage>442.e5</lpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.devcel.2020.12.010</pub-id><pub-id pub-id-type="pmid">33422265</pub-id><pub-id pub-id-type="pmcid">PMC7832235</pub-id></element-citation></ref><ref id="b136-ijmm-56-05-05614"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Tsui</surname><given-names>JLH</given-names></name><name name-style="western"><surname>Gutierrez</surname><given-names>B</given-names></name><name name-style="western"><surname>Busch Moreno</surname><given-names>S</given-names></name><name name-style="western"><surname>du Plessis</surname><given-names>L</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J</given-names></name><name name-style="western"><surname>Bajaj</surname><given-names>S</given-names></name><name name-style="western"><surname>Suchard</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pybus</surname><given-names>OG</given-names></name><etal/></person-group><article-title>COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses</article-title><source>Science</source><volume>386</volume><fpage>eadq3003</fpage><year>2024</year><pub-id pub-id-type="doi">10.1126/science.adq3003</pub-id><pub-id pub-id-type="pmid">39509510</pub-id><pub-id pub-id-type="pmcid">PMC11760156</pub-id></element-citation></ref><ref id="b137-ijmm-56-05-05614"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lederhofer</surname><given-names>J</given-names></name><name name-style="western"><surname>Tsybovsky</surname><given-names>Y</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>L</given-names></name><name name-style="western"><surname>Raab</surname><given-names>JE</given-names></name><name name-style="western"><surname>Creanga</surname><given-names>A</given-names></name><name name-style="western"><surname>Stephens</surname><given-names>T</given-names></name><name name-style="western"><surname>Gillespie</surname><given-names>RA</given-names></name><name name-style="western"><surname>Syeda</surname><given-names>HZ</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>BE</given-names></name><name name-style="western"><surname>Skertic</surname><given-names>M</given-names></name><etal/></person-group><article-title>Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase</article-title><source>Immunity</source><volume>57</volume><fpage>574</fpage><lpage>586.e7</lpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.immuni.2024.02.003</pub-id><pub-id pub-id-type="pmid">38430907</pub-id><pub-id pub-id-type="pmcid">PMC10962683</pub-id></element-citation></ref><ref id="b138-ijmm-56-05-05614"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>M</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shen</surname><given-names>C</given-names></name><name name-style="western"><surname>Yang</surname><given-names>W</given-names></name><name name-style="western"><surname>Peng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Shen</surname><given-names>HM</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>GF</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>A human monoclonal antibody targeting the monomeric N6 neuraminidase confers protection against avian H5N6 influenza virus infection</article-title><source>Nat Commun</source><volume>15</volume><fpage>8871</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41467-024-53301-6</pub-id><pub-id pub-id-type="pmid">39402031</pub-id><pub-id pub-id-type="pmcid">PMC11473554</pub-id></element-citation></ref><ref id="b139-ijmm-56-05-05614"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>LE</given-names></name><name name-style="western"><surname>Kowal</surname><given-names>S</given-names></name><name name-style="western"><surname>Cardenas</surname><given-names>DA</given-names></name><name name-style="western"><surname>Beauchemin</surname><given-names>CAA</given-names></name></person-group><article-title>Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors</article-title><source>PLoS One</source><volume>12</volume><fpage>e0183621</fpage><year>2017</year><pub-id pub-id-type="doi">10.1371/journal.pone.0183621</pub-id><pub-id pub-id-type="pmid">28837615</pub-id><pub-id pub-id-type="pmcid">PMC5570347</pub-id></element-citation></ref><ref id="b140-ijmm-56-05-05614"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>T</given-names></name><name name-style="western"><surname>Jin</surname><given-names>X</given-names></name><name name-style="western"><surname>Fu</surname><given-names>W</given-names></name><name name-style="western"><surname>Teng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name><name name-style="western"><surname>Xu</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>PB2 residue 473 contributes to the mammalian virulence of H7N9 avian influenza virus by modulating viral polymerase activity via ANP32A</article-title><source>J Virol</source><volume>98</volume><fpage>e0194423</fpage><year>2024</year><pub-id pub-id-type="doi">10.1128/jvi.01944-23</pub-id><pub-id pub-id-type="pmid">38421166</pub-id><pub-id pub-id-type="pmcid">PMC10949425</pub-id></element-citation></ref><ref id="b141-ijmm-56-05-05614"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#252;nl</surname><given-names>F</given-names></name><name name-style="western"><surname>Krischuns</surname><given-names>T</given-names></name><name name-style="western"><surname>Schreiber</surname><given-names>JA</given-names></name><name name-style="western"><surname>Henschel</surname><given-names>L</given-names></name><name name-style="western"><surname>Wahrenburg</surname><given-names>M</given-names></name><name name-style="western"><surname>Drexler</surname><given-names>HCA</given-names></name><name name-style="western"><surname>Leidel</surname><given-names>SA</given-names></name><name name-style="western"><surname>Cojocaru</surname><given-names>V</given-names></name><name name-style="western"><surname>Seebohm</surname><given-names>G</given-names></name><name name-style="western"><surname>Mellmann</surname><given-names>A</given-names></name><etal/></person-group><article-title>The ubiquitination landscape of the influenza A virus polymerase</article-title><source>Nat Commun</source><volume>14</volume><fpage>787</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41467-023-36389-0</pub-id><pub-id pub-id-type="pmid">36774438</pub-id><pub-id pub-id-type="pmcid">PMC9922279</pub-id></element-citation></ref><ref id="b142-ijmm-56-05-05614"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Meng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Deng</surname><given-names>K</given-names></name><name name-style="western"><surname>Gao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Cai</surname><given-names>J</given-names></name></person-group><article-title>Vpr driving DNA methylation variation of CD4 + T cells in HIV-1 infection</article-title><source>Virol J</source><volume>21</volume><fpage>97</fpage><year>2024</year><pub-id pub-id-type="doi">10.1186/s12985-024-02363-5</pub-id><pub-id pub-id-type="pmid">38671522</pub-id><pub-id pub-id-type="pmcid">PMC11046818</pub-id></element-citation></ref><ref id="b143-ijmm-56-05-05614"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biradar</surname><given-names>S</given-names></name><name name-style="western"><surname>Agarwal</surname><given-names>Y</given-names></name><name name-style="western"><surname>Das</surname><given-names>A</given-names></name><name name-style="western"><surname>Shu</surname><given-names>ST</given-names></name><name name-style="western"><surname>Samal</surname><given-names>J</given-names></name><name name-style="western"><surname>Ho</surname><given-names>S</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>N</given-names></name><name name-style="western"><surname>Mahesh</surname><given-names>D</given-names></name><name name-style="western"><surname>Teredesai</surname><given-names>S</given-names></name><name name-style="western"><surname>Castronova</surname><given-names>I</given-names></name><etal/></person-group><article-title>Nef defect attenuates HIV viremia and immune dysregulation in the bone marrow-liver-thymus-spleen (BLTS) humanized mouse model</article-title><source>Virology</source><volume>598</volume><fpage>110192</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.virol.2024.110192</pub-id><pub-id pub-id-type="pmid">39106585</pub-id><pub-id pub-id-type="pmcid">PMC11458258</pub-id></element-citation></ref><ref id="b144-ijmm-56-05-05614"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schenck</surname><given-names>JK</given-names></name><name name-style="western"><surname>Clarkson-Paredes</surname><given-names>C</given-names></name><name name-style="western"><surname>Pushkarsky</surname><given-names>T</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Miller</surname><given-names>RH</given-names></name><name name-style="western"><surname>Bukrinsky</surname><given-names>MI</given-names></name></person-group><article-title>Nef mediates neuroimmune response, myelin impairment, and neuronal injury in EcoHIV-infected mice</article-title><source>Life Sci Alliance</source><volume>8</volume><fpage>e202402879</fpage><year>2024</year><pub-id pub-id-type="doi">10.26508/lsa.202402879</pub-id><pub-id pub-id-type="pmid">39532531</pub-id><pub-id pub-id-type="pmcid">PMC11557684</pub-id></element-citation></ref><ref id="b145-ijmm-56-05-05614"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shu</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zou</surname><given-names>J</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yi</surname><given-names>Z</given-names></name></person-group><article-title>NS5-independent Ablation of STAT2 by Zika virus to antagonize interferon signalling</article-title><source>Emerg Microbes Infect</source><volume>10</volume><fpage>1609</fpage><lpage>1625</lpage><year>2021</year><pub-id pub-id-type="doi">10.1080/22221751.2021.1964384</pub-id><pub-id pub-id-type="pmid">34340648</pub-id><pub-id pub-id-type="pmcid">PMC8366623</pub-id></element-citation></ref><ref id="b146-ijmm-56-05-05614"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lebeau</surname><given-names>G</given-names></name><name name-style="western"><surname>Hoareau</surname><given-names>M</given-names></name><name name-style="western"><surname>Rivi&#232;re</surname><given-names>S</given-names></name><name name-style="western"><surname>El Safadi</surname><given-names>D</given-names></name><name name-style="western"><surname>Da Silva</surname><given-names>CR</given-names></name><name name-style="western"><surname>Krejbich-Trotot</surname><given-names>P</given-names></name><name name-style="western"><surname>Viranaicken</surname><given-names>W</given-names></name></person-group><article-title>Cell cycle and mitosis progression during ZIKA virus infection: The viral non-structural protein NS5 as a master regulator of the APC/cyclosome?</article-title><source>Biochimie</source><volume>221</volume><fpage>75</fpage><lpage>80</lpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.biochi.2024.01.016</pub-id><pub-id pub-id-type="pmid">38307244</pub-id></element-citation></ref><ref id="b147-ijmm-56-05-05614"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>ZH</given-names></name><name name-style="western"><surname>Xing</surname><given-names>L</given-names></name></person-group><article-title>Neurovirulence of Zika virus-encoded proteins</article-title><source>Arch Virol</source><volume>170</volume><fpage>150</fpage><year>2025</year><pub-id pub-id-type="doi">10.1007/s00705-025-06338-x</pub-id><pub-id pub-id-type="pmid">40483309</pub-id></element-citation></ref><ref id="b148-ijmm-56-05-05614"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>W</given-names></name><name name-style="western"><surname>Fu</surname><given-names>C</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ju</surname><given-names>X</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name><name name-style="western"><surname>Song</surname><given-names>J</given-names></name><name name-style="western"><surname>Gong</surname><given-names>M</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fan</surname><given-names>W</given-names></name><name name-style="western"><surname>Yao</surname><given-names>J</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Q</given-names></name></person-group><article-title>Zika virus NS5 protein inhibits type I interferon signaling via CRL3 E3 ubiquitin ligase-mediated degradation of STAT2</article-title><source>Proc Natl Acad Sci USA</source><volume>121</volume><fpage>e2403235121</fpage><year>2024</year><pub-id pub-id-type="doi">10.1073/pnas.2403235121</pub-id><pub-id pub-id-type="pmid">39145933</pub-id><pub-id pub-id-type="pmcid">PMC11348293</pub-id></element-citation></ref><ref id="b149-ijmm-56-05-05614"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruedas</surname><given-names>JB</given-names></name><name name-style="western"><surname>Arnold</surname><given-names>CE</given-names></name><name name-style="western"><surname>Palacios</surname><given-names>G</given-names></name><name name-style="western"><surname>Connor</surname><given-names>JH</given-names></name></person-group><article-title>Growth-adaptive mutations in the Ebola virus makona glycoprotein alter different steps in the virus entry pathway</article-title><source>J Virol</source><volume>92</volume><fpage>e00820</fpage><lpage>18</lpage><year>2018</year><pub-id pub-id-type="doi">10.1128/JVI.00820-18</pub-id><pub-id pub-id-type="pmid">30021890</pub-id><pub-id pub-id-type="pmcid">PMC6146795</pub-id></element-citation></ref><ref id="b150-ijmm-56-05-05614"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ilinykh</surname><given-names>PA</given-names></name><name name-style="western"><surname>Huang</surname><given-names>K</given-names></name><name name-style="western"><surname>Gunn</surname><given-names>BM</given-names></name><name name-style="western"><surname>Kuzmina</surname><given-names>NA</given-names></name><name name-style="western"><surname>Kedarinath</surname><given-names>K</given-names></name><name name-style="western"><surname>Jurado-Cobena</surname><given-names>E</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>F</given-names></name><name name-style="western"><surname>Subramani</surname><given-names>C</given-names></name><name name-style="western"><surname>Hyde</surname><given-names>MA</given-names></name><name name-style="western"><surname>Velazquez</surname><given-names>JV</given-names></name><etal/></person-group><article-title>Antibodies targeting the glycan cap of Ebola virus glycoprotein are potent inducers of the complement system</article-title><source>Commun Biol</source><volume>7</volume><fpage>871</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s42003-024-06556-0</pub-id><pub-id pub-id-type="pmid">39020082</pub-id><pub-id pub-id-type="pmcid">PMC11255267</pub-id></element-citation></ref><ref id="b151-ijmm-56-05-05614"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrne</surname><given-names>PO</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>BE</given-names></name><name name-style="western"><surname>Ambrozak</surname><given-names>DR</given-names></name><name name-style="western"><surname>Blade</surname><given-names>EG</given-names></name><name name-style="western"><surname>Tsybovsky</surname><given-names>Y</given-names></name><name name-style="western"><surname>Graham</surname><given-names>BS</given-names></name><name name-style="western"><surname>McLellan</surname><given-names>JS</given-names></name><name name-style="western"><surname>Loomis</surname><given-names>RJ</given-names></name></person-group><article-title>Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein</article-title><source>Nat Commun</source><volume>14</volume><fpage>1494</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41467-023-36995-y</pub-id><pub-id pub-id-type="pmid">36932063</pub-id><pub-id pub-id-type="pmcid">PMC10021056</pub-id></element-citation></ref><ref id="b152-ijmm-56-05-05614"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>K</given-names></name><name name-style="western"><surname>Chan</surname><given-names>YP</given-names></name><name name-style="western"><surname>Bradel-Tretheway</surname><given-names>B</given-names></name><name name-style="western"><surname>Akyol-Ataman</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dutta</surname><given-names>S</given-names></name><name name-style="western"><surname>Yan</surname><given-names>L</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>LF</given-names></name><name name-style="western"><surname>Skiniotis</surname><given-names>G</given-names></name><etal/></person-group><article-title>Crystal structure of the pre-fusion nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly</article-title><source>PLoS Pathog</source><volume>11</volume><fpage>e1005322</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.ppat.1005322</pub-id><pub-id pub-id-type="pmid">26646856</pub-id><pub-id pub-id-type="pmcid">PMC4672880</pub-id></element-citation></ref><ref id="b153-ijmm-56-05-05614"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>T</given-names></name><name name-style="western"><surname>Cui</surname><given-names>H</given-names></name><name name-style="western"><surname>Bai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Luo</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><name name-style="western"><surname>Di</surname><given-names>L</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A human commensal-pathogenic fungus suppresses host immunity via targeting TBK1</article-title><source>Cell Host Microbe</source><volume>32</volume><fpage>1536</fpage><lpage>1551.e6</lpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.chom.2024.07.003</pub-id><pub-id pub-id-type="pmid">39084229</pub-id></element-citation></ref><ref id="b154-ijmm-56-05-05614"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naglik</surname><given-names>JR</given-names></name><name name-style="western"><surname>Challacombe</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Hube</surname><given-names>B</given-names></name></person-group><article-title>Candida albicans secreted aspartyl proteinases in virulence and pathogenesis</article-title><source>Microbiol Mol Biol Rev</source><volume>67</volume><fpage>400</fpage><lpage>428</lpage><year>2003</year><pub-id pub-id-type="doi">10.1128/MMBR.67.3.400-428.2003</pub-id><pub-id pub-id-type="pmid">12966142</pub-id><pub-id pub-id-type="pmcid">PMC193873</pub-id></element-citation></ref><ref id="b155-ijmm-56-05-05614"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staib</surname><given-names>P</given-names></name><name name-style="western"><surname>Kretschmar</surname><given-names>M</given-names></name><name name-style="western"><surname>Nichterlein</surname><given-names>T</given-names></name><name name-style="western"><surname>Hof</surname><given-names>H</given-names></name><name name-style="western"><surname>Morschh&#228;user</surname><given-names>J</given-names></name></person-group><article-title>Differential activation of a Candida albicans virulence gene family during infection</article-title><source>Proc Natl Acad Sci USA</source><volume>97</volume><fpage>6102</fpage><lpage>6107</lpage><year>2000</year><pub-id pub-id-type="doi">10.1073/pnas.110031497</pub-id><pub-id pub-id-type="pmid">10811913</pub-id><pub-id pub-id-type="pmcid">PMC18565</pub-id></element-citation></ref><ref id="b156-ijmm-56-05-05614"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Staib</surname><given-names>P</given-names></name><name name-style="western"><surname>Kretschmar</surname><given-names>M</given-names></name><name name-style="western"><surname>Nichterlein</surname><given-names>T</given-names></name><name name-style="western"><surname>Hof</surname><given-names>H</given-names></name><name name-style="western"><surname>Morschh&#228;user</surname><given-names>J</given-names></name></person-group><article-title>Transcriptional regulators Cph1p and Efg1p mediate activation of the Candida albicans virulence gene SAP5 during infection</article-title><source>Infect Immun</source><volume>70</volume><fpage>921</fpage><lpage>927</lpage><year>2002</year><pub-id pub-id-type="doi">10.1128/IAI.70.2.921-927.2002</pub-id><pub-id pub-id-type="pmid">11796627</pub-id><pub-id pub-id-type="pmcid">PMC127704</pub-id></element-citation></ref><ref id="b157-ijmm-56-05-05614"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>DK</given-names></name><name name-style="western"><surname>N&#233;meth</surname><given-names>T</given-names></name><name name-style="western"><surname>Papp</surname><given-names>A</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>R</given-names></name><name name-style="western"><surname>Luk&#225;csi</surname><given-names>S</given-names></name><name name-style="western"><surname>Heidingsfeld</surname><given-names>O</given-names></name><name name-style="western"><surname>Dostal</surname><given-names>J</given-names></name><name name-style="western"><surname>V&#225;gv&#246;lgyi</surname><given-names>C</given-names></name><name name-style="western"><surname>Bajtay</surname><given-names>Z</given-names></name><name name-style="western"><surname>J&#243;zsi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Functional characterization of secreted aspartyl proteases in Candida parapsilosis</article-title><source>mSphere</source><volume>4</volume><fpage>e00484</fpage><lpage>19</lpage><year>2019</year><pub-id pub-id-type="doi">10.1128/mSphere.00484-19</pub-id><pub-id pub-id-type="pmid">31434748</pub-id><pub-id pub-id-type="pmcid">PMC6706470</pub-id></element-citation></ref><ref id="b158-ijmm-56-05-05614"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nobile</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>AP</given-names></name></person-group><article-title>Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p</article-title><source>Curr Boil</source><volume>15</volume><fpage>1150</fpage><lpage>1155</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.cub.2005.05.047</pub-id><pub-id pub-id-type="pmid">15964282</pub-id></element-citation></ref><ref id="b159-ijmm-56-05-05614"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Latg&#233;</surname><given-names>JP</given-names></name><name name-style="western"><surname>Chamilos</surname><given-names>G</given-names></name></person-group><article-title>Aspergillus fumigatus and aspergillosis in 2019</article-title><source>Clin Microbiol Rev</source><volume>33</volume><fpage>e00140</fpage><lpage>18</lpage><year>2019</year><pub-id pub-id-type="doi">10.1128/CMR.00140-18</pub-id><pub-id pub-id-type="pmid">31722890</pub-id><pub-id pub-id-type="pmcid">PMC6860006</pub-id></element-citation></ref><ref id="b160-ijmm-56-05-05614"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fr&#233;alle</surname><given-names>E</given-names></name><name name-style="western"><surname>Aliouat-Denis</surname><given-names>CM</given-names></name><name name-style="western"><surname>Delhaes</surname><given-names>L</given-names></name><name name-style="western"><surname>Hot</surname><given-names>D</given-names></name><name name-style="western"><surname>Dei-Cas</surname><given-names>E</given-names></name></person-group><article-title>Transcriptomic insights into the oxidative response of stress-exposed Aspergillus fumigatus</article-title><source>Curr Pharm Des</source><volume>19</volume><fpage>3713</fpage><lpage>3737</lpage><year>2013</year><pub-id pub-id-type="doi">10.2174/1381612811319200011</pub-id><pub-id pub-id-type="pmid">23278536</pub-id></element-citation></ref><ref id="b161-ijmm-56-05-05614"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>L</given-names></name><name name-style="western"><surname>Sen</surname><given-names>P</given-names></name><name name-style="western"><surname>Bhattacharya</surname><given-names>AK</given-names></name><name name-style="western"><surname>Vijayaraghavan</surname><given-names>P</given-names></name></person-group><article-title>Isoeugenol affects expression pattern of conidial hydrophobin gene RodA and transcriptional regulators MedA and SomA responsible for adherence and biofilm formation in Aspergillus fumigatus</article-title><source>Arch Microbiol</source><volume>204</volume><fpage>214</fpage><year>2022</year><pub-id pub-id-type="doi">10.1007/s00203-022-02817-w</pub-id><pub-id pub-id-type="pmid">35314887</pub-id><pub-id pub-id-type="pmcid">PMC8938220</pub-id></element-citation></ref><ref id="b162-ijmm-56-05-05614"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>H</given-names></name><name name-style="western"><surname>Rong</surname><given-names>C</given-names></name><name name-style="western"><surname>Wu</surname><given-names>N</given-names></name><name name-style="western"><surname>Chu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Shang</surname><given-names>H</given-names></name></person-group><article-title>Evolutionary accumulation of FKS1 mutations from clinical echinocandin-resistant Candida auris</article-title><source>Emerg Microbes Infect</source><volume>13</volume><fpage>2377584</fpage><year>2024</year><pub-id pub-id-type="doi">10.1080/22221751.2024.2377584</pub-id><pub-id pub-id-type="pmid">38989545</pub-id><pub-id pub-id-type="pmcid">PMC11265302</pub-id></element-citation></ref><ref id="b163-ijmm-56-05-05614"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiyohara</surname><given-names>M</given-names></name><name name-style="western"><surname>Miyazaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Okamoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Hirayama</surname><given-names>T</given-names></name><name name-style="western"><surname>Makimura</surname><given-names>K</given-names></name><name name-style="western"><surname>Chibana</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakada</surname><given-names>N</given-names></name><name name-style="western"><surname>Ito</surname><given-names>Y</given-names></name><name name-style="western"><surname>Sumiyoshi</surname><given-names>M</given-names></name><name name-style="western"><surname>Ashizawa</surname><given-names>N</given-names></name><etal/></person-group><article-title>Evaluation of a novel FKS1 R1354H mutation associated with caspofungin resistance in Candida auris using the CRISPR-Cas9 system</article-title><source>J Fungi (Basel)</source><volume>9</volume><fpage>529</fpage><year>2023</year><pub-id pub-id-type="doi">10.3390/jof9050529</pub-id><pub-id pub-id-type="pmid">37233240</pub-id><pub-id pub-id-type="pmcid">PMC10219442</pub-id></element-citation></ref><ref id="b164-ijmm-56-05-05614"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz</surname><given-names>JF</given-names></name><name name-style="western"><surname>Gade</surname><given-names>L</given-names></name><name name-style="western"><surname>Chow</surname><given-names>NA</given-names></name><name name-style="western"><surname>Loparev</surname><given-names>VN</given-names></name><name name-style="western"><surname>Juieng</surname><given-names>P</given-names></name><name name-style="western"><surname>Berkow</surname><given-names>EL</given-names></name><name name-style="western"><surname>Farrer</surname><given-names>RA</given-names></name><name name-style="western"><surname>Litvintseva</surname><given-names>AP</given-names></name><name name-style="western"><surname>Cuomo</surname><given-names>CA</given-names></name></person-group><article-title>Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species</article-title><source>Nat Commun</source><volume>9</volume><fpage>5346</fpage><year>2018</year><pub-id pub-id-type="doi">10.1038/s41467-018-07779-6</pub-id><pub-id pub-id-type="pmid">30559369</pub-id><pub-id pub-id-type="pmcid">PMC6297351</pub-id></element-citation></ref><ref id="b165-ijmm-56-05-05614"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>B</given-names></name><name name-style="western"><surname>Feng</surname><given-names>C</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ye</surname><given-names>C</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Z</given-names></name></person-group><article-title>Mobile genetic elements encoding antibiotic resistance genes and virulence genes in Klebsiella pneumoniae: Important pathways for the acquisition of virulence and resistance</article-title><source>Front Microbiol</source><volume>16</volume><fpage>1529157</fpage><year>2025</year><pub-id pub-id-type="doi">10.3389/fmicb.2025.1529157</pub-id><pub-id pub-id-type="pmid">40066273</pub-id><pub-id pub-id-type="pmcid">PMC11891212</pub-id></element-citation></ref><ref id="b166-ijmm-56-05-05614"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>JX</given-names></name><name name-style="western"><surname>Ma</surname><given-names>GN</given-names></name><name name-style="western"><surname>Li</surname><given-names>YT</given-names></name><name name-style="western"><surname>Shi</surname><given-names>YP</given-names></name><name name-style="western"><surname>Liang</surname><given-names>GW</given-names></name></person-group><article-title>Resistance and virulence genes characteristic of a south Asia Clade (I) Candida auris strain isolated from blood in Beijing</article-title><source>Clinics (Sao Paulo)</source><volume>79</volume><fpage>100497</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.clinsp.2024.100497</pub-id><pub-id pub-id-type="pmid">39284275</pub-id><pub-id pub-id-type="pmcid">PMC11419799</pub-id></element-citation></ref><ref id="b167-ijmm-56-05-05614"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>SD</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>N</given-names></name><name name-style="western"><surname>Zaas</surname><given-names>AK</given-names></name><name name-style="western"><surname>Schell</surname><given-names>WA</given-names></name><name name-style="western"><surname>Perfect</surname><given-names>JR</given-names></name><name name-style="western"><surname>Cowen</surname><given-names>LE</given-names></name></person-group><article-title>Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin</article-title><source>PLoS Pathog</source><volume>5</volume><fpage>e1000532</fpage><year>2009</year><pub-id pub-id-type="doi">10.1371/journal.ppat.1000532</pub-id><pub-id pub-id-type="pmid">19649312</pub-id><pub-id pub-id-type="pmcid">PMC2712069</pub-id></element-citation></ref><ref id="b168-ijmm-56-05-05614"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Tan</surname><given-names>J</given-names></name><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>R</given-names></name></person-group><article-title>Antifungal activity of geldanamycin alone or in combination with fluconazole against Candida species</article-title><source>Mycopathologia</source><volume>175</volume><fpage>273</fpage><lpage>279</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s11046-012-9612-1</pub-id><pub-id pub-id-type="pmid">23341047</pub-id></element-citation></ref><ref id="b169-ijmm-56-05-05614"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yin</surname><given-names>W</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Biofilms: The microbial 'protective clothing' in extreme environments</article-title><source>Int J Mol Sci</source><volume>20</volume><fpage>3423</fpage><year>2019</year><pub-id pub-id-type="doi">10.3390/ijms20143423</pub-id><pub-id pub-id-type="pmid">31336824</pub-id><pub-id pub-id-type="pmcid">PMC6679078</pub-id></element-citation></ref><ref id="b170-ijmm-56-05-05614"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>J</given-names></name><name name-style="western"><surname>Deng</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>H</given-names></name></person-group><article-title>Tailored multilayer nanoparticles against resistant P. aeruginosa by disrupting the thickened mucus, dense biofilm and hyperinflammation</article-title><source>J Control Release</source><volume>378</volume><fpage>588</fpage><lpage>604</lpage><year>2025</year><pub-id pub-id-type="doi">10.1016/j.jconrel.2024.12.040</pub-id><pub-id pub-id-type="pmid">39710209</pub-id></element-citation></ref><ref id="b171-ijmm-56-05-05614"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahmat Ullah</surname><given-names>S</given-names></name><name name-style="western"><surname>Irum</surname><given-names>S</given-names></name><name name-style="western"><surname>Mahnoor</surname><given-names>I</given-names></name><name name-style="western"><surname>Ismatullah</surname><given-names>H</given-names></name><name name-style="western"><surname>Mumtaz</surname><given-names>M</given-names></name><name name-style="western"><surname>Andleeb</surname><given-names>S</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>A</given-names></name><name name-style="western"><surname>Jamal</surname><given-names>M</given-names></name></person-group><article-title>Exploring the resistome, virulome, and mobilome of multidrug-resistant Klebsiella pneumoniae isolates: Deciphering the molecular basis of carbapenem resistance</article-title><source>BMC Genomics</source><volume>25</volume><fpage>408</fpage><year>2024</year><pub-id pub-id-type="doi">10.1186/s12864-024-10139-y</pub-id><pub-id pub-id-type="pmid">38664636</pub-id><pub-id pub-id-type="pmcid">PMC11044325</pub-id></element-citation></ref><ref id="b172-ijmm-56-05-05614"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Du</surname><given-names>FL</given-names></name><name name-style="western"><surname>Huang</surname><given-names>QS</given-names></name><name name-style="western"><surname>Wei</surname><given-names>DD</given-names></name><name name-style="western"><surname>Mei</surname><given-names>YF</given-names></name><name name-style="western"><surname>Long</surname><given-names>D</given-names></name><name name-style="western"><surname>Liao</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Wan</surname><given-names>LG</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name></person-group><article-title>Prevalence of carbapenem-resistant Klebsiella pneumoniae co-harboring blaKPC-carrying plasmid and pLVPK-Like virulence plasmid in bloodstream infections</article-title><source>Front Cell Infect Microbiol</source><volume>10</volume><fpage>556654</fpage><year>2021</year><pub-id pub-id-type="doi">10.3389/fcimb.2020.556654</pub-id><pub-id pub-id-type="pmid">33777826</pub-id><pub-id pub-id-type="pmcid">PMC7996060</pub-id></element-citation></ref><ref id="b173-ijmm-56-05-05614"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otarigho</surname><given-names>B</given-names></name><name name-style="western"><surname>Falade</surname><given-names>MO</given-names></name></person-group><article-title>Computational screening of approved drugs for inhibition of the antibiotic resistance gene mecA in methicillin-resistant Staphylococcus aureus (MRSA) strains</article-title><source>BioTech (Basel)</source><volume>12</volume><fpage>25</fpage><year>2023</year><pub-id pub-id-type="doi">10.3390/biotech12020025</pub-id><pub-id pub-id-type="pmid">37092469</pub-id><pub-id pub-id-type="pmcid">PMC10123713</pub-id></element-citation></ref><ref id="b174-ijmm-56-05-05614"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nikolic</surname><given-names>P</given-names></name><name name-style="western"><surname>Mudgil</surname><given-names>P</given-names></name></person-group><article-title>The cell wall, cell membrane and virulence factors of Staphylococcus aureus and their role in antibiotic resistance</article-title><source>Microorganisms</source><volume>11</volume><fpage>259</fpage><year>2023</year><pub-id pub-id-type="doi">10.3390/microorganisms11020259</pub-id><pub-id pub-id-type="pmid">36838224</pub-id><pub-id pub-id-type="pmcid">PMC9965861</pub-id></element-citation></ref><ref id="b175-ijmm-56-05-05614"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sully</surname><given-names>EK</given-names></name><name name-style="western"><surname>Malachowa</surname><given-names>N</given-names></name><name name-style="western"><surname>Elmore</surname><given-names>BO</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>SM</given-names></name><name name-style="western"><surname>Femling</surname><given-names>JK</given-names></name><name name-style="western"><surname>Gray</surname><given-names>BM</given-names></name><name name-style="western"><surname>DeLeo</surname><given-names>FR</given-names></name><name name-style="western"><surname>Otto</surname><given-names>M</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>AL</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance</article-title><source>PLoS Pathog</source><volume>10</volume><fpage>e1004174</fpage><year>2014</year><pub-id pub-id-type="doi">10.1371/journal.ppat.1004174</pub-id><pub-id pub-id-type="pmid">24945495</pub-id><pub-id pub-id-type="pmcid">PMC4055767</pub-id></element-citation></ref><ref id="b176-ijmm-56-05-05614"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>VFDB 2025: An integrated resource for exploring anti-virulence compounds</article-title><source>Nucleic Acids Res</source><volume>53</volume><issue>D1</issue><fpage>D871</fpage><lpage>D877</lpage><year>2025</year><pub-id pub-id-type="doi">10.1093/nar/gkae968</pub-id><pub-id pub-id-type="pmid">39470738</pub-id><pub-id pub-id-type="pmcid">PMC11701737</pub-id></element-citation></ref><ref id="b177-ijmm-56-05-05614"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abd El-Aleam</surname><given-names>RH</given-names></name><name name-style="western"><surname>George</surname><given-names>RF</given-names></name><name name-style="western"><surname>Georgey</surname><given-names>HH</given-names></name><name name-style="western"><surname>Abdel-Rahman</surname><given-names>HM</given-names></name></person-group><article-title>Bacterial virulence factors: A target for heterocyclic compounds to combat bacterial resistance</article-title><source>RSC Adv</source><volume>11</volume><fpage>36459</fpage><lpage>36482</lpage><year>2021</year><pub-id pub-id-type="doi">10.1039/D1RA06238G</pub-id><pub-id pub-id-type="pmid">35494393</pub-id><pub-id pub-id-type="pmcid">PMC9043591</pub-id></element-citation></ref><ref id="b178-ijmm-56-05-05614"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldsmith</surname><given-names>JA</given-names></name><name name-style="western"><surname>Dewar</surname><given-names>V</given-names></name><name name-style="western"><surname>Hermand</surname><given-names>P</given-names></name><name name-style="western"><surname>Blais</surname><given-names>N</given-names></name><name name-style="western"><surname>McLellan</surname><given-names>JS</given-names></name></person-group><article-title>Structural basis for binding of neutralizing antibodies to Clostridioides difficile binary toxin</article-title><source>J Bacterial</source><volume>205</volume><fpage>e0045622</fpage><year>2023</year><pub-id pub-id-type="doi">10.1128/jb.00456-22</pub-id><pub-id pub-id-type="pmcid">PMC10127577</pub-id><pub-id pub-id-type="pmid">36951574</pub-id></element-citation></ref><ref id="b179-ijmm-56-05-05614"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mangal</surname><given-names>P</given-names></name><name name-style="western"><surname>Jha</surname><given-names>RK</given-names></name><name name-style="western"><surname>Jain</surname><given-names>M</given-names></name><name name-style="western"><surname>Singh</surname><given-names>AK</given-names></name><name name-style="western"><surname>Muthukumaran</surname><given-names>J</given-names></name></person-group><article-title>Identification and prioritization of promising lead molecules from Syzygium aromaticum against sortase C from Streptococcus pyogenes: An in silico investigation</article-title><source>J Biomol Struct Dyn</source><volume>41</volume><fpage>5418</fpage><lpage>5435</lpage><year>2023</year><pub-id pub-id-type="doi">10.1080/07391102.2022.2086921</pub-id><pub-id pub-id-type="pmid">35706070</pub-id></element-citation></ref><ref id="b180-ijmm-56-05-05614"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aljarallah</surname><given-names>KM</given-names></name></person-group><article-title>Conventional and alternative treatment approaches for Clostridium difficile infection</article-title><source>Int J Health Sci (Qassim)</source><volume>11</volume><fpage>1</fpage><lpage>10</lpage><year>2017</year><pub-id pub-id-type="pmcid">PMC5327666</pub-id><pub-id pub-id-type="pmid">28293151</pub-id></element-citation></ref><ref id="b181-ijmm-56-05-05614"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussack</surname><given-names>G</given-names></name><name name-style="western"><surname>Tanha</surname><given-names>J</given-names></name></person-group><article-title>Toxin-specific antibodies for the treatment of Clostridium difficile: Current status and future perspectives</article-title><source>Toxins (Basel)</source><volume>2</volume><fpage>998</fpage><lpage>1018</lpage><year>2010</year><pub-id pub-id-type="doi">10.3390/toxins2050998</pub-id><pub-id pub-id-type="pmid">22069622</pub-id><pub-id pub-id-type="pmcid">PMC3153223</pub-id></element-citation></ref><ref id="b182-ijmm-56-05-05614"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lux</surname><given-names>J</given-names></name><name name-style="western"><surname>Portmann</surname><given-names>H</given-names></name><name name-style="western"><surname>S&#225;nchez Garc&#237;a</surname><given-names>L</given-names></name><name name-style="western"><surname>Erhardt</surname><given-names>M</given-names></name><name name-style="western"><surname>Holivololona</surname><given-names>L</given-names></name><name name-style="western"><surname>Laloli</surname><given-names>L</given-names></name><name name-style="western"><surname>Licheri</surname><given-names>MF</given-names></name><name name-style="western"><surname>Gallay</surname><given-names>C</given-names></name><name name-style="western"><surname>Hoepner</surname><given-names>R</given-names></name><name name-style="western"><surname>Croucher</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>Klebsiella pneumoniae peptide hijacks a Streptococcus pneumoniae permease to subvert pneumococcal growth and colonization</article-title><source>Commun Boil</source><volume>7</volume><fpage>425</fpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s42003-024-06113-9</pub-id><pub-id pub-id-type="pmcid">PMC11001997</pub-id><pub-id pub-id-type="pmid">38589539</pub-id></element-citation></ref><ref id="b183-ijmm-56-05-05614"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>W</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Ye</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Dong</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Simplified Helicobacter pylori therapy for patients with penicillin allergy: A randomised controlled trial of vonoprazan-tetracycline dual therapy</article-title><source>Gut</source><volume>73</volume><fpage>1414</fpage><lpage>1420</lpage><year>2024</year><pub-id pub-id-type="doi">10.1136/gutjnl-2024-332640</pub-id><pub-id pub-id-type="pmid">38906695</pub-id><pub-id pub-id-type="pmcid">PMC11347262</pub-id></element-citation></ref><ref id="b184-ijmm-56-05-05614"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerding</surname><given-names>DN</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S</given-names></name><name name-style="western"><surname>Rupnik</surname><given-names>M</given-names></name><name name-style="western"><surname>Aktories</surname><given-names>K</given-names></name></person-group><article-title>Clostridium difficile binary toxin CDT: Mechanism, epidemiology, and potential clinical importance</article-title><source>Gut Microbes</source><volume>5</volume><fpage>15</fpage><lpage>27</lpage><year>2014</year><pub-id pub-id-type="doi">10.4161/gmic.26854</pub-id><pub-id pub-id-type="pmid">24253566</pub-id><pub-id pub-id-type="pmcid">PMC4049931</pub-id></element-citation></ref><ref id="b185-ijmm-56-05-05614"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamaguchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Terao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mori</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hamada</surname><given-names>S</given-names></name><name name-style="western"><surname>Kawabata</surname><given-names>S</given-names></name></person-group><article-title>PfbA, a novel plasmin- and fibronectin-binding protein of Streptococcus pneumoniae, contributes to fibronectin-dependent adhesion and antiphagocytosis</article-title><source>J Biol Chem</source><volume>283</volume><fpage>36272</fpage><lpage>36279</lpage><year>2008</year><pub-id pub-id-type="doi">10.1074/jbc.M807087200</pub-id><pub-id pub-id-type="pmid">18974092</pub-id><pub-id pub-id-type="pmcid">PMC2662297</pub-id></element-citation></ref><ref id="b186-ijmm-56-05-05614"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name><name name-style="western"><surname>Xie</surname><given-names>S</given-names></name><name name-style="western"><surname>Huang</surname><given-names>K</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Ultrasound-activated persistent luminescence imaging and bacteria-triggered drug release for Helicobacter pylori infection theranostics</article-title><source>ACS Appl Mater Interfaces</source><volume>14</volume><fpage>26418</fpage><lpage>26430</lpage><year>2022</year><pub-id pub-id-type="doi">10.1021/acsami.2c04683</pub-id><pub-id pub-id-type="pmid">40708133</pub-id></element-citation></ref><ref id="b187-ijmm-56-05-05614"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>TY</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>JT</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>JR</given-names></name><name name-style="western"><surname>Lan</surname><given-names>CH</given-names></name></person-group><article-title>High dose PPI-amoxicillin dual therapy for the treatment of Helicobacter pylori infection: A systematic review with meta-analysis</article-title><source>Therap Adv Gastroenterol</source><volume>13</volume><fpage>1756284820937115</fpage><year>2020</year><pub-id pub-id-type="doi">10.1177/1756284820937115</pub-id><pub-id pub-id-type="pmid">33110448</pub-id><pub-id pub-id-type="pmcid">PMC7559363</pub-id></element-citation></ref><ref id="b188-ijmm-56-05-05614"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barakat</surname><given-names>SH</given-names></name><name name-style="western"><surname>Hanafy</surname><given-names>HM</given-names></name><name name-style="western"><surname>Guimei</surname><given-names>M</given-names></name><name name-style="western"><surname>Elsawy</surname><given-names>EH</given-names></name><name name-style="western"><surname>Khalil</surname><given-names>AFM</given-names></name></person-group><article-title>Different regimens for eradication of Helicobacter pylori infection in children: A randomized controlled trial</article-title><source>Eur J Pediatr</source><volume>184</volume><fpage>13</fpage><year>2024</year><pub-id pub-id-type="doi">10.1007/s00431-024-05833-8</pub-id><pub-id pub-id-type="pmid">39546028</pub-id><pub-id pub-id-type="pmcid">PMC11568052</pub-id></element-citation></ref><ref id="b189-ijmm-56-05-05614"><label>189</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thi</surname><given-names>MTT</given-names></name><name name-style="western"><surname>Wibowo</surname><given-names>D</given-names></name><name name-style="western"><surname>Rehm</surname><given-names>BHA</given-names></name></person-group><article-title>Pseudomonas aeruginosa biofilms</article-title><source>Int J Mol Sci</source><volume>21</volume><fpage>8671</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/ijms21228671</pub-id><pub-id pub-id-type="pmid">33212950</pub-id><pub-id pub-id-type="pmcid">PMC7698413</pub-id></element-citation></ref><ref id="b190-ijmm-56-05-05614"><label>190</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kamel</surname><given-names>NA</given-names></name><name name-style="western"><surname>Tohamy</surname><given-names>ST</given-names></name><name name-style="western"><surname>Alshahrani</surname><given-names>MY</given-names></name><name name-style="western"><surname>Aboshanab</surname><given-names>KM</given-names></name></person-group><article-title>Evaluation of fortimicin antibiotic combinations against MDR Pseudomonas aeruginosa and resistome analysis of a whole genome sequenced pan-drug resistant isolate</article-title><source>BMC Microbiol</source><volume>24</volume><fpage>164</fpage><year>2024</year><pub-id pub-id-type="doi">10.1186/s12866-024-03316-2</pub-id><pub-id pub-id-type="pmid">38745145</pub-id><pub-id pub-id-type="pmcid">PMC11092080</pub-id></element-citation></ref><ref id="b191-ijmm-56-05-05614"><label>191</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lamppa</surname><given-names>JW</given-names></name><name name-style="western"><surname>Griswold</surname><given-names>KE</given-names></name></person-group><article-title>Alginate lyase exhibits catalysis-independent biofilm dispersion and antibiotic synergy</article-title><source>Antimicrob Agents Chemother</source><volume>57</volume><fpage>137</fpage><lpage>145</lpage><year>2013</year><pub-id pub-id-type="doi">10.1128/AAC.01789-12</pub-id><pub-id pub-id-type="pmid">23070175</pub-id><pub-id pub-id-type="pmcid">PMC3535929</pub-id></element-citation></ref><ref id="b192-ijmm-56-05-05614"><label>192</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pleszczy&#324;ska</surname><given-names>M</given-names></name><name name-style="western"><surname>Wiater</surname><given-names>A</given-names></name><name name-style="western"><surname>Janczarek</surname><given-names>M</given-names></name><name name-style="western"><surname>Szczodrak</surname><given-names>J</given-names></name></person-group><article-title>(1&#8594;3)-&#945;-D-Glucan hydrolases in dental biofilm prevention and control: A review</article-title><source>Int J Biol Macromol</source><volume>79</volume><fpage>761</fpage><lpage>778</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2015.05.052</pub-id><pub-id pub-id-type="pmid">26047901</pub-id></element-citation></ref><ref id="b193-ijmm-56-05-05614"><label>193</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Majhi</surname><given-names>A</given-names></name><name name-style="western"><surname>Adhikary</surname><given-names>R</given-names></name><name name-style="western"><surname>Bhattacharyya</surname><given-names>A</given-names></name><name name-style="western"><surname>Mahanti</surname><given-names>S</given-names></name><name name-style="western"><surname>Bishayi</surname><given-names>B</given-names></name></person-group><article-title>Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin</article-title><source>Antimicrob Agents Chemother</source><volume>58</volume><fpage>5164</fpage><lpage>5180</lpage><year>2014</year><pub-id pub-id-type="doi">10.1128/AAC.03245-14</pub-id><pub-id pub-id-type="pmid">24957840</pub-id><pub-id pub-id-type="pmcid">PMC4135890</pub-id></element-citation></ref><ref id="b194-ijmm-56-05-05614"><label>194</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walls</surname><given-names>AC</given-names></name><name name-style="western"><surname>Park</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Tortorici</surname><given-names>MA</given-names></name><name name-style="western"><surname>Wall</surname><given-names>A</given-names></name><name name-style="western"><surname>McGuire</surname><given-names>AT</given-names></name><name name-style="western"><surname>Veesler</surname><given-names>D</given-names></name></person-group><article-title>Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein</article-title><source>Cell</source><volume>181</volume><fpage>281</fpage><lpage>292.e6</lpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.cell.2020.02.058</pub-id><pub-id pub-id-type="pmid">32155444</pub-id><pub-id pub-id-type="pmcid">PMC7102599</pub-id></element-citation></ref><ref id="b195-ijmm-56-05-05614"><label>195</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cipriani</surname><given-names>G</given-names></name><name name-style="western"><surname>Helmersen</surname><given-names>K</given-names></name><name name-style="western"><surname>Mazzon</surname><given-names>RR</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>G</given-names></name><name name-style="western"><surname>Aamot</surname><given-names>HV</given-names></name><name name-style="western"><surname>Ferreira</surname><given-names>FA</given-names></name></person-group><article-title>Evaluation of whole-genome sequencing protocols for detection of antimicrobial resistance, virulence factors and mobile genetic elements in antimicrobial-resistant bacteria</article-title><source>J Med Microbiol</source><volume>74</volume><fpage>001990</fpage><year>2025</year><pub-id pub-id-type="doi">10.1099/jmm.0.001990</pub-id><pub-id pub-id-type="pmid">40105741</pub-id><pub-id pub-id-type="pmcid">PMC11923095</pub-id></element-citation></ref><ref id="b196-ijmm-56-05-05614"><label>196</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szoboszlay</surname><given-names>M</given-names></name><name name-style="western"><surname>Schramm</surname><given-names>L</given-names></name><name name-style="western"><surname>Pinzauti</surname><given-names>D</given-names></name><name name-style="western"><surname>Scerri</surname><given-names>J</given-names></name><name name-style="western"><surname>Sandionigi</surname><given-names>A</given-names></name><name name-style="western"><surname>Biazzo</surname><given-names>M</given-names></name></person-group><article-title>Nanopore is preferable over illumina for 16S amplicon sequencing of the gut microbiota when species-level taxonomic classification, accurate estimation of richness, or focus on rare taxa is required</article-title><source>Microorganisms</source><volume>11</volume><fpage>804</fpage><year>2023</year><pub-id pub-id-type="doi">10.3390/microorganisms11030804</pub-id><pub-id pub-id-type="pmid">36985377</pub-id><pub-id pub-id-type="pmcid">PMC10059749</pub-id></element-citation></ref><ref id="b197-ijmm-56-05-05614"><label>197</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>A</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Mulder</surname><given-names>J</given-names></name><name name-style="western"><surname>Heyn</surname><given-names>H</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name></person-group><article-title>Spatiotemporal omics for biology and medicine</article-title><source>Cell</source><volume>187</volume><fpage>4488</fpage><lpage>4519</lpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.cell.2024.07.040</pub-id><pub-id pub-id-type="pmid">39178830</pub-id></element-citation></ref><ref id="b198-ijmm-56-05-05614"><label>198</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>KD</given-names></name><name name-style="western"><surname>Kong</surname><given-names>DC</given-names></name><name name-style="western"><surname>Ye</surname><given-names>JF</given-names></name></person-group><article-title>Advances in phage display based nano immunosensors for cholera toxin</article-title><source>Front Immunol</source><volume>14</volume><fpage>1224397</fpage><year>2023</year><pub-id pub-id-type="doi">10.3389/fimmu.2023.1224397</pub-id><pub-id pub-id-type="pmid">37781379</pub-id><pub-id pub-id-type="pmcid">PMC10534012</pub-id></element-citation></ref><ref id="b199-ijmm-56-05-05614"><label>199</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D</given-names></name><name name-style="western"><surname>Seo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Jung</surname><given-names>HG</given-names></name><name name-style="western"><surname>Jang</surname><given-names>JW</given-names></name><name name-style="western"><surname>Park</surname><given-names>D</given-names></name><name name-style="western"><surname>Kim</surname><given-names>I</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>G</given-names></name><name name-style="western"><surname>Hwang</surname><given-names>KS</given-names></name><etal/></person-group><article-title>Caco-2 cell-derived biomimetic electrochemical biosensor for cholera toxin detection</article-title><source>Biosens Bioelectron</source><volume>226</volume><fpage>115105</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.bios.2023.115105</pub-id><pub-id pub-id-type="pmid">36746024</pub-id></element-citation></ref><ref id="b200-ijmm-56-05-05614"><label>200</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saha</surname><given-names>A</given-names></name><name name-style="western"><surname>Dixit</surname><given-names>NM</given-names></name></person-group><article-title>Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection</article-title><source>PLoS Comput Biol</source><volume>16</volume><fpage>e1008434</fpage><year>2020</year><pub-id pub-id-type="doi">10.1371/journal.pcbi.1008434</pub-id><pub-id pub-id-type="pmid">33253162</pub-id><pub-id pub-id-type="pmcid">PMC7728175</pub-id></element-citation></ref><ref id="b201-ijmm-56-05-05614"><label>201</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammadipour</surname><given-names>S</given-names></name><name name-style="western"><surname>Tavakkoli</surname><given-names>H</given-names></name><name name-style="western"><surname>Fatemi</surname><given-names>SN</given-names></name><name name-style="western"><surname>Sharifi</surname><given-names>A</given-names></name><name name-style="western"><surname>Mahmoudi</surname><given-names>P</given-names></name></person-group><article-title>Designing a multi-epitope universal vaccine for concurrent infections of SARS-CoV-2 and influenza viruses using an immunoinformatics approach</article-title><source>BMC Infect Dis</source><volume>25</volume><fpage>688</fpage><year>2025</year><pub-id pub-id-type="doi">10.1186/s12879-025-11066-3</pub-id><pub-id pub-id-type="pmid">40348967</pub-id><pub-id pub-id-type="pmcid">PMC12065216</pub-id></element-citation></ref><ref id="b202-ijmm-56-05-05614"><label>202</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewitus</surname><given-names>E</given-names></name><name name-style="western"><surname>Hoang</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Bai</surname><given-names>H</given-names></name><name name-style="western"><surname>Rolland</surname><given-names>M</given-names></name></person-group><article-title>Optimal sequence-based design for multi-antigen HIV-1 vaccines using minimally distant antigens</article-title><source>PLoS Comput Biol</source><volume>18</volume><fpage>e1010624</fpage><year>2022</year><pub-id pub-id-type="doi">10.1371/journal.pcbi.1010624</pub-id><pub-id pub-id-type="pmid">36315492</pub-id><pub-id pub-id-type="pmcid">PMC9621458</pub-id></element-citation></ref><ref id="b203-ijmm-56-05-05614"><label>203</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pierce</surname><given-names>CG</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>AK</given-names></name><name name-style="western"><surname>Lazzell</surname><given-names>AL</given-names></name><name name-style="western"><surname>Powell</surname><given-names>AT</given-names></name><name name-style="western"><surname>Saville</surname><given-names>SP</given-names></name><name name-style="western"><surname>McHardy</surname><given-names>SF</given-names></name><name name-style="western"><surname>Lopez-Ribot</surname><given-names>JL</given-names></name></person-group><article-title>A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance</article-title><source>NPJ Biofilms Microbiomes</source><volume>1</volume><fpage>15012</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/npjbiofilms.2015.12</pub-id><pub-id pub-id-type="pmid">26691764</pub-id><pub-id pub-id-type="pmcid">PMC4681527</pub-id></element-citation></ref><ref id="b204-ijmm-56-05-05614"><label>204</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobs</surname><given-names>SE</given-names></name><name name-style="western"><surname>Zagaliotis</surname><given-names>P</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>TJ</given-names></name></person-group><article-title>Novel antifungal agents in clinical trials</article-title><source>F1000Res</source><volume>10</volume><fpage>507</fpage><year>2021</year><pub-id pub-id-type="doi">10.12688/f1000research.28327.1</pub-id><pub-id pub-id-type="pmid">35136573</pub-id><pub-id pub-id-type="pmcid">PMC8787557</pub-id></element-citation></ref><ref id="b205-ijmm-56-05-05614"><label>205</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ernst</surname><given-names>O</given-names></name><name name-style="western"><surname>Manes</surname><given-names>NP</given-names></name><name name-style="western"><surname>Oyler</surname><given-names>BL</given-names></name><name name-style="western"><surname>Fraser</surname><given-names>IDC</given-names></name><name name-style="western"><surname>Goodlett</surname><given-names>DR</given-names></name><name name-style="western"><surname>Nita-Lazar</surname><given-names>A</given-names></name></person-group><article-title>Multi-omics strategies uncover host-pathogen interactions</article-title><source>ACS Infect Dis</source><volume>5</volume><fpage>493</fpage><lpage>505</lpage><year>2019</year><pub-id pub-id-type="doi">10.1021/acsinfecdis.9b00080</pub-id><pub-id pub-id-type="pmid">30857388</pub-id></element-citation></ref><ref id="b206-ijmm-56-05-05614"><label>206</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>T</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>You</surname><given-names>X</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H</given-names></name></person-group><article-title>Nanosuspension as an efficient carrier for improved ocular permeation of voriconazole</article-title><source>Curr Pharm Biotechnol</source><volume>22</volume><fpage>245</fpage><lpage>253</lpage><year>2021</year><pub-id pub-id-type="doi">10.2174/1389201021999200820154918</pub-id><pub-id pub-id-type="pmid">32867650</pub-id></element-citation></ref><ref id="b207-ijmm-56-05-05614"><label>207</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrade</surname><given-names>LM</given-names></name><name name-style="western"><surname>Rocha</surname><given-names>KAD</given-names></name><name name-style="western"><surname>De S&#225;</surname><given-names>FAP</given-names></name><name name-style="western"><surname>Marreto</surname><given-names>RN</given-names></name><name name-style="western"><surname>Lima</surname><given-names>EM</given-names></name><name name-style="western"><surname>Gratieri</surname><given-names>T</given-names></name><name name-style="western"><surname>Taveira</surname><given-names>SF</given-names></name></person-group><article-title>Voriconazole-loaded nanostructured lipid carriers for ocular drug delivery</article-title><source>Cornea</source><volume>35</volume><fpage>866</fpage><lpage>871</lpage><year>2016</year><pub-id pub-id-type="doi">10.1097/ICO.0000000000000825</pub-id><pub-id pub-id-type="pmid">27055213</pub-id></element-citation></ref><ref id="b208-ijmm-56-05-05614"><label>208</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jumper</surname><given-names>J</given-names></name><name name-style="western"><surname>Evans</surname><given-names>R</given-names></name><name name-style="western"><surname>Pritzel</surname><given-names>A</given-names></name><name name-style="western"><surname>Green</surname><given-names>T</given-names></name><name name-style="western"><surname>Figurnov</surname><given-names>M</given-names></name><name name-style="western"><surname>Ronneberger</surname><given-names>O</given-names></name><name name-style="western"><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name name-style="western"><surname>Bates</surname><given-names>R</given-names></name><name name-style="western"><surname>&#381;&#237;dek</surname><given-names>A</given-names></name><name name-style="western"><surname>Potapenko</surname><given-names>A</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><year>2021</year><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id><pub-id pub-id-type="pmcid">PMC8371605</pub-id></element-citation></ref><ref id="b209-ijmm-56-05-05614"><label>209</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goyette-Desjardins</surname><given-names>G</given-names></name><name name-style="western"><surname>Calzas</surname><given-names>C</given-names></name><name name-style="western"><surname>Shiao</surname><given-names>TC</given-names></name><name name-style="western"><surname>Neubauer</surname><given-names>A</given-names></name><name name-style="western"><surname>Kempker</surname><given-names>J</given-names></name><name name-style="western"><surname>Roy</surname><given-names>R</given-names></name><name name-style="western"><surname>Gottschalk</surname><given-names>M</given-names></name><name name-style="western"><surname>Segura</surname><given-names>M</given-names></name></person-group><article-title>Protection against streptococcus suis serotype 2 infection using a capsular polysaccharide glycoconjugate vaccine</article-title><source>Infect Immun</source><volume>84</volume><fpage>2059</fpage><lpage>2075</lpage><year>2016</year><pub-id pub-id-type="doi">10.1128/IAI.00139-16</pub-id><pub-id pub-id-type="pmid">27113360</pub-id><pub-id pub-id-type="pmcid">PMC4936365</pub-id></element-citation></ref><ref id="b210-ijmm-56-05-05614"><label>210</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stacey</surname><given-names>HL</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>J</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>JT</given-names></name><name name-style="western"><surname>Williams-Diaz</surname><given-names>A</given-names></name><name name-style="western"><surname>Gakhar</surname><given-names>V</given-names></name><name name-style="western"><surname>Sterling</surname><given-names>TM</given-names></name><name name-style="western"><surname>Acosta</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>KM</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Pedley</surname><given-names>A</given-names></name><etal/></person-group><article-title>Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults</article-title><source>Hum Vaccin Immunother</source><volume>15</volume><fpage>530</fpage><lpage>539</lpage><year>2019</year><pub-id pub-id-type="doi">10.1080/21645515.2018.1532249</pub-id><pub-id pub-id-type="pmid">30648919</pub-id><pub-id pub-id-type="pmcid">PMC6605726</pub-id></element-citation></ref><ref id="b211-ijmm-56-05-05614"><label>211</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Helaine</surname><given-names>S</given-names></name><name name-style="western"><surname>Cheverton</surname><given-names>AM</given-names></name><name name-style="western"><surname>Watson</surname><given-names>KG</given-names></name><name name-style="western"><surname>Faure</surname><given-names>LM</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>SA</given-names></name><name name-style="western"><surname>Holden</surname><given-names>DW</given-names></name></person-group><article-title>Internalization of Salmonella by macrophages induces formation of nonreplicating persisters</article-title><source>Science</source><volume>343</volume><fpage>204</fpage><lpage>208</lpage><year>2014</year><pub-id pub-id-type="doi">10.1126/science.1244705</pub-id><pub-id pub-id-type="pmid">24408438</pub-id><pub-id pub-id-type="pmcid">PMC6485627</pub-id></element-citation></ref><ref id="b212-ijmm-56-05-05614"><label>212</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gencay</surname><given-names>YE</given-names></name><name name-style="western"><surname>Jasinskyt&#279;</surname><given-names>D</given-names></name><name name-style="western"><surname>Robert</surname><given-names>C</given-names></name><name name-style="western"><surname>Semsey</surname><given-names>S</given-names></name><name name-style="western"><surname>Mart&#237;nez</surname><given-names>V</given-names></name><name name-style="western"><surname>Petersen</surname><given-names>AQ</given-names></name><name name-style="western"><surname>Brunner</surname><given-names>K</given-names></name><name name-style="western"><surname>de Santiago Torio</surname><given-names>A</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>A</given-names></name><name name-style="western"><surname>Turcu</surname><given-names>IC</given-names></name><etal/></person-group><article-title>Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice</article-title><source>Nat Biotechnol</source><volume>42</volume><fpage>265</fpage><lpage>274</lpage><year>2024</year><pub-id pub-id-type="doi">10.1038/s41587-023-01759-y</pub-id><pub-id pub-id-type="pmid">37142704</pub-id><pub-id pub-id-type="pmcid">PMC10869271</pub-id></element-citation></ref><ref id="b213-ijmm-56-05-05614"><label>213</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scheaffer</surname><given-names>SM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D</given-names></name><name name-style="western"><surname>Whitener</surname><given-names>B</given-names></name><name name-style="western"><surname>Ying</surname><given-names>B</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name><name name-style="western"><surname>Liang</surname><given-names>CY</given-names></name><name name-style="western"><surname>Jani</surname><given-names>H</given-names></name><name name-style="western"><surname>Martin</surname><given-names>P</given-names></name><name name-style="western"><surname>Amato</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Avena</surname><given-names>LE</given-names></name><etal/></person-group><article-title>Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice</article-title><source>Nat Med</source><volume>29</volume><fpage>247</fpage><lpage>257</lpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41591-022-02092-8</pub-id><pub-id pub-id-type="pmid">36265510</pub-id><pub-id pub-id-type="pmcid">PMC11752949</pub-id></element-citation></ref><ref id="b214-ijmm-56-05-05614"><label>214</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><name name-style="western"><surname>He</surname><given-names>X</given-names></name><name name-style="western"><surname>Shi</surname><given-names>H</given-names></name><name name-style="western"><surname>He</surname><given-names>C</given-names></name><name name-style="western"><surname>Lei</surname><given-names>H</given-names></name><name name-style="western"><surname>He</surname><given-names>H</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Shen</surname><given-names>G</given-names></name><name name-style="western"><surname>Yang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages</article-title><source>Signal Transduct Target Ther</source><volume>10</volume><fpage>47</fpage><year>2025</year><pub-id pub-id-type="doi">10.1038/s41392-025-02139-5</pub-id><pub-id pub-id-type="pmid">39870636</pub-id><pub-id pub-id-type="pmcid">PMC11772742</pub-id></element-citation></ref><ref id="b215-ijmm-56-05-05614"><label>215</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Edwards</surname><given-names>JE</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Schwartz</surname><given-names>MM</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>CS</given-names></name><name name-style="western"><surname>Sobel</surname><given-names>JD</given-names></name><name name-style="western"><surname>Nyirjesy</surname><given-names>P</given-names></name><name name-style="western"><surname>Schodel</surname><given-names>F</given-names></name><name name-style="western"><surname>Marchus</surname><given-names>E</given-names></name><name name-style="western"><surname>Lizakowski</surname><given-names>M</given-names></name><name name-style="western"><surname>DeMontigny</surname><given-names>EA</given-names></name><name name-style="western"><surname>Hoeg</surname><given-names>J</given-names></name><etal/></person-group><article-title>A fungal immunotherapeutic vaccine (NDV-3A) for treatment of recurrent vulvovaginal candidiasis-A phase 2 randomized, double-blind, placebo-controlled trial</article-title><source>Clin Infect Dis</source><volume>66</volume><fpage>1928</fpage><lpage>1936</lpage><year>2018</year><pub-id pub-id-type="doi">10.1093/cid/ciy185</pub-id><pub-id pub-id-type="pmid">29697768</pub-id><pub-id pub-id-type="pmcid">PMC5982716</pub-id></element-citation></ref><ref id="b216-ijmm-56-05-05614"><label>216</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>FS</given-names></name><name name-style="western"><surname>Varmus</surname><given-names>H</given-names></name></person-group><article-title>A new initiative on precision medicine</article-title><source>N Engl J Med</source><volume>372</volume><fpage>793</fpage><lpage>795</lpage><year>2015</year><pub-id pub-id-type="doi">10.1056/NEJMp1500523</pub-id><pub-id pub-id-type="pmid">25635347</pub-id><pub-id pub-id-type="pmcid">PMC5101938</pub-id></element-citation></ref><ref id="b217-ijmm-56-05-05614"><label>217</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naithani</surname><given-names>N</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>S</given-names></name><name name-style="western"><surname>Misra</surname><given-names>P</given-names></name><name name-style="western"><surname>Vasudevan</surname><given-names>B</given-names></name><name name-style="western"><surname>Sahu</surname><given-names>R</given-names></name></person-group><article-title>Precision medicine: Concept and tools</article-title><source>Med J Armed Forces India</source><volume>77</volume><fpage>249</fpage><lpage>257</lpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.mjafi.2021.06.021</pub-id><pub-id pub-id-type="pmid">34305276</pub-id><pub-id pub-id-type="pmcid">PMC8282508</pub-id></element-citation></ref><ref id="b218-ijmm-56-05-05614"><label>218</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>KB</given-names></name><name name-style="western"><surname>Wei</surname><given-names>WQ</given-names></name><name name-style="western"><surname>Weeraratne</surname><given-names>D</given-names></name><name name-style="western"><surname>Frisse</surname><given-names>ME</given-names></name><name name-style="western"><surname>Misulis</surname><given-names>K</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>K</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>J</given-names></name><name name-style="western"><surname>Snowdon</surname><given-names>JL</given-names></name></person-group><article-title>Precision medicine, AI, and the future of personalized health care</article-title><source>Clin Transl Sci</source><volume>14</volume><fpage>86</fpage><lpage>93</lpage><year>2021</year><pub-id pub-id-type="doi">10.1111/cts.12884</pub-id><pub-id pub-id-type="pmid">32961010</pub-id><pub-id pub-id-type="pmcid">PMC7877825</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="f1-ijmm-56-05-05614" orientation="portrait"><label>Figure 1</label><caption><p>Mechanisms of action of various virulence genes. FimH (type 1 fimbrial adhesin), FnbA (fibronectin-binding protein A), IpaBCD (invasion plasmid antigens B, C and D), CtxAB (cholera toxin subunits A and B), CPS (capsular polysaccharide synthesis locus), and In1 (internalin-like invasion factor). FimH mediates mannose-based adhesion of <italic toggle="yes">E. coli</italic> to uroepithelium; FnbA anchors <italic toggle="yes">Staphylococcus aureus</italic> to fibronectin for tissue invasion; IpaBCD drives <italic toggle="yes">Shigella</italic> entry via actin remodeling; CtxAB triggers chloride/water efflux causing diarrhea; Botulinum toxin blocks acetylcholine release producing flaccid paralysis; InlA/InlB enable <italic toggle="yes">Listeria</italic> to cross intestinal epithelia; CPS forms <italic toggle="yes">pneumococcal</italic> capsules that resist phagocytosis; together they exemplify adhesion, invasion, immune evasion and toxin production.</p></caption><graphic position="float" orientation="portrait" xlink:href="ijmm-56-05-05614-g00.jpg"/></fig><fig position="float" id="f2-ijmm-56-05-05614" orientation="portrait"><label>Figure 2</label><caption><p>Mechanisms underlying the association between virulence genes and drug resistance. Tn554 (staphylococcal transposon 554), IncF (incompatibility group F plasmid), Pel (Pel polysaccharide synthesis locus), Psl (Pseudomonas surface polysaccharide locus). Tn554 and IncF act as mobile genetic elements that co-transfer virulence and antibiotic-resistance genes, accelerating spread. Pel and Psl encode exopolysaccharides needed for <italic toggle="yes">Pseudomonas aeruginosa</italic> biofilm formation; once the matrix is built, antibiotics penetrate poorly and resistance determinants are amplified within the protected community.</p></caption><graphic position="float" orientation="portrait" xlink:href="ijmm-56-05-05614-g01.jpg"/></fig><table-wrap position="float" id="tI-ijmm-56-05-05614" orientation="portrait"><label>Table I</label><caption><p>Functional classification of virulence genes in bacterial, viral and fungal pathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" rowspan="1" colspan="1">Category</th><th valign="top" align="center" rowspan="1" colspan="1">Function</th><th valign="top" align="center" rowspan="1" colspan="1">Examples</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Goldsmith <italic toggle="yes">et al</italic>, 2023; Gerding <italic toggle="yes">et al</italic>, 2014</td><td valign="top" align="left" rowspan="1" colspan="1">Toxin genes</td><td valign="top" align="left" rowspan="1" colspan="1">Encode toxins that disrupt host cell integrity and physiological function or induce tissue damage</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">ctxAB</italic> of <italic toggle="yes">Vibrio cholerae</italic> causes severe diarrhea and electrolyte imbalance; botulinum toxin of <italic toggle="yes">Clostridium botulinum</italic> is a neurotoxin blocking neurotransmitter release; <italic toggle="yes">TcdA</italic> and <italic toggle="yes">TcdB</italic> of <italic toggle="yes">Clostridioides difficile</italic> are enterotoxins inducing colonic inflammation and epithelial damage</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>,<xref rid="b184-ijmm-56-05-05614" ref-type="bibr">184</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ullah <italic toggle="yes">et al</italic>, 2023; Speziale <italic toggle="yes">et al</italic>, 2020; Bing <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Adhesin genes</td><td valign="top" align="left" rowspan="1" colspan="1">Mediate pathogen attachment to host cell receptors, facilitating colonization and invasion</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">fimH</italic> of <italic toggle="yes">Escherichia coli</italic> is a type 1 fimbrial tip protein that binds urinary epithelial mannose receptors; <italic toggle="yes">fnbA</italic> and <italic toggle="yes">fnbB</italic> of <italic toggle="yes">Staphylococcus aureus</italic> are fibronectin-binding proteins that enhance tissue adhesion; <italic toggle="yes">ALS3</italic> of <italic toggle="yes">Candida auris</italic> is a hyphal adhesin that promotes biofilm formation on medical devices</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>,<xref rid="b24-ijmm-56-05-05614" ref-type="bibr">24</xref>,<xref rid="b74-ijmm-56-05-05614" ref-type="bibr">74</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Watanabe <italic toggle="yes">et al</italic>, 2024; Yang <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Invasion genes</td><td valign="top" align="left" rowspan="1" colspan="1">Enable pathogens to breach host barriers and invade tissues or cells</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">ipaBCD</italic> of <italic toggle="yes">Shigella</italic> encodes <italic toggle="yes">T3SS</italic> effectors (<italic toggle="yes">ipaB</italic>, <italic toggle="yes">ipaC</italic>, <italic toggle="yes">ipaD</italic>) that mediate both adhesion to and invasion of intestinal epithelial cells.; <italic toggle="yes">inlA</italic> and <italic toggle="yes">inlB</italic> of <italic toggle="yes">Listeria monocytogenes</italic> are internalins mediating host cell entry via E-cadherin; <italic toggle="yes">T3SS</italic> (<italic toggle="yes">esc</italic> cluster) of enteropathogenic <italic toggle="yes">Escherichia coli</italic> injects effector Tir to induce actin pedestal formation</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b94-ijmm-56-05-05614" ref-type="bibr">94</xref>,<xref rid="b27-ijmm-56-05-05614" ref-type="bibr">27</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chun <italic toggle="yes">et al</italic>, 2023; Liang <italic toggle="yes">et al</italic>, 2024; Lin <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Immune evasion genes</td><td valign="top" align="left" rowspan="1" colspan="1">Interfere with immune recognition, suppress host defense or evade clearance mechanisms</td><td valign="top" align="left" rowspan="1" colspan="1">In <italic toggle="yes">Streptococcus pneumoniae</italic>, the capsular polysaccharide synthesis gene inhibits phagocytosis; UL49.5 of herpes viruses blocks antigen presentation by host MHC-I; EFG1 of <italic toggle="yes">Candida albicans</italic> regulates hyphal transition and <italic toggle="yes">SAP</italic> protease secretion to degrade host antimicrobial peptides</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b28-ijmm-56-05-05614" ref-type="bibr">28</xref>,<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>,<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-ijmm-56-05-05614"><p><italic toggle="yes">ctxAB</italic>, <italic toggle="yes">cholera</italic> toxin A-B subunit; Tcd, <italic toggle="yes">Clostridioides difficile</italic> toxins; <italic toggle="yes">fimH</italic>, type 1 fimbrial adhesin; fnb, fibronectin-binding protein; <italic toggle="yes">ALS3</italic>, agglutinin-like sequence 3; <italic toggle="yes">ipaBCD</italic>, invasion plasmid antigens B, C and D; T3SS, type III secretion system; inl, internalin; <italic toggle="yes">esc</italic>, enteropathogenic secretion genes; Tir, translocated intimin receptor; UL49.5, herpesvirus UL49.5 protein; MHC-I, major histocompatibility complex class I; Efg, enhanced filamentous growth protein; SAP, secreted aspartyl protease.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tII-ijmm-56-05-05614" orientation="portrait"><label>Table II</label><caption><p>Mechanisms of action of virulence genes in pathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="9" valign="top" align="left" rowspan="1">A, Bacteria
<hr/></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" rowspan="1" colspan="1">Virulence gene</th><th valign="top" align="center" rowspan="1" colspan="1">Mechanism</th><th valign="top" align="center" rowspan="1" colspan="1">Impact on host cells</th><th valign="top" align="center" rowspan="1" colspan="1">Impact on the intracellular environment</th><th valign="top" align="center" rowspan="1" colspan="1">Impact on host tissues</th><th valign="top" align="center" rowspan="1" colspan="1">Immune evasion strategy</th><th valign="top" align="center" rowspan="1" colspan="1">Host immune driver</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Yang <italic toggle="yes">et al</italic>, 2023; Schnappinger <italic toggle="yes">et al</italic>, 2003; Rahlwes <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">EPEC <italic toggle="yes">esc/eae</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">T3SS</italic> injects effectors (such as <italic toggle="yes">Tir</italic>), inducing actin rearrangement and pedestal formation</td><td valign="top" align="left" rowspan="1" colspan="1">Cytoskeletal disruption and tight junction damage</td><td valign="top" align="left" rowspan="1" colspan="1">Hijacks host signaling pathways (Rho GTPases)</td><td valign="top" align="left" rowspan="1" colspan="1">Disrupts intestinal barrier, causing diarrhea</td><td valign="top" align="left" rowspan="1" colspan="1">Molecular mimicry of host signals</td><td valign="top" align="left" rowspan="1" colspan="1">TNF-&#945;/IFN-&#947; from mucosal inflammation triggers effector secretion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b27-ijmm-56-05-05614" ref-type="bibr">27</xref>,<xref rid="b33-ijmm-56-05-05614" ref-type="bibr">33</xref>,<xref rid="b86-ijmm-56-05-05614" ref-type="bibr">86</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Korshoj <italic toggle="yes">et al</italic>, 2024; Peng <italic toggle="yes">et al</italic>, 2022; Li <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus agr/ica</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">agr</italic> quorum sensing regulate toxin (<italic toggle="yes">hla</italic>) and biofilm (<italic toggle="yes">icaABCD</italic>) expression; <italic toggle="yes">ica</italic> synthesizes biofilm matrix</td><td valign="top" align="left" rowspan="1" colspan="1">&#945;-hemolysin lyses erythrocytes; biofilm creates physical barrier</td><td valign="top" align="left" rowspan="1" colspan="1">Metabolic dormancy in biofilm niches; ROS resistance</td><td valign="top" align="left" rowspan="1" colspan="1">Skin necrosis; chronic implant infection</td><td valign="top" align="left" rowspan="1" colspan="1">Biofilm blocks phagocyte penetration; <italic toggle="yes">PVL</italic> lyses neutrophils</td><td valign="top" align="left" rowspan="1" colspan="1">Neutrophil-derived ROS upregulate <italic toggle="yes">ica</italic> expression</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b29-ijmm-56-05-05614" ref-type="bibr">29</xref>,<xref rid="b35-ijmm-56-05-05614" ref-type="bibr">35</xref>,<xref rid="b101-ijmm-56-05-05614" ref-type="bibr">101</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cheng <italic toggle="yes">et al</italic>, 2024; Gao <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Mycobacterium tuberculosis dosR/pks</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">dosR</italic> induces dormancy in hypoxia; <italic toggle="yes">pks</italic> synthesizes cell wall lipids, resisting degradation</td><td valign="top" align="left" rowspan="1" colspan="1">Inhibits phagolysosome fusion; alters antigen presentation</td><td valign="top" align="left" rowspan="1" colspan="1">Epigenetic silencing of host pro-inflammatory genes</td><td valign="top" align="left" rowspan="1" colspan="1">Granuloma formation; lung cavitation</td><td valign="top" align="left" rowspan="1" colspan="1">Dormancy avoids immune detection; wax D resists lysosomal enzymes</td><td valign="top" align="left" rowspan="1" colspan="1">IFN-&#947; suppresses <italic toggle="yes">dosR</italic>, reactivating infection</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>)</td></tr><tr><td colspan="9" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td colspan="9" valign="top" align="left" rowspan="1">B, Viruses</td></tr><tr><td colspan="9" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Addetia <italic toggle="yes">et al</italic>, 2023; Suzuki <italic toggle="yes">et al</italic>, 2022; Bdeir <italic toggle="yes">et al</italic>, 2025</td><td valign="top" align="left" rowspan="1" colspan="1">SARS-CoV-2 S/<italic toggle="yes">ORF3a</italic></td><td valign="top" align="left" rowspan="1" colspan="1">S protein (RBD) binds ACE2; <italic toggle="yes">ORF3a</italic> disrupts ion channels and induces apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">Membrane fusion enables viral entry; mitochondrial dysfunction</td><td valign="top" align="left" rowspan="1" colspan="1">ER stress; inflammasome activation</td><td valign="top" align="left" rowspan="1" colspan="1">Diffuse alveolar damage; multiorgan failure</td><td valign="top" align="left" rowspan="1" colspan="1">S mutation (such as &#959; N501Y) evade neutralizing antibodies</td><td valign="top" align="left" rowspan="1" colspan="1">Antibody pressure drives RBD antigenic evolution</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b131-ijmm-56-05-05614" ref-type="bibr">131</xref>,<xref rid="b133-ijmm-56-05-05614" ref-type="bibr">133</xref>)</td></tr><tr><td colspan="9" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ding <italic toggle="yes">et al</italic>, 2024; Lederhofer <italic toggle="yes">et al</italic>, 2024; Zhang <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">Influenza <italic toggle="yes">HA</italic>/<italic toggle="yes">PB2</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">HA</italic> mediates receptor binding; <italic toggle="yes">PB2</italic> mutations enhance polymerase activity in mammalian cells</td><td valign="top" align="left" rowspan="1" colspan="1">Receptor-mediated endocytosis</td><td valign="top" align="left" rowspan="1" colspan="1">Altered viral RNA synthesis kinetics</td><td valign="top" align="left" rowspan="1" colspan="1">Respiratory epithelial destruction; viral pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">HA1</italic> domain mutations cause antigenic drift</td><td valign="top" align="left" rowspan="1" colspan="1">Seasonal vaccine pressure selects <italic toggle="yes">HA</italic> mutants</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>,<xref rid="b137-ijmm-56-05-05614" ref-type="bibr">137</xref>, <xref rid="b140-ijmm-56-05-05614" ref-type="bibr">140</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhang <italic toggle="yes">et al</italic>, 2023; Fu <italic toggle="yes">et al</italic>, 2024; Li <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">HIV <italic toggle="yes">env/tat</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Env</italic> encodes gp120/gp41 for CD4<sup>+</sup> binding; <italic toggle="yes">tat</italic> transactivates viral transcription</td><td valign="top" align="left" rowspan="1" colspan="1">Membrane fusion; CD4<sup>+</sup> T cell depletion</td><td valign="top" align="left" rowspan="1" colspan="1">Disrupts NF-&#954;B signaling; inhibits DNA repair</td><td valign="top" align="left" rowspan="1" colspan="1">Lymphoid tissue destruction; AIDS progression</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Env</italic> hypermutation in V3 loop evades neutralizing antibodies</td><td valign="top" align="left" rowspan="1" colspan="1">CD8<sup>+</sup>/T cell pressure drives <italic toggle="yes">env</italic> diversification</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>,<xref rid="b43-ijmm-56-05-05614" ref-type="bibr">43</xref>,<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>)</td></tr><tr><td colspan="9" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td colspan="9" valign="top" align="left" rowspan="1">C, Fungi</td></tr><tr><td colspan="9" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liang <italic toggle="yes">et al</italic>, 2024; Zhang <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Candida albicans</italic> EFG1/<italic toggle="yes">SAP</italic></td><td valign="top" align="left" rowspan="1" colspan="1">EFG1 triggers hyphal transition at 37&#176;C; <italic toggle="yes">SAP</italic> proteases degrade host defensins</td><td valign="top" align="left" rowspan="1" colspan="1">Hyphal penetration of epithelial barriers</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Sap2-6</italic> degrade antimicrobial peptides in phagolysosomes</td><td valign="top" align="left" rowspan="1" colspan="1">Mucosal thrush; disseminated candidiasis</td><td valign="top" align="left" rowspan="1" colspan="1">Hyphae resist phagocytosis; cell wall mannan masking</td><td valign="top" align="left" rowspan="1" colspan="1">Macrophage ROS induce EFG1-mediated morphogenesis</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>,<xref rid="b57-ijmm-56-05-05614" ref-type="bibr">57</xref>)</td></tr><tr><td colspan="9" valign="bottom" align="left" rowspan="1">
<hr/></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Carrion <italic toggle="yes">et al</italic>, 2013; Hoang <italic toggle="yes">et al</italic>, 2022; Liu <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus RodA/SidA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">RodA</italic> mediates conidial adhesion; <italic toggle="yes">SidA</italic> acquires iron under hypoxia</td><td valign="top" align="left" rowspan="1" colspan="1">Epithelial damage; endothelial invasion</td><td valign="top" align="left" rowspan="1" colspan="1">HIF-1&#945;-mediated iron scavenging enhances survival</td><td valign="top" align="left" rowspan="1" colspan="1">Tissue-invasive aspergillosis; hemorrhagic necrosis</td><td valign="top" align="left" rowspan="1" colspan="1">Melanin shields antigens; gliotoxin induces immune cell apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">Hypoxia upregulates <italic toggle="yes">SidA</italic> via host epithelial HIF-1&#945;</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b61-ijmm-56-05-05614" ref-type="bibr">61</xref>,<xref rid="b69-ijmm-56-05-05614" ref-type="bibr">69</xref>,<xref rid="b70-ijmm-56-05-05614" ref-type="bibr">70</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Kim <italic toggle="yes">et al</italic>, 2019; Tian <italic toggle="yes">et al</italic>, 2024; Mu&#241;oz <italic toggle="yes">et al</italic>, 2018</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Candida auris ssa1</italic>/<italic toggle="yes">ERG11</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">ssa1</italic> (HSP90) enables thermotolerance; <italic toggle="yes">ERG11</italic> mutations confer azole resistance</td><td valign="top" align="left" rowspan="1" colspan="1">Enhanced biofilm formation on medical devices</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Ssa1</italic> stabilizes efflux pumps (<italic toggle="yes">CDR1</italic>); biofilm decreases drug penetration</td><td valign="top" align="left" rowspan="1" colspan="1">Persistent catheter-associated infection</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">HSP90</italic>-calcineurin axis promotes hyphal escape from phagolysosomes</td><td valign="top" align="left" rowspan="1" colspan="1">Neutrophil ROS activate the <italic toggle="yes">HSP90</italic>-calcineurin stress response</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b62-ijmm-56-05-05614" ref-type="bibr">62</xref>,<xref rid="b162-ijmm-56-05-05614" ref-type="bibr">162</xref>,<xref rid="b164-ijmm-56-05-05614" ref-type="bibr">164</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-ijmm-56-05-05614"><p>EPEC, enteropathogenic <italic toggle="yes">E. coli</italic>; <italic toggle="yes">esc</italic>, enteropathogenic secretion genes; <italic toggle="yes">eae</italic>, <italic toggle="yes">E. coli</italic> attaching and effacing; T3SS, type III secretion system; Tir, translocated intimin receptor; agr, accessory gene regulator; <italic toggle="yes">icaABCD</italic>, intracellular adhesion locus ABCD; <italic toggle="yes">hla</italic>, &#945;-hemolysin; ROS, reactive oxygen species; PVL, Panton-Valentine leukocidin; SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2; S mutations, Spike protein mutations; RBD, receptor-binding domain; <italic toggle="yes">ORF3a</italic>, Open Reading Frame 3a; ER, endoplasmic reticulum; <italic toggle="yes">HA</italic>, hemagglutinin; <italic toggle="yes">PB2</italic>, polymerase basic 2; HIV, human immunodeficiency virus; <italic toggle="yes">env</italic>, envelope gene; <italic toggle="yes">tat</italic>, transactivator of transcription; gp, glycoprotein; AIDS, acquired immune deficiency syndrome; Efg, enhanced filamentous growth protein; SAP, secreted aspartyl protease; <italic toggle="yes">RodA</italic>, rodlet protein A; <italic toggle="yes">SidA</italic>, siderophore biosynthesis enzyme A; <italic toggle="yes">ssa1</italic>, stress seventy subfamily A member 1; ERG, ergosterol biosynthesis gene; HSP, heat shock protein; CDR, Candida drug resistance; ACE2, angiotensin-converting enzyme 2; <italic toggle="yes">dosR</italic>, dormancy survival regulator; HIF-1&#945;, hypoxia-inducible factor 1&#945;; <italic toggle="yes">pks</italic>, polyketide synthase; <italic toggle="yes">S</italic>/<italic toggle="yes">ORF3a</italic>, spike protein/Open Reading Frame 3a.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tIII-ijmm-56-05-05614" orientation="portrait"><label>Table III</label><caption><p>Classification of virulence genes in bacteria.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" rowspan="1" colspan="1">Bacteria name</th><th valign="top" align="center" rowspan="1" colspan="1">Virulence gene</th><th valign="top" align="center" rowspan="1" colspan="1">Coding product</th><th valign="top" align="center" rowspan="1" colspan="1">Type of infection</th><th valign="top" align="center" rowspan="1" colspan="1">Functional role and pathogenic impact</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Ullah <italic toggle="yes">et al</italic>, 2023; Zhang <italic toggle="yes">et al</italic>, 2020</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Escherichia coli</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">fimH</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Type 1 fimbriae tip protein</td><td valign="top" align="left" rowspan="1" colspan="1">Urinary tract</td><td valign="top" align="left" rowspan="1" colspan="1">Binds mannose receptors on uroepithelialcells; colocalized with <italic toggle="yes">blaCTX-M</italic> on <italic toggle="yes">IncF</italic> plasmids in ESBL strains; expression regulated by gut microbiota SCFAs</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>,<xref rid="b88-ijmm-56-05-05614" ref-type="bibr">88</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ullah <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">papC</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">P pilus-associated protein</td><td valign="top" align="left" rowspan="1" colspan="1">Urinary tract</td><td valign="top" align="left" rowspan="1" colspan="1">Mediates bacterial adhesion to urethral epithelium via P-pili assembly; <italic toggle="yes">papC</italic> gene prevalence is significantly higher in ESBL-producing strains compared with non-ESBL-producing strains</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ullah <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">hlyA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">&#945;-hemolysin</td><td valign="top" align="left" rowspan="1" colspan="1">Bloodstream/tissue</td><td valign="top" align="left" rowspan="1" colspan="1">Forms pores in host cell membranes (erythrocytes/leukocytes), causing lysis and inflammation; higher prevalence in ESBL strains</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Yang <italic toggle="yes">et al</italic>, 2023; Watanabe <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">esc</italic> (<italic toggle="yes">T3SS</italic>)</td><td valign="top" align="left" rowspan="1" colspan="1">T3SS</td><td valign="top" align="left" rowspan="1" colspan="1">Enteric</td><td valign="top" align="left" rowspan="1" colspan="1">Forms molecular syringe to inject effectors (such as <italic toggle="yes">Tir</italic>) into intestinal cells, inducing actin pedestal formation and barrier disruption</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b27-ijmm-56-05-05614" ref-type="bibr">27</xref>,<xref rid="b94-ijmm-56-05-05614" ref-type="bibr">94</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Watanabe <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">eae</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Intimin adhesin</td><td valign="top" align="left" rowspan="1" colspan="1">Enteric</td><td valign="top" align="left" rowspan="1" colspan="1">Mediates tight attachment to epithelial cells, triggering cytoskeletal rearrangement</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b94-ijmm-56-05-05614" ref-type="bibr">94</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liu <italic toggle="yes">et al</italic>, 2020; Li <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">agr</italic> locus</td><td valign="top" align="left" rowspan="1" colspan="1">Quorum-sensing regulator</td><td valign="top" align="left" rowspan="1" colspan="1">Skin/soft tissue, pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Orchestrates virulence phase transition via quorum sensing; upregulates <italic toggle="yes">fnbA</italic>-mediated adhesion in early infection, then switches to <italic toggle="yes">hla</italic>/<italic toggle="yes">PVL</italic> toxin expression during proliferation; pharmacologically inhibited by savirin (a small-molecule agr quorum-sensing inhibitor)</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b98-ijmm-56-05-05614" ref-type="bibr">98</xref>,<xref rid="b101-ijmm-56-05-05614" ref-type="bibr">101</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Peng <italic toggle="yes">et al</italic>, 2022</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">icaABCD</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Exopolysaccharide synthase</td><td valign="top" align="left" rowspan="1" colspan="1">Medical device</td><td valign="top" align="left" rowspan="1" colspan="1">Synthesizes biofilm matrix; decreases antibiotic penetration and phagocytosis; upregulated by neutrophil ROS</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b35-ijmm-56-05-05614" ref-type="bibr">35</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Karimzadeh <italic toggle="yes">et al</italic>, 2022</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">nuc</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Thermostable nuclease</td><td valign="top" align="left" rowspan="1" colspan="1">Skin/bloodstream</td><td valign="top" align="left" rowspan="1" colspan="1">Maintains activity at high temperatures; key pathogenicity marker</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b107-ijmm-56-05-05614" ref-type="bibr">107</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Hodille <italic toggle="yes">et al</italic>, 2020</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">PVL</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Panton-Valentine leukocidin</td><td valign="top" align="left" rowspan="1" colspan="1">Necrotizing pneumonia</td><td valign="top" align="left" rowspan="1" colspan="1">Lyses leukocytes; co-integrated with <italic toggle="yes">SCCmec</italic> (<italic toggle="yes">mecA</italic>) in hypervirulent MRSA</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b109-ijmm-56-05-05614" ref-type="bibr">109</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Haghi <italic toggle="yes">et al</italic>, 2021</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">sea-see</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Enterotoxin</td><td valign="top" align="left" rowspan="1" colspan="1">Food poisoning</td><td valign="top" align="left" rowspan="1" colspan="1">Heat-stable; stimulates vomiting center, causing severe diarrhea</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b113-ijmm-56-05-05614" ref-type="bibr">113</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Speziale <italic toggle="yes">et al</italic>, 2020</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">fnbA/fnbB</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Fibronectin-binding protein</td><td valign="top" align="left" rowspan="1" colspan="1">Skin</td><td valign="top" align="left" rowspan="1" colspan="1">Mediates adhesion to extracellular matrix of skin tissue</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b24-ijmm-56-05-05614" ref-type="bibr">24</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Claes <italic toggle="yes">et al</italic>, 2017</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">coa/cal</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Coagulase</td><td valign="top" align="left" rowspan="1" colspan="1">Skin</td><td valign="top" align="left" rowspan="1" colspan="1">Promotes plasma coagulation to resist phagocytosis</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b25-ijmm-56-05-05614" ref-type="bibr">25</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cheng <italic toggle="yes">et al</italic>, 2024; Liu <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Mycobacterium tuberculosis</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">dosR</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Hypoxia-responsive regulator</td><td valign="top" align="left" rowspan="1" colspan="1">Latent/reactivated TB</td><td valign="top" align="left" rowspan="1" colspan="1">Induces dormancy in granuloma; silencing by host IFN-&#947; leads to reactivation and ESAT-6 release</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b30-ijmm-56-05-05614" ref-type="bibr">30</xref>,<xref rid="b34-ijmm-56-05-05614" ref-type="bibr">34</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pei <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">rpoB</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">RNA polymerase &#946;-subunit</td><td valign="top" align="left" rowspan="1" colspan="1">Drug-resistant TB</td><td valign="top" align="left" rowspan="1" colspan="1">Mutations confer rifampicin resistance and alter global virulence gene expression</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b85-ijmm-56-05-05614" ref-type="bibr">85</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gao <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">pks</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Polyketide synthase</td><td valign="top" align="left" rowspan="1" colspan="1">Active TB</td><td valign="top" align="left" rowspan="1" colspan="1">Synthesizes wax D for cell wall integrity, resisting lysosomal degradation</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b31-ijmm-56-05-05614" ref-type="bibr">31</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Takahashi-Kanemitsu <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Helicobacter pylori</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">cagA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Cytotoxin-associated protein</td><td valign="top" align="left" rowspan="1" colspan="1">Gastric ulcer/cancer</td><td valign="top" align="left" rowspan="1" colspan="1">Injected via T4SS, disrupts cell polarity and promotes precancerous lesions</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b117-ijmm-56-05-05614" ref-type="bibr">117</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Son <italic toggle="yes">et al</italic>, 2025</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">vacA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Vacuolating cytotoxin</td><td valign="top" align="left" rowspan="1" colspan="1">Gastric</td><td valign="top" align="left" rowspan="1" colspan="1">AB toxin induces mitochondrial apoptosis; s1/m1 subtype more virulent</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b118-ijmm-56-05-05614" ref-type="bibr">118</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sedaghat <italic toggle="yes">et al</italic>, 2014</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">iceA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Inducible catalase</td><td valign="top" align="left" rowspan="1" colspan="1">Gastric colonization</td><td valign="top" align="left" rowspan="1" colspan="1">Associated with gastric mucosal colonization and inflammation</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b120-ijmm-56-05-05614" ref-type="bibr">120</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sedaghat <italic toggle="yes">et al</italic>, 2014</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">oipA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Outer membrane inflammatory protein</td><td valign="top" align="left" rowspan="1" colspan="1">Gastric disease</td><td valign="top" align="left" rowspan="1" colspan="1">Modulates bacteria-host cell interaction and immune regulation</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b120-ijmm-56-05-05614" ref-type="bibr">120</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sedaghat <italic toggle="yes">et al</italic>, 2014</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">babA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Blood group antigen-binding adhesin</td><td valign="top" align="left" rowspan="1" colspan="1">Gastric colonization</td><td valign="top" align="left" rowspan="1" colspan="1">Mediates binding to blood group antigens on gastric epithelium</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b120-ijmm-56-05-05614" ref-type="bibr">120</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Song <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">iucA</italic> (hvKP)</td><td valign="top" align="left" rowspan="1" colspan="1">Aerobactin siderophore</td><td valign="top" align="left" rowspan="1" colspan="1">Liver/lung abscesses</td><td valign="top" align="left" rowspan="1" colspan="1">Enhances iron acquisition in iron-limited host environments</td><td valign="top" align="center" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Song <italic toggle="yes">et al</italic>, 2024; Jiang <italic toggle="yes">et al</italic>, 2025</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">rmpA</italic> (hvKP)</td><td valign="top" align="left" rowspan="1" colspan="1">Mucoid phenotype regulator</td><td valign="top" align="left" rowspan="1" colspan="1">Invasive</td><td valign="top" align="left" rowspan="1" colspan="1">Upregulates capsular polysaccharide for hypermucoviscosity and antiphagocytic activity</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b9-ijmm-56-05-05614" ref-type="bibr">9</xref>,<xref rid="b13-ijmm-56-05-05614" ref-type="bibr">13</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Song <italic toggle="yes">et al</italic>, 2024; Jiang <italic toggle="yes">et al</italic>, 2025</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">blaKPC</italic> (CRKP)</td><td valign="top" align="left" rowspan="1" colspan="1">KPC carbapenemase</td><td valign="top" align="left" rowspan="1" colspan="1">Hospital-acquired</td><td valign="top" align="left" rowspan="1" colspan="1">Co-localized with <italic toggle="yes">rmpA</italic> on <italic toggle="yes">pLVPK</italic> plasmid in hypervirulent-resistant strains; driven by ICU antibiotic pressure</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b9-ijmm-56-05-05614" ref-type="bibr">9</xref>,<xref rid="b13-ijmm-56-05-05614" ref-type="bibr">13</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhang <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">blaCTX-M</italic> (cKP)</td><td valign="top" align="left" rowspan="1" colspan="1">ESBL enzyme</td><td valign="top" align="left" rowspan="1" colspan="1">Opportunistic</td><td valign="top" align="left" rowspan="1" colspan="1">Confers resistance to &#946;-lactam antibiotics in classical strains</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b10-ijmm-56-05-05614" ref-type="bibr">10</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn3-ijmm-56-05-05614"><p><italic toggle="yes">fimH</italic>, fimbrial adhesion H gene; <italic toggle="yes">blaCTX-M</italic>, cefotaxime-Munich &#946;-lactamase; IncF, incompatibility group F plasmid; ESBL, extended-spectrum &#946;-lactamase; SCFA, short-chain fatty acids; <italic toggle="yes">papC</italic>, pyelonephritis-associated pilus assembly protein C; <italic toggle="yes">hlyA</italic>, &#945;-hemolysin gene; <italic toggle="yes">esc</italic>, enteropathogenic secretion genes; T3SS, type III secretion system; Tir, translocated intimin receptor; <italic toggle="yes">eae</italic>, <italic toggle="yes">E. coli</italic> attaching and effacing gene; agr, accessory gene regulator; fnb, fibronectin-binding protein; <italic toggle="yes">PVL</italic>, Panton-Valentine leukocidin; <italic toggle="yes">hla</italic>, &#945;-hemolysin; <italic toggle="yes">icaABCD</italic>, intracellular adhesion locus ABCD; SCCmec, staphylococcal cassette chromosome mec; <italic toggle="yes">nuc</italic>, staphylococcal thermonuclease; mecA, methicillin resistance determinant A; MRSA, methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic>; <italic toggle="yes">sea</italic>-<italic toggle="yes">see</italic>, staphylococcal enterotoxins A-E; <italic toggle="yes">coa</italic>/<italic toggle="yes">cal</italic>, coagulase/coagulase-like protein; <italic toggle="yes">dosR</italic>, dormancy survival regulator; TB, tuberculosis; <italic toggle="yes">rpoB</italic>, RNA polymerase &#946;-subunit; <italic toggle="yes">pks</italic>, polyketide synthase; <italic toggle="yes">cagA</italic>, polyketide synthase; <italic toggle="yes">vacA</italic>, vacuolating cytotoxin gene A; AB, A subunit (active) + B subunit (binding); <italic toggle="yes">iceA</italic>, inducible catalase; <italic toggle="yes">oipA</italic>, outer membrane inflammatory protein; <italic toggle="yes">babA</italic>, blood group antigen-binding adhesin; <italic toggle="yes">iucA</italic>, aerobactin synthesis gene; hvKP, hypervirulent <italic toggle="yes">K. pneumoniae</italic>; <italic toggle="yes">rmpA</italic>, regulator of mucoid phenotype A; <italic toggle="yes">blaKPC</italic>, <italic toggle="yes">K. pneumoniae</italic> carbapenemase; CRKP, carbapenem-resistant <italic toggle="yes">K. pneumoniae</italic>; cKP, classical <italic toggle="yes">K. pneumoniae</italic>; ICU, intensive care unit; ESAT-6, early secreted antigenic target 6 kDa; pLVPK, plasmid for <italic toggle="yes">K. pneumoniae</italic> virulence; ROS, reactive oxygen species; T4SS, type IV secretion system.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tIV-ijmm-56-05-05614" orientation="portrait"><label>Table IV</label><caption><p>Classification of virulence genes in viral pathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" rowspan="1" colspan="1">Viral pathogen</th><th valign="top" align="center" rowspan="1" colspan="1">Virulence gene</th><th valign="top" align="center" rowspan="1" colspan="1">Coding product</th><th valign="top" align="center" rowspan="1" colspan="1">Type of infection</th><th valign="top" align="center" rowspan="1" colspan="1">Pathogenic mechanism</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Addetia <italic toggle="yes">et al</italic>, 2023; Xu <italic toggle="yes">et al</italic>, 2022; Suzuki <italic toggle="yes">et al</italic>, 2022; Uriu <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">SARS-CoV-2</td><td valign="top" align="left" rowspan="1" colspan="1">Spike protein</td><td valign="top" align="left" rowspan="1" colspan="1">Trimeric spike glycoprotein</td><td valign="top" align="left" rowspan="1" colspan="1">COVID-19</td><td valign="top" align="left" rowspan="1" colspan="1">Mediates viral entry by binding ACE2 receptors through receptor-binding domain; key mutations (such as <italic toggle="yes">N501Y</italic> in &#959; variants) enhance ACE2 binding affinity; ACE2 dysregulation contributes to extrapulmonary complications, including acute respiratory distress syndrome; continuous antigenic drift enables pandemic persistence</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b19-ijmm-56-05-05614" ref-type="bibr">19</xref>,<xref rid="b130-ijmm-56-05-05614" ref-type="bibr">130</xref>-<xref rid="b132-ijmm-56-05-05614" ref-type="bibr">132</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Su <italic toggle="yes">et al</italic>, 2023; Miao <italic toggle="yes">et al</italic>, 2021</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">ORF3a</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">ORF3a ion channel protein</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Induces NLRP3 inflammasome activation, disrupts intracellular ion homeostasis and triggers apoptosis; upregulated in patients with severe COVID-19, associated with cytokine storm severity and thrombotic complications</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b134-ijmm-56-05-05614" ref-type="bibr">134</xref>,<xref rid="b135-ijmm-56-05-05614" ref-type="bibr">135</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chauhan <italic toggle="yes">et al</italic>, 2022; Luo <italic toggle="yes">et al</italic>, 2024; Ding <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">Influenza A virus</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">HA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">HA</td><td valign="top" align="left" rowspan="1" colspan="1">Influenza</td><td valign="top" align="left" rowspan="1" colspan="1">Facilitates viral attachment to sialic acid receptors; antigenic drift (such as mutations in <italic toggle="yes">H3N2</italic> HA1 domain) alters antibody epitopes, enabling immune evasion and decreasing vaccine efficacy; directly contributes to endothelial damage in severe pneumonia</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b37-ijmm-56-05-05614" ref-type="bibr">37</xref>,<xref rid="b46-ijmm-56-05-05614" ref-type="bibr">46</xref>, <xref rid="b53-ijmm-56-05-05614" ref-type="bibr">53</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lederhofer <italic toggle="yes">et al</italic>, 2024; Wang <italic toggle="yes">et al</italic>, 2024; Liao <italic toggle="yes">et al</italic>, 2017</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Neuraminidase</td><td valign="top" align="left" rowspan="1" colspan="1">Neuraminidase</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Cleaves sialic acid residues to release progeny virions; mutations in avian strains (such as <italic toggle="yes">H5N1</italic> and <italic toggle="yes">H7N9</italic>) enhance enzymatic efficiency and zoonotic adaptation</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b137-ijmm-56-05-05614" ref-type="bibr">137</xref>-<xref rid="b139-ijmm-56-05-05614" ref-type="bibr">139</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhang <italic toggle="yes">et al</italic>, 2024; G&#252;nl <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Polymerase genes <italic toggle="yes">(PB1</italic>, <italic toggle="yes">PB2</italic> and <italic toggle="yes">PA)</italic></td><td valign="top" align="left" rowspan="1" colspan="1">RNA-dependent RNA polymerase complex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Governs viral genome replication; <italic toggle="yes">PB2</italic> mutations (such as E627K) enhance polymerase activity in mammalian cells; key for pathogenicity in pandemic strains (such as 2009 <italic toggle="yes">H1N1</italic>)</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b140-ijmm-56-05-05614" ref-type="bibr">140</xref>,<xref rid="b141-ijmm-56-05-05614" ref-type="bibr">141</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhang <italic toggle="yes">et al</italic>, 2023; Xie <italic toggle="yes">et al</italic>, 2024; Fu <italic toggle="yes">et al</italic>, 2024; Bennett <italic toggle="yes">et al</italic>, 2021 Qian <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">HIV</td><td valign="top" align="center" rowspan="1" colspan="1">
<italic toggle="yes">env</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Envelope gp120/gp41</td><td valign="top" align="left" rowspan="1" colspan="1">AIDS</td><td valign="top" align="left" rowspan="1" colspan="1">gp120 binds CD4<sup>+</sup>/CCR5<sup>+</sup> T cells via V3 loop; rapid glycosylation changes in hypervariable regions enable immune evasion; primary driver of cell-to-cell transmission</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b41-ijmm-56-05-05614" ref-type="bibr">41</xref>-<xref rid="b45-ijmm-56-05-05614" ref-type="bibr">45</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Emert-Sedlak <italic toggle="yes">et al</italic>, 2024; Li <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">
<italic toggle="yes">tat</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Tat</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Enhances viral transcription via TAR RNA binding; induces bystander cell apoptosis and CD8<sup>+</sup> T cell exhaustion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>,<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fu <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">
<italic toggle="yes">rev</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Rev</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Enables nuclear export of unspliced viral RNA; maintains latent reservoirs by suppressing immunogenic protein expression</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b43-ijmm-56-05-05614" ref-type="bibr">43</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Emert-Sedlak <italic toggle="yes">et al</italic>, 2024; Li <italic toggle="yes">et al</italic>, 2024; Biradar <italic toggle="yes">et al</italic>, 2024; Schenck <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">
<italic toggle="yes">nef</italic>
</td><td valign="top" align="center" rowspan="1" colspan="1">Nef</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Downregulates MHC-I and CD4 via clathrin-mediated endocytosis; enhances virion infectivity and promotes immune evasion</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b38-ijmm-56-05-05614" ref-type="bibr">38</xref>,<xref rid="b52-ijmm-56-05-05614" ref-type="bibr">52</xref>,<xref rid="b143-ijmm-56-05-05614" ref-type="bibr">143</xref>, <xref rid="b144-ijmm-56-05-05614" ref-type="bibr">144</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn4-ijmm-56-05-05614"><p>SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2; COVID, Coronavirus disease 2019; ACE2, angiotensin-converting enzyme 2; <italic toggle="yes">ORF3a</italic>, Open Reading Frame 3a; <italic toggle="yes">HA</italic>, hemagglutinin; PB, polymerase basic; PA, polymerase acidic; HIV, human immunodeficiency virus; <italic toggle="yes">env</italic>, envelope gene; gp, glycoprotein; AIDS, acquired immune deficiency syndrome; <italic toggle="yes">tat</italic>, transactivator of transcription; TAR, Trans-activation response element; <italic toggle="yes">rev</italic>, regulator of expression of virion proteins; <italic toggle="yes">nef</italic>, negative regulatory factor; MHC-I, major histocompatibility complex class I; CCR, C-C chemokine receptor; NLRP3, NACHT, LRR and PYD domains-containing protein 3.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tV-ijmm-56-05-05614" orientation="portrait"><label>Table V</label><caption><p>Classification of virulence genes in fungal pathogens.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Author/s, year</th><th valign="top" align="center" rowspan="1" colspan="1">Fungal pathogen</th><th valign="top" align="center" rowspan="1" colspan="1">Virulence gene</th><th valign="top" align="center" rowspan="1" colspan="1">Coding product</th><th valign="top" align="center" rowspan="1" colspan="1">Type of infection</th><th valign="top" align="center" rowspan="1" colspan="1">Pathogenic mechanism</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Glazier, 2022; Liang <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Candida albicans</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">EFG1</td><td valign="top" align="left" rowspan="1" colspan="1">Transcription factor</td><td valign="top" align="left" rowspan="1" colspan="1">Superficial/deep infection in immunocompromised hosts</td><td valign="top" align="left" rowspan="1" colspan="1">Master regulator of yeast-to-hyphal transition at body temperature; binds promoters of hyphal-specific genes (<italic toggle="yes">HWP1</italic> and <italic toggle="yes">ALS3</italic>); hyphae penetrate epithelial barriers and secrete <italic toggle="yes">SAP</italic>; in response to macrophage-derived ROS), EFG1 activates hyphal morphogenesis coupled with <italic toggle="yes">Sap2</italic>-<italic toggle="yes">6</italic> secretion to degrade antimicrobial peptides</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b16-ijmm-56-05-05614" ref-type="bibr">16</xref>,<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lin <italic toggle="yes">et al</italic>, 2023; Naglik <italic toggle="yes">et al</italic>, 2003</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Sap2</italic>-<italic toggle="yes">Sap6</italic></td><td valign="top" align="left" rowspan="1" colspan="1">SAP</td><td valign="top" align="left" rowspan="1" colspan="1">Mucosal and systemic</td><td valign="top" align="left" rowspan="1" colspan="1">Degrade host immunoglobulin, complement components and antimicrobial peptides; upregulated during mucosal invasion; <italic toggle="yes">SAP5</italic> cleaves E-cadherin, disrupting epithelial barriers</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b55-ijmm-56-05-05614" ref-type="bibr">55</xref>,<xref rid="b154-ijmm-56-05-05614" ref-type="bibr">154</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Nobile <italic toggle="yes">et al</italic>, 2006; Nobile and Mitchell, 2005</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Bcr1</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Biofilm regulator</td><td valign="top" align="left" rowspan="1" colspan="1">Catheter-associated</td><td valign="top" align="left" rowspan="1" colspan="1">Upregulates exopolysaccharide synthesis genes (<italic toggle="yes">ALS1</italic> and <italic toggle="yes">ALS3</italic>) for biofilm matrix formation; biofilms decrease antifungal penetration efficiency and are associated with persistent infection; cooperates with <italic toggle="yes">Cph1</italic> in adhesion maintenance</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b63-ijmm-56-05-05614" ref-type="bibr">63</xref>,<xref rid="b158-ijmm-56-05-05614" ref-type="bibr">158</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liang <italic toggle="yes">et al</italic>, 2024; Zhang <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">HWP1</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Hyphal wall protein</td><td valign="top" align="left" rowspan="1" colspan="1">Mucosal colonization</td><td valign="top" align="left" rowspan="1" colspan="1">Mediates adhesion to epithelial cells via covalent cross-linking to host transglutaminase; essential for tissue penetration and resistance to mechanical clearance</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b54-ijmm-56-05-05614" ref-type="bibr">54</xref>,<xref rid="b57-ijmm-56-05-05614" ref-type="bibr">57</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Latg&#233; and Chamilos, 2019; Fr&#233;alle <italic toggle="yes">et al</italic>, 2013</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Aspergillus fumigatus</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">chs</italic> (<italic toggle="yes">chsA-G</italic>)</td><td valign="top" align="left" rowspan="1" colspan="1">Chitin synthase</td><td valign="top" align="left" rowspan="1" colspan="1">Invasive aspergillosis</td><td valign="top" align="left" rowspan="1" colspan="1">Upregulated at human body temperature for cell wall thickening; chitin layers resist lysosomal degradation in macrophages; mutants show decreased virulence in infection models</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b159-ijmm-56-05-05614" ref-type="bibr">159</xref>,<xref rid="b160-ijmm-56-05-05614" ref-type="bibr">160</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liu <italic toggle="yes">et al</italic>, 2023; Lupt&#225;kov&#225; <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">SidA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Siderophore synthase</td><td valign="top" align="left" rowspan="1" colspan="1">Pulmonary</td><td valign="top" align="left" rowspan="1" colspan="1">Synthesizes fusarinine C for iron acquisition; hypoxia-inducible via host HIF-1&#945; signaling; critical for growth in iron-limited lung environments</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b70-ijmm-56-05-05614" ref-type="bibr">70</xref>,<xref rid="b71-ijmm-56-05-05614" ref-type="bibr">71</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Carrion Sde, 2013</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">RodA</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Hydrophobin</td><td valign="top" align="left" rowspan="1" colspan="1">Respiratory adhesion</td><td valign="top" align="left" rowspan="1" colspan="1">Coats conidia to mediate adhesion to pulmonary epithelial cells; masks &#946;-glucan to decrease immune recognition; deletion increases phagocytosis efficiency</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b61-ijmm-56-05-05614" ref-type="bibr">61</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn5-ijmm-56-05-05614"><p>EFG, enhanced filamentous growth protein; HWP, hyphal wall protein; ALS, agglutinin-like sequence; SAP, secreted aspartyl protease; BCR, biofilm and cell wall regulator; CPH, Cyanobacterial phytochrome; chs, chitin synthase; <italic toggle="yes">SidA</italic>, siderophore biosynthesis enzyme A; HIF, hypoxia-inducible factor; <italic toggle="yes">RodA</italic>, rodlet protein A; ROS, reactive oxygen species.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tVI-ijmm-56-05-05614" orientation="portrait"><label>Table VI</label><caption><p>Mechanistic association between virulence genes and drug resistance.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Authors, year</th><th valign="top" align="center" rowspan="1" colspan="1">Strategy type</th><th valign="top" align="center" rowspan="1" colspan="1">Study type</th><th valign="top" align="center" rowspan="1" colspan="1">Pathogen</th><th valign="top" align="center" rowspan="1" colspan="1">Genetic or molecular target</th><th valign="top" align="center" rowspan="1" colspan="1">Key findings</th><th valign="top" align="center" rowspan="1" colspan="1">(Refs.)</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Ullah <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Horizontal gene transfer</td><td valign="top" align="left" rowspan="1" colspan="1">Clinical isolate-based study of hospital-acquired infections</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Klebsiella pneumoniae</italic></td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">IncF</italic> plasmid carrying carbapenemase resistance, adhesin (<italic toggle="yes">fimH</italic>) and iron uptake system gene</td><td valign="top" align="left" rowspan="1" colspan="1">Plasmid-mediated horizontal transfer contributes to coexistence of drug resistance and virulence, complicating treatment</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b5-ijmm-56-05-05614" ref-type="bibr">5</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Ji <italic toggle="yes">et al</italic>, 2022</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Transposon-mediated resistance-virulence co-transfer study</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Staphylococcus aureus</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Tn554</italic> transposon with erythromycin resistance (<italic toggle="yes">erm</italic>) and exfoliative toxin gene (<italic toggle="yes">etb</italic>)</td><td valign="top" align="left" rowspan="1" colspan="1">Transposon movement leads to spread of resistance and enhanced virulence, increasing the difficulty of treating infection</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b75-ijmm-56-05-05614" ref-type="bibr">75</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhang <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Biofilm formation</td><td valign="top" align="left" rowspan="1" colspan="1">Biofilm-associated chronic lung infection model</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas aeruginosa</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1"><italic toggle="yes">Pel</italic> and <italic toggle="yes">Psl</italic> genes regulating biofilm formation</td><td valign="top" align="left" rowspan="1" colspan="1">Activation of these genes results in biofilm formation, which decreases drug penetration and enhances drug resistance, causing chronic infection</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Goldsmith <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1">Targeted drug development</td><td valign="top" align="left" rowspan="1" colspan="1">Structure-based antitoxin drug development</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Clostridium difficile</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Toxins A (<italic toggle="yes">TcdA</italic>) and B (<italic toggle="yes">TcdB</italic>)</td><td valign="top" align="left" rowspan="1" colspan="1">Structural analysis led to the design of a small molecule inhibitor that blocks toxin binding</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b178-ijmm-56-05-05614" ref-type="bibr">178</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mangal <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Anti-adhesin peptide development for colonization prevention</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus pneumoniae</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Adhesin</td><td valign="top" align="left" rowspan="1" colspan="1">Peptide drugs competitively bind adhesin key sites</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b179-ijmm-56-05-05614" ref-type="bibr">179</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gao <italic toggle="yes">et al</italic>, 2024</td><td valign="top" align="left" rowspan="1" colspan="1">Combination therapy</td><td valign="top" align="left" rowspan="1" colspan="1">Combination therapy with anti-virulence peptides</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Helicobacter pylori</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Amoxicillin combined with anti-virulence peptide</td><td valign="top" align="left" rowspan="1" colspan="1">Combination therapy increases eradication rate compared with single antibiotic use</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b183-ijmm-56-05-05614" ref-type="bibr">183</xref>)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zhang <italic toggle="yes">et al</italic>, 2023</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">Enzyme-antibiotic combination therapy for biofilm infection</td><td valign="top" align="left" rowspan="1" colspan="1">
<italic toggle="yes">Pseudomonas aeruginosa</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">Tobramycin and specific biological enzyme preparation</td><td valign="top" align="left" rowspan="1" colspan="1">Combination therapy enhances bacterial clearance rate</td><td valign="top" align="center" rowspan="1" colspan="1">(<xref rid="b72-ijmm-56-05-05614" ref-type="bibr">72</xref>)</td></tr></tbody></table><table-wrap-foot><fn id="tfn6-ijmm-56-05-05614"><p>IncF, incompatibility group F plasmid; <italic toggle="yes">fimH</italic>, fimbrial adhesion H gene; Tn554, transposon 554; erm, erythromycin resistance methylase; etb, erythromycin resistance methylase; Pel, Pel polysaccharide synthesis locus; Psl, Pseudomonas surface polysaccharide locus; Tcd, toxin of <italic toggle="yes">Clostridioides difficile</italic>.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>